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ABSTRACT
The aim of this study was to elucidate the effect of type I collagen degradation 
by a physiological enzyme on cell-coUagen interactions. Type I collagen is 
degraded in vivo by collagenases, which are members of the matrix 
metalloproteinase family of enzymes. The ability of HT1080 cells, which 
express the major cell-surface collagen receptor (X2P1 integrin, to attach to and 
invade through coUagenase-cleaved collagen was investigated in cell attachment 
and invasion assays in comparison with the intact molecule.
Binding studies of purified, platelet «2Pi integrin, and of ligand-binding A 
domain of this integrin to native collagen and to purified 3/4 and 1/4 fragments 
of collagen, generated by collagenase-3 revealed the necessity for retention of 
the triple-helical conformation of the collagen fragments for a 2pi integrin 
binding. HT1080 cell attachment to type I collagen was o2Pl integrin-mediated, 
and coUagenase-cleavage of type I collagen perturbed cell attachment via this 
integrin at physiological temperature. This is likely to be due to melting of the 
collagen fragments, destabilizing of the triple-helical conformation of type I 
collagen and the resultant loss of 02pi integrin binding sites on the collagen 
molecules. However, cell attachment to the native collagen fragments was still 
possible at room temperature, indicating that coUagenase does not destroy 02pi 
integrin binding sites on type I collagen, and that attachment can occur below 
physiological temperature.
HT1080 cell invasion assays through equivalent molar concentrations of native 
type I collagen and the 3/4 and 1/4 fragments of collagen revealed that HT 1080 
cell invasion through both collagen fragments was significantly greater relative 
to cell invasion through native collagen. These results may reflect the decreased 
adhesion to heat-unwound collagen fragments seen in attachment assays.
CoUagenase degradation of type I collagen significantly alters «2Pl integrin- 
mediated cell interactions with collagen, and also results in increased cell 
invasion through the degraded substrate. Matrix metalloproteinases may thus 
have an important role in ceU-coUagen interactions during tumour invasion and 
metastasis, where upregulation of matrix metaUoproteinase synthesis by tumour 
and stromal cells is often observed.
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Chapter 1 
Introduction
(i) Structure of the Extracellular Matrix
Extracellular matrix proteins such as the laminins, nidogen (entactin), type IV collagen, 
osteonectin (SPARC, BM-40) and heparan sulphate proteoglycans are primarily 
secreted by epithelial cells and assimilate in vivo into a complex, insoluble, 
macromolecular meshwork structure called the basement membrane (BM; reviewed by 
Mosher et al., 1992; Yurchenco and O'Rear, 1993; Timpl and Brown, 1994). The 
connective tissue stroma, which underlies the basement membrane in many tissues is 
primarily composed of a latticework of type I collagen fibres and fibronectin, secreted 
by connective tissue cells. Small proteoglycans such as decorin are also present in the 
stroma, in association with coUagen fibrils (reviewed by Scott, 1995). The exact 
mechanism by which the basement membrane becomes linked to the underlying 
connective tissue is not known, however, mouse mammary epitheUal cells have been 
demonstrated to produce heparan sulphate proteoglycans which bind to type I coUagen 
and become stably associated with coUagen fibrils (Koda and Bemfield, 1984).
(ii) Some Principal Extracellular Matrix Molecules
(a) The Laminins
The first laminin was isolated from the Engelbreth-Holm-Swarm (EHS) tumour. Since 
then many other tissue-specific laminin isoforms have been identified, reviewed by 
Paulsson. (1993). Laminins are characterized by their domain structure; one heavy (A 
or a )  chain and two light (B1 or P, and B2 or y) chains. These are generally arranged 
into cross-shaped molecules, in which the N-terminal regions of the three domains form
1
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the short arms of the cross and the bulk of the three domains associate together into the 
long arm of the cross (reviewed by Engel, 1993; Timpl and Brown, 1994). Laminins 
self-assemble into large networks which interact with many other constituents of the 
ECM, for instance nidogen, thereby providing a structural basis for basement 
membrane assembly.
(b) Type IV Collagen
There are six known varieties of type IV collagen a-chains, a l - a 6 . Monomers of type 
rv  collagen are composed of a tissue-specific combination of three a-chains wound into 
a triple helix. The a-chains possess multiple interruptions in their triple helix 
conformation, resulting in highly flexible fibrils. Monomers of type IV collagen 
aggregate into fibrils which assimilate into an insoluble meshwork. The C-terminal 
domain of the type IV collagen chains which is globular in structure (the NCI domain), 
and the N-terminal domain (7S domain) which is rich in cysteines and lysines, are 
thought to play a major role in type IV collagen molecule polymerisation. Lateral 
association of type IV collagen monomers via their triple-helical domains is also 
possible (reviewed by Kuhn, 1995). Cross hnking of collagen IV fibrils contributes to 
formation of a stable, nonreversible scaffolding for basement membranes.
(c) Proteoglycans
Proteoglycans are proteins which have one or more attached glycosaminoglycan side 
chains which are covalently bound to the core protein. The glycosaminoglycans side 
chains are composed of either chondroitin sulphate, dermatan sulphate, keratan sulphate 
or heparan sulphate. Many proteoglycans, such as aggrecan and betaglycan, carry more 
than one type of side chain (reviewed by Hardingham and Fosang, 1992). Chondroitin 
sulphate proteoglycans found in mammals (such as aggrecan, decorin and biglycan) are 
most abundant in cartilage and are essential for distributing load in weight-bearing
joints. Of the heparan sulphate proteoglycans, perlecan is the most predominant and 
well characterized (reviewed by Noonan and Hassell, 1993) and is the principal 
proteoglycan found in basement membranes.
Proteoglycans are found both in the extracellular matrix, and on the cell-surface 
(discussed later in this chapter). The role of the extracellular matrix proteoglycans is still 
under investigation, however, several aspects of their function has been elucidated. The 
principal physical properties of the negatively charged glycosammoglycan side chains is 
that they act as water attractants, and also exclude macromolecules from the matrix 
whilst remaining permeable to smaller soluble molecules. Thus ECM proteoglycans 
keep the matrix hydrated and may concentrate extracellular macromolecules or act as a 
molecular "sieve". Proteoglycans bind to each other and to other ECM components and 
cell-surface molecules such as type IV collagen and heparan sulphate. The structural 
role of proteoglycans in basement membrane is thought to be that of linking and filling 
molecules, binding the laminin and type IV collagen networks together and 
interweaving the gaps in the meshwork structure. Proteoglycans such as decorin may 
also have a role in ECM organization, by binding to coliagens type I and II and 
modulating collagen fibril formation (reviewed by Hardingham and Fosang, 1992).
(d) Type I Collagen
Type I collagen is a member of the fibrillar collagen familiy, and is one of the most 
abundant components of the ECM in many tissues. It is particularly abundant in skin, 
tendons, ligaments, uterus, large blood vessels and bone, which all require high tensile 
strength without loss of flexibility. Fibrillar coliagens (types I, II and HI) consist of 
three polypeptide chains (a-chains) that are coiled into a semirigid helical structure. 
Type I collagen is composed of two a l ( l )  chains and one a2 (l) chain (fig.1.1). These 
chains are very similar but are the products of two separate genes located on the human 
chromosomes 17 and 7 respectively (reviewed by Chu and Prockop, 1993) The a
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chains each contain just over 1,000  amino acids and have molecular weights of 
approximately 95,000 kDa. Thirty three percent of the amino acid residues of fibrillar 
coliagens (including type I collagen) are glycines, and these are arranged at every third 
residue to give rise to a polymer of tripeptide units, -Gly-X-Y-. This repeating 
tripeptide sequence is critical for triple-helix formation, and imparts structural integrity 
to collagen fibrils. Some flexibility is conferred by the imino acid composition of the 
helix tripeptides, Gly-Pro-Hyp being much more rigid than Gly-Pro-Y or Gly-X-Hyp. 
The C-terminal end of the triple-helical domain of the a l(I)  and o2(I) chains contains a 
fivefold repeat of the Gly-Pro-Hyp triplet which forms a very stable region during 
triple-helix formation at this potentially weak point of the molecule. The triple-rhelical 
conformation occurs throughout 95% of the length of the rod-like monomer, leaving a 
few N-terminal and C-terminal residues (telopeptides) in a less rigid conformation.
Type I procollagen a-chains are translated with an N-terminal signal peptide sequence. 
This signal peptide is proteolytically removed when the proa-chains reach the 
endoplasmic reticulum (ER). Following entry into the ER, type I collagen proa-chains 
undergo extensive post-translational modification, including hydroxylation, 
glycosylation and triple-helix assembly. ProHne and lysine residues in the -Y- position 
o f the -Gly-X-Y- triplets are hydroT^ated by ^ed fic  hydroxylases (reviewed by Kiehy 
et aL, 1993).. All three
hydroxylating enzymes require the collagen peptide chains to be in the non-helical 
conformation, therefore, hydroxylation must occur before triple-helix formation of the 
proa-chains. Hydroxylation of these specific proline residues directly
contributes to folding and stabilization of the procollagen a-chains into triple-helical 
molecules. Hydroxylated lysine (hydroxylysine) residues are further modified in the ER 
by glycosylation. This is achieved by a glucosyl- and a galactosyl-transferase enzyme, 
and the resulting glycosylation of procolagen a-chains is thought to facilitate fibril 
organization. Association of the procollagen a-chains occurs initially via residues 
within the C-terminal region of the peptides and is stabilized by disulphide bond
.y:
formation. The initial interaction of proa-chains allows propagation of triple helix 
folding, prior to procollagen secretion via the Golgi apparatus into the extracellular 
space.
Specific extracellular metalloproteinases (procollagen N-proteinase and procollagen C- 
proteinase) process procollagen to the mature form by removal of the globular N and C- 
terminal propeptide domains (reviewed by Kielty et al., 1993). The resulting molecules 
are primarily triple-helical, rod shaped proteins which spontaneously aggregate into 
homo- and heterotypic fibrils (reviewed by Kiihn, 1987; Kielty et al., 1993; Brodsky 
and Ramshaw, 1997). These fibrils become crossed-linked from within and between 
the collagen molecules, which serves to stabilize and strengthen the collagen lattice. The 
cross-linked collagen fibrils are arranged into quarter-staggered arrays and organised 
according to their tissue type (e.g. parallel bundles in tendon; partially oriented coarse 
network in skin).
(iii) The ECM as an Effector of Cell Activity
The BM has been found to be of great importance in maintainance of tissue structure by 
providing a scaffold resistant to mechanical forces and physically separating the tissue 
compartments, but other biological activities such as sequestration and inhibition of 
growth factors like TGF-p by decorin have been reported (reviewed by Ruoslahti and 
Yamaguchi, 1991). Other growth factors such as basic FGF are bound by heparan 
sulphate-containing ECM proteoglycans and are brought into close association with 
ceUs,'and-allowing bFGF binding to its cell surface receptor (Ullrich and Schlessinger, 
1990). The significance of ECM-bound growth factor influence on cell activity has been 
reviewed by Taipale and Keski-Oja (1997), and these are likely have a major influence 
on cell behaviour during events such as neoplastic growth of primary tumours and 
tumour metastasis (discussed later in this chapter).
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Culture of cells on ECM components, such as type I collagen gels, have been shown to 
directly regulate activation of matrix-degrading enzymes such as gelatinase A (Azzam 
and Thompson, 1992). Culture of cells in three-dimensional type I collagen gels has 
also been shown to induce fibroblast (Langholz et al., 1995) and osteosarcoma cell 
expression of coUagenase-1 (Riikonen et al., 1995). Other authors have reported that 
culture of fibroblasts in type I collagen gels upregulated activation of endogenous 
fibroblast gelatinase A, relative to gelatinase A produced by fibroblasts cultured on thin 
collagen films (Seltzer et al., 1994). These enzymes are responsible for ECM 
remodeling and may profoundly alter ceU function (discussed in more detail later in this 
chapter). CeU contact with the ECM regulates other aspects of ceU behaviour, including 
prevention of apoptosis (Boudreau et al., 1996) or smooth muscle cell proUferation 
(Koyama et al., 1996), cell attachment to the ECM (Shrestha et al., 1996; Wu et al., 
1996), mammary carcinoma ceU response to bFGF (EUiott et al., 1992) and tumour ceU 
migration and invasion (reviewed by Ruoslahti, 1992; Chintala et al., 1996). The 
pathway by which ECM-mediated regulation of cell activity is achieved is discussed in 
more detail later in this chapter.
Proteolytic fragments of basement membrane proteins have also been shown to effect 
ceU interactions with the extraceUular matrix. Type I coUagen fragments produced by 
coUagenase degradation of type 1 coUagen have been shown to be chemotactic for 
human dermal fibroblasts (Albini and Adelmann-GriU ,1985). Gelatinase-A cleavage of 
laminin-5 was shown to generate an altered form of laminm-5 which induced migration 
of breast epitheUal cells (Giannelli et al., 1997). Angiogenesis, the process by which 
new blood vessels are formed by endothelial cells lining existing vasculature, is 
influenced both at the cell-adhesion and cell-proliferation stages by cleaved ECM 
components (reviewed by Sage, 1997). In addition, the cell differentiation and 
migration-stimulatory effects of native plasma fibronectin have been shown to be 
exposed only after incubation of the fibronectin with matrix metalloproteinases (Fukai et 
al., 1995).
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The breadth of influence of the ECM on cell behaviour is still not fully understood and 
therefore under intense examination, however, it is clear from the above results that cell 
interactions with the ECM have the potential to modulate most aspects of cell activity. 
Regulation and/or maintainance of these interactions are crucial to cell function and are 
discussed below.
(iv) Cell Surface Receptors for Extracellular Matrix
Several classes of cell-surface receptors for ECM are expressed by cells. These include 
glycoproteins such as the integrin family of receptors (discussed later in this chapter), 
and glycoproteins such as the heparan sulphate proteoglycans, CD44 glycoproteins and 
the syndecans. CD44 was originally identified as the lymphocyte homing receptor 
which bound to endothelial cell addressin, but has since been found to be expressed by 
many cell types in both low and high molecular weight forms. The differences in CD44 
composition appear to be tissue or ceU-type specific. The high molecular weight forms, 
such as found on epithelial cells, bear glycosaminoglycan side chains such as heparan 
sulphate and chondroitin sulphate. The low molecular weight forms, the predominant 
form found on lymphocytes, are not proteoglycans. CD44 has been shown to bind to 
fibrillar collagen, fibronectin, tenascin and hyaluronan in some cell types (reviewed by 
Hardingham and Fosang, 1992; Wright et al., 1992).
Syndecans are a family of integral membrane, heparan sulphate-carrying proteoglycans 
bind to interstitial matrix proteins such as fibrillar collagen, fibronectin and tenascin via 
their heparan sulphate and chondroitin sulphate side chains (reviewed by Hardingham 
and Fosang, 1992; Rapraeger, 1993; Elenius and Jalkanen, 1994). Ligand binding by 
syndecans is specific, as syndecans do not bind to laminin- 1 or vitronectin despite their 
heparin binding domains. It has also been proposed that syndecans may interact with 
integrins to mediate cell adhesion (reviewed by Elenius and Jalkanen, 1994), thus co-
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ordination of adhesion receptor expression may be necessary to bring about attachment 
of some cell types to the ECM.
(v) Structure and Function of the Integrins
(a) Integrin Structure
A principal group of cell surface receptors for ECM proteins are the integrins. Integrins 
are heterodimeric glycoproteins composed of non-covalently associated a  and p 
subunits (reviewed by Hynes, 1992; Kiihn and Eble, 1994; Newham and Humphries, 
1996) (fig. 1.2). At least fourteen a  subunits and 8 P subunits have been identified to 
date, although the total number of possible subunit combinations is limited by the fact 
that not every a  subunit is able to associate with every P subunit (Table 1.1). Often the 
a  subunits are only able to complex with a single, common p subunit, although the tty 
integrin subunit is a notable exception to this case.
Each integrin subunit is anchored into the cell membrane by a single hydrophobic 
transmembrane domain. Most integrins (apart from the P4 integrin subunit) have short 
cytoplasmic tails of less than 50 amino acids, with no evidence of intrinsic tyrosine 
kinase activity. Electron microscopy of several integrins show a globular head 
comprising parts of both subunits, supported by two stalks which extend into the 
plasma membrane (Carrell et al., 1985; Nermut et al., 1988). The N-terminal half of all 
a  subunits contain a seven-fold repeat structure, parts of which are thought to be 
involved in binding of divalent cations, which are essential to the function of some 
integrins as cell adhesion receptors (Staatz et al., 1989; Kirchhofer et al., 1991; 
Grzesiak et al., 1992). The ligand binding domain of the a  subunits is also thought to 
be contained within the seven-fold repeats, but this site is unlikely to be at the same 
location as the cation binding site (Masumoto and Hemler, 1993). A common feature of 
the P subunits is a four-fold repreat of a disulphide-bonded, cysteine-rich domain
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which is thought to be involved in ligand binding (for a review of integrin structure, see 
Loftus et al., 1994; Takada et al., 1997). \
Some a  subunits ( a i ,  tt2 , a n ,  «E» (%L, (%M and a x )  also have an extra domain of 
approximately 180 amino acids, known as the I-(inserted) domain, between repeats II 
and m  of the seven-fold repeat structure. These domains are homologous to the A- 
domain modules of von Willebrand factor (Pareti et al., 1987) which mediates collagen 
binding, and A-domain-like sequences found in type VI collagen, complement factor B 
and cartilage matrix protein (Colombatti et al., 1993). The inserted regions of the 
integrins are therefore usually referred to as A-domains rather than I-domains. The A- 
domain of the a 2 integrin subunit has been demonstrated to be the ligand-binding 
region of the molecule (Kamata and Takada, 1994; Tuckwell et al, 1995) and it is likely 
that the A-domains of the other integrins will also be involved in ligand binding. Lee et 
al. (1995) postulated that the p3 integrin subunit may also contain an A-domain module 
and evidence for putative A-domains in other P subunits have recently been published 
(Tuckwell et al, 1995; Tozer et al, 1996; Tuckwell and Humphries, 1997).
Binding of divalent cations such as Mg^+, Mn^+ and Ca^+ induces reversible 
conformational changes in the integrin heterodimer extracellular domains. Binding of 
the stimulatory cations (Mg^+ or Mn^+) is essential for inducing a conformational 
change which promotes ligand binding (integrin-activation) (reviewed by Humphries,
1996). Cation dependence was demonstrated by addition of the divalent metal ion- 
chelator ethylenediaminetetraacetic acid (EDTA), which abolishes integrin-mediated cell 
adhesion (Santoro, 1986; Diamond and Springer, 1994). Integrin activation may also 
induce changes in the conformation of the cytoplasmic domains of the integrin subunits, 
potentially leading to alterations in the signals transduced by the active versus inactive 
integrin (see below). Binding of Ca^+ generally induces an inactive conformational state 
in most integrins, (when Ca^+ is in the mM concentration range), which does not 
permit ligand binding to the integrin (Humphries, 1996).
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(b) Integrin Function; Integrins as Signal-transducing Molecules
In addition to being receptors for matrix proteins, integrins have second, more 
significant role, as signal transducing molecules (reviewed by Clark and Bragge, 1995; 
Richardson and Parsons, 1995; Dedhar and Hannigan, 1996; Yamada, 1997a and 
references therein). Cell regulation of integrin-mediated interaction with the ECM is 
usually as a direct consequence of transduction of information about the extracellular 
environment either via integrins themselves or other cell-surface receptors (reviewed by 
Juliano and Haskill, 1993; RoskeUey and Bissell, 1995; Humphries, 1996). Signaling 
via integrins occurs in two directions; inside-out signaling which regulates the affimty 
and conformation of the receptors, and outside-in signaling which is triggered by ligand 
binding of the receptors and can lead to a multitude of responses including modulation 
of integrin-mediated adhesion. Signaling is mediated by the cytoplasmic domains of the 
integrins, particularly the P subunits (reviewed by Sastry and Horwitz, 1993; Laflamme 
et al., 1997; O'Toole, 1997), but since the integrins possess no intrinsic kinase activity 
of their own they must interact with other proteins to activate signals.
The precise mechanism by which signals are transmitted following ligand binding is not 
yet fully established, although recent papers have shed much light onto this process. 
Ligand-bound integrins are recruited into specialized structures called focal adhesions, 
which also involve proteins of the cytoskeleton and signaling proteins such as focal 
adhesion kinase (FAK; reviewed by Giian, 1997). Marcantonio and David (1997) 
proposed a mechanism by which the short cytoplasmic tail of the integrin P subunits 
might become involved with other proteins. Briefly, they postulate that the a  subunit 
maintains integrin signaling latency when the receptor is ligand-unoccupied by 
prevention of the formation of a-helical structures within the integrin P subunit 
cytoplasmic domains. Ligand binding is thought to alter the relationship of the 
cytoplasmic domains which leads to formation of the a-helicies needed for interaction
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with signal transducing proteins. Most p integrin subunits have tyrosine residues with 
conserved motifs which may be phosphorylated, leading to signal transduction via 
classical signaling pathways such as Ras/MAP kinase cascades, although other 
mechanisms may be possible (Laflamme et al., 1997; O'Toole, 1997), Ligand binding 
by some integrins, such as tt2pi integrin, has also been shown to trigger release of 
intracellular calcium and bring about calcium-mediated cell signaling (reviewed by 
Sjaastad and Nelson, 1997).
The mechanisms governing inside-out signaling or integrin activation are less well 
understood, although some progress has recently been made in this area (reviewed by 
Ginsberg et al., 1992; Dedhar and Hannigan, 1996). Activation of several integrins has 
been shown to be mediated by novel cytoplasmic proteins binding to specific P integrin 
subunits. Examples of this include activation of lymphocyte P2 integrin by cytohesion-1 
(Kolanus et al., 1996) and activation of platelet P3 integrin by endonexin (Shattil et al.,
1995). Another novel integrin binding protein, named integrin linked kinase (ILK), has 
been found to bind Pi, P2 and P3 integrin cytoplasmic domains (Hannigan et al.,
1996). Integrin activation has also been shown to be regulated by divalent cations such 
as Mg^+ and Ca^+. Mg^+ and Mn^+ have been postulated to bind to the integrin at 
"Ligand Competent Sites" and may thereby regulate the rate of ligand association. 
Ca2+, on the other hand, may bind the integrin at "AUosteric Inhibitory Sites" which 
prevent ligand binding and therefore regulates the rate of ligand dissociation (Smith,
1997).
(vi) Regulation of Integrin Activity
Cells are able to regulate integrin-mediated interactions with the ECM at multiple levels. 
Firstly, several integrins have been shown to have alternatively spliced regions in their 
cytoplasmic tails which may account for the difference in specificity of a given integrin 
from cell type to cell type, or within the same cell at different stages in development
11
.y:
(Kirchhofer et al., 1990; Fomaro and Languino, 1997). Secondly, the specificity and 
affinity of a given integrin on a ceU are not always constant (reviewed by Diamond and 
Springer, 1994). A well documented example of this has been reported for the platelet 
aiibp3 integrin on the surface of resting platelets, which is unable to bind soluble 
fibrinogen until the platelet is activated by agonists such as collagen or thrombin 
(Phillips et al., 1991). Platelet activation induces a conformational change in the anbPs 
integrin which permits binding to soluble fibrinogen. Cells are also able to regulate 
adhesion and migration on the ECM by modulation of their integrin repertoire (Skinner 
et al., 1994; Beauvais et al., 1995). An example of this phenomenon is the loss of ttvPs 
and gain of a s  Pi integrin in a highly metastatic melanoma cell line (C8161) in 
comparision to a moderately invasive melanoma cell line (A375M) (Seftor et al., 1993). 
Modulation of integrin expression and activation states can have profound effects on 
processes as diverse as keratinocyte differentiation (Adams and Watt, 1990), tumour 
cell proliferation, cell survival (Giancotti, 1997; Meredith and Schwartz, 1997) and 
metastasis (reviewed by Varner and Cheresh, 1996).
Studies using mice in which integrin subunits have been "knocked out" have shown 
that complete ablation of the Pi subunit causes eof-y embryonic death
(Fassler and Meyer, 1995a). In contrast, mice which carry a homozygous null mutation 
for the a i  integrin and ag integrin subunits develop to adulthood and are fertile. 
Ablation of the a i  integrin subunit confers no apparent phenotype, suggesting other 
integrins are able to compensate to a large extent for the loss of a ip i  integrin (Gardner 
et al., 1996). However, loss of the ag integrin disrupts development and maintenance 
of the epidermal basement membrane and leads to blistering at the dermal-epidermal 
junction of skin (DiPersio et al., 1997). Therefore, expression of some integrins are 
essential for normal development, although loss of single integrins such as a ip i  
integrin may be compensated for due to the overlapping ligand specificities of many 
integrins.
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(vii) Cell Interactions With Type I Collagen
The principal type I collagen receptors on cells are the a i p i  and a 2Pi integrins 
(Gulberg et al., 1992; Santoro and Zutter, 1995). Some groups have reported agpi 
integrin binding to type I collagen (Grenz et al., 1993; Yamamoto and Yamamoto, 
1994), but this is probably restricted to a few select cell types. tt2Pi integrin is 
expressed by many cell types and is thought to exist in at least three different functional 
activation states (Chan and Hemler, 1993), all of which are functionally Mg^+/Mn^+- 
dependent. It is thought that the activation state of the integrin may responsible for the 
differences in ligand binding specificity, as « 2Pl integrin has been found to be a 
receptor for laminin as well as coUagens on some cell types (Elices and Hemler, 1989; 
Kirchhofer et al., 1990). This integrin can be activated from the resting state (unable to 
bind collagens) into the activated state by activating anti-pi integrin antibodies, which 
bind the pi subunit at a location distinct from the ligand binding site and induce a 
conformational change into the activated (collagen-binding) integrin conformation 
(Arroyo et al., 1992; Humphries, 1996; Wilkins et al., 1996). The ability of inactive 
tt2Pi integrin to undergo activation in vitro suggests that cells may also be able to 
manipulate ot2pi integrin activity in vivo. Unlike many of the other integrins, (%ipi and 
OC2P1 integrin binding to ligands is an RGD-independent process. Cardarelli et al. 
(1992) reported that a cyclic RGD (single letter amino acid code)-containing peptide 
inhibited « 2pl integrin binding to type I collagen, but Eble et al. (1993) found that 
these peptides had no effect on (Xipi integrin binding to type I collagen. Staatz et al.
(1991) reported that platelet binding to type I collagen could be inhibited by a DGEA- 
containing peptide, suggesting that this was the tt2pi integrin adhesive motif on type I 
collagen. However, other reports have not confirmed this result (reviewed by Tuckwell 
and Humphries, 1996b).
Cell attachment to denatured fibrillar collagens has been postulated to be mediated by 
cryptic RGD sites which become exposed upon unwinding of the collagen triple hehx.
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avp3 integrin has been suggested to bind to the exposed RGD peptides (Davis, 1992; 
Montgomery et ai., 1994), however, a ^ p i and a i P i  integrin interactions are 
completely ablated by collagen dénaturation. Cell attachment to denatured type H 
collagen has also been shown to be mediated by (X5P1 integrin. This rather unexpected 
result was explained by the collagen-binding ability of fibronectin, which was shown to 
form a bridge between cells and denatured type II collagen (Tuckwell et al. 1994). This 
result is potentially important for maintainance of cell attachment to a substratum which 
has been subject to proteolytic remodeling.
tt2Pi integrin has been found to bind to collagens I-VI and XI, although its interactions 
with type I collagen are the best understood. Several groups have identified regions of 
the type I collagen molecule thought to be involved in tt2Pi integrin binding. The most 
frequently reported data relates to the a l(I)  chain cyanogen bromide fragments numbers 
3 and 7 (a  1(I)-CB3; Staatz et al., 1990) (fig. 1.3), although other regions of the 
collagen molecule have been shown to support tt2pi integrin-mediated cell adhesion too 
(Fitzsimmons et al., 1986; Morton et al., 1994). One study pinpointed the o^P l 
integrin recognition sequence as the tetrapeptide DGEA, which corresponds to residues 
435-438 of the al(I)-CB3 fragment of type I collagen (Staatz et al., 1991), however, at 
present this is not conclusively defined. As has already been mentioned, the location of 
the collagen binding site on « 2Pl integrin is much more clearly defined, Kamata and 
Takada (1994) and Tuckwell et al (1995) independently reported that recomibinant 
tt2Pi integrin A-domain bound specifically to type I collagen. A later study extended 
this to collagens type I, H, IV and XI but not to synthetic triple-helical collagenous 
peptides, suggesting that the A-domain is able to recognize sequence-specific ligands 
(Tuckwell et al, 1996a).
Despite the structural diversity of collagenous molecules with which tt2Pi integrin is 
able to interact, a common feature is the requirement for collagen triple-helical 
conformation in order to support (X2P1 integrin adhesion. This has been demonstrated
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using non-physiological, cyanogen bromide derived peptides of collagen (Vanderberg 
et al., 1991; Pfaff et al., 1993; Morton et al., 1994; Ruggiero et al., 1994; Tuckwell et 
al., 1994). This is potentially a critical feature of tt2pi integrin-mediated cell adhesion 
to collagens and laminin, as it is well documented that loss of cell contact with the ECM 
can lead to apoptotic cell death (reviewed by Ruoslahti and Reed, 1994; Meredith and 
Schwartz, 1997). Pilcher^^t al. (1997) showed that keratinocyte migration was 
maintained when cells were prevented from adhering firmly to type I collagen by 
dénaturation of the substrate. In vitro studies using cells transfected with « 2Pl integrin 
(Keely et al., 1995) and ay p i integrin (Echtermeyer et al., 1996) have shown that 
expression of an integrin type not previously expressed by the cell type in question can 
dramatically increase cell motility over ECM proteins, suggesting that cells may also be 
able to respond to external stimuli by induction of integrins which are not normally 
expressed by the particular cell type. This has important implications for the processes 
of tumour cell transformation, invasion and metastasis, where gain or upregulation 
receptors such tt2Pi integrin (Santala et al., 1994), Pi integrins (Bartolazzi et al., 1994) 
and P3 integrins (Albelda et al., 1990; Danen et al., 1995a) have been reported 
(reveiwed by Juliano and Vamer, 1993; Tang and Honn, 1994).
A study by Keely et al. (1995) showed that expression of tt2 integrin antisense mRNA^
in a human breast carcinoma cell line reduced cell adhesion to types I and IV collagen,
without effecting adhesion to fibronectin or laminin. Cells which exhibited intermediate
levels of adhesion to collagen were found to be more motile across collagen-coated
filters during haptotaxis assays. The level of motility over collagen directly
corresponded with the level of antisense tt2 integrin expressed by the cells; highly
but low levels of
expressing cells showed unchanged levels of migratiog^<^Grence, weakly expressing 
cells showed increased adherence but a low level of migration. Antisense a 2 integrin 
expressing cells were also unable to organize into glandular epithelial-like structures 
when cultured in three-dimensional collagen gels, unlike the parent cell line. Therefore,
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tt2pi integrin is essential for maintenance of collagen-dependent morphogenic capacity 
of mammary epithelial cells.
Recent studies have highlighted the link between integrin-mediated signal transduction 
and signaling via classical signaling pathways. Signaling via integrins are thought to 
activate signaling pathways shared with mitogens such as growth factors. This can lead 
to convergence of adhesion-mediated and growth factor-mediated signalling pathways, 
transduced by proteins such as Ras, MAPK and Rho (reviewed by Dedhar and 
Hannigan, 1996; Giancotti, 1997). The integration of the soluble and adhesion- 
dependent signals has been shown to be vital for cell co-ordination of events such as 
cell proliferation and migration (McNamee et al., 1993; Jones et al., 1996b). Even more 
interestingly, Schneller et al. (1997) reported that a small, highly tyrosine- 
phosphorylated fraction of the PDGFp receptor and the insulin receptor co- 
immunoprecipitated with the ttvPs integrin from human foreskin fibroblast cells. This 
supports the idea that growth factor-growth factor receptor complexes may be recruited 
into focal adhesion complexes within the cell membrane (Plopper et al., 1995), leading 
to a highly complex association of signaling proteins and activation of a single signaling 
cascade.
(viii) Structure and Function of the Extracellular Matrix-Degrading 
Matrix Metalloproteinases
Extracellular matrix remodelling is mediated by proteolytic enzymes, particularly by 
members of the matrix metalloproteinase (MMP) family (reviewed by Matrisian, 1992; 
Murphy and Reynolds, 1993; Birkedal-Hansen, 1995). MMPs can be synthesized by 
many cell types including connective tissue cells, haemopoetic and tumour cells. MMPs 
are part of the metzincin group of proteinases, which are derived from a larger family of 
zinc-dependent metallopeptidases. All nineteen mammalian MMPs discovered to date 
have a putative Zn^+-binding site and are dependent on Ca^+ for stability, however.
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they can be broadly subdivided into 5 groups based on their structure and substrate 
preference (Table 1.2). All MMPs carry a propeptide domain which is lost during 
activation, (discussed later in this chapter), and a catalytic domain which contains the 
active site of the enzyme. The majority of MMPs (except matrilysin) also carry a C- 
terminal domain which is composed of hemopexin-like repeats. The C-terminal domain 
is joined to the N-terminal catalytic domain by a flexible linker sequence (flg.1.4).
CoUagenases are members of a very small group of physiological proteinases which are 
able to degrade triple-helical collagens. There are three vertebrate collagenases known at 
present, collagenase-1 to -3. Collagenase-1 (CL-1) was originally described by Gross 
and Lapiere (1962) as the enzyme responsible for tadpole tail involution, and was the 
first vertebrate MMP to be discovered. CL-1 is produced by many cell types including 
fibroblastic cells and bone cells (reviewed by Harris and Krane, 1974). Later, a second 
collagenase (CL-2, MMP-8), which is structurally different from CL-1, was isolated 
from neutrophils (Hasty et al., 1990). This coUagenase has since been found to also be 
produced by chondrocytes in human cartilage, and to be upregulated in osteoarthritic 
cartilage and in response to interleukin-1 (IL-1) (Chubinskaya et al., 1996). The 
primary fibrillar collagen present in articular joints is type II collagen, and this is likely 
to be the principal substrate of CL-2 produced by chrondrocytes and neutrophils in 
normal and arthritic joints. Interestingly, CL-2 is also able to cleave the major articular 
proteoglycan, aggrecan, although CL-2 is not now thought to be the primary enzyme 
responsible for aggrecan degradation (Amer et al., 1997). The most recently discovered 
collagenase, collagenase-3 (CL-3, MMP-13), was isolated from a human breast tumour 
library (Freije et al., 1994). Collagenase-3 has since been expressed, purified and 
biochemically characterized (Knauper et al., 1996a; Knauper et al., 1997a; Knauper et 
al., 1997b).
Fibrillar collagens (collagen I, II and HI) are highly resistant to proteolytic degradation 
due to their triple-helical structure. However, the mammalian collagenases exhibit C-
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terminal domain binding to the collagen triple helix resulting in the destabilization of this 
region and subsequent cleavage (De Souza et al., 1996). A recent study by Lemaître 
(1997) showed that recombinant mouse collagenase-3 catalytic domain expressed in 
Escherichia coli was able to degrade gelatin, casein and the N-telopeptides of type I 
collagen, although the catalytic domain on its own was not able to cleave the triple­
helical domain of collagen. The importance of the C-terminal domain of CL-3 for 
interaction with fibrillar collagens was demonstrated, since deletion of this region 
ablated triple-helicase activity and also reduced CL-3 interaction with TIMPs 1 and 3 
(Knauper et al., 1997b). These report and others confirm the necessity for the C- 
terminal domain of collagenases in mediating collagen cleavage (De Souza et al., 1996; 
Gomis-Rüth et al., 1996). The hinge region of collagenases is also important for 
maintenance of the stability and collagenolytic ability of collagenases (Knauper et al., 
1997a), and it has been suggested from computer modeling studies that this region may 
assume a coUagen-like conformation (De Souza et al., 1996). The region of the collagen 
triple-helix surrounding the collagenase-cleavage site contains less imino acids is less 
stable than the rest of the triple-helix (reviewed by Gross et al., 1980; Kielty et al., 
1993), Destabilization or relaxation of the triple helix allows collagenases to cleave all 
three chains of type I collagen at a single locus between residues 775 and 776, that is, 
between one Gly-Ile in each a l  chain and one Gly-Leu in the a2  chain (Highbergeret 
al. 1979). The fragments generated are approximately 3/4 and 1/4 of the total length of 
the native molecule and melt below 37°C (Sakai and Gross, 1967; -Stark End Kiihn, 
4968a). Interestingly, Krane et al. (1996) showed that rodent interstitial collagenase, 
which is highly homologous to human CL-3, cleaves type I collagen at two locations. 
As well as cleaving at the classical site within the collagen triple helix, rodent 
collagenase has an additional cleavage site within the aminotelopeptide region. Human 
collagenase-3 has also recently been demonstrated to cleave at this additional, 
aminotelopeptide, cleavage site (Knauper et al., 1997b). Liu et al. used mice which 
expressed mutant collagen, that was resistant to collagenase degradation at the classical 
triple-helical site, to show that rodent collagenase cleavage of type I collagen at the
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nonhelical N-telopeptide site was important for resorption of collagen during 
development.
Gelatinases were so called because they are very efficient at degrading denatured 
collagens. Native type IV collagen was also thought to be a substrate for the gelatinases 
but this was later proved to be due to a reducing step during the purification of type IV 
coUagen. Neither gelatinase A (GLA) or B (GLB) have been found to cleave unreduced 
type IV collagen (Eble et al., 1996). The catalytic domain of gelatinases contain three 
repeated units which are closely related to the type II domains of fibronectin. These 
fibronectin-like repeats are unique to gelatinases amongst the MMPs and are responsible 
for mediating gelatinase binding to gelatin (Murphy et al., 1994a). In vitro^ gelatin is 
generated by heat-denaturation of collagens and is usually reversible if the gelatin is 
allowed to slowly renature at room temperature. In vivOy this situation is not possible 
and therefore true gelatin can only be generated by collagenase degradation of collagen 
into the 3/4 and 1/4 fragments (an irreversible process). As already mentioned, the 
fragments generated by collagenase degradation of collagens are not stable at 
physiological temperature and probably denature into gelatin as as soon as they are 
formed. Since these gelatinized collagens and collagenase-generated fragments of 
collagens are extemely susceptible to degradation by many proteinases including 
gelatinases, it is unlikely that gelatins are present in the extracellular environment for a 
significant length of time. However, this does not mean that gelatins have no 
physiological role to play, and the dramatic change in cell substrate from highly 
structured, fibrillar coUagen to random coil, gelatinized alpha chains has been shown to 
have significant impact on cell interactions with the substrate (Tucker et al., 1990; 
Pilcher et al., 1997).
Stromelysin-1 and -2 (SL-1 and SL-2) have the widest substrate specificity of the 
MMPs idenified to date (see Table 1.2). These are unusual among the soluble MMPs in 
that they are only activated by proteinases outside of the MMP family (e.g. plasmin.
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trypsin, elastase, cathepsin G; (Nagase et al., 1990)). Stromelysin-3 (SL-3) has a more 
restricted substrate specificity than SL-1 and SL-2, and has been shown to be activated 
intracellularly prior to secretion (discussed in more detail later in this chapter).
The most recently discovered members of the MMP familiy are the membrane-type 
matrix metalloproteinases (MT-MMPs). Four MT-MMPs have been identified to date 
(Sato et al., 1994; Takino et al., 1995; Will and Hinzmann, 1995; Puente et al., 1996). 
The transmembrane domain? of these MMPs localizes their activity to the pericellular 
environment, however, MT-1 MMP has been shown to degrade most of the ECM 
proteins in the test tube (Pei and Weiss, 1996). MT-1 and -2 MMPs have also been 
demonstrated to be involved in the activation of GLA^and this is discussed later in this 
chapter.
(ix) Cellular Regulation of Matrix Metalloproteinase Activity
MMP activity is regulated at three seperate levels: synthesis, activation and inhibition 
(reviewed below).
(a) Synthesis
Transcription of many MMPs is mediated by the interaction of AP I and a number of 
other transcription factors with specific promoter sequences within the MMP genes 
(reviewed by Renbow and Brinckerhoff, 1997). Transcription of MMPs can be 
regulated by cell interactions with the ECM, for example: attachment of rabbit synovial 
fibroblasts to peptides derived from fibronectin induced collagenase and stromelysin 
expression (Werb et al., 1989), and decorin regulated fibroblast expression of 
collagenase when cultured on vitronectin (Huttenlocher et al., 1996). Other examples of 
ECM regulation of MMP synthesis include; laminin, type IV collagen, fibronectin and 
tenascin stimulation of mouse macrophages to express GLB (Khan and Falcone, 1997),
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and induction of keratinocyte expression of collagenase-1 by cell contact with native 
type 1 collagen (Sudbeck et al., 1997). Interestingly, for kératinocytes, contact with 
type I collagen induces CL-1 expression, however, contact with laminin-1 represses 
CL-1 expression (Sudbeck et al., 1997). Expression of MMPs can be influenced by 
integrin-mediated signaling, for example, perturbation of the ttypa a sp i integrins 
on invasive melanoma cells have been shown to upregulate to a small extent gelatinase 
A expression and secretion (Seftor et al., 1992; Seftor et al., 1993). MMP synthesis 
can also be induced by stimulation of cells with cytokines and growth factors, such as 
EOF (Shima et al., 1993; Zeigler et al., 1996), PDGF (Yanagi et al., 1992), TGF-p 
(Overall et al., 1991) and TNF-a (Jasser et al., 1994).
(b) Activation of Matrix Metalloproteinases
All the MMPs described so far, with the exception of stromelysin-3 (SL-3) and the 
membrane-type matrix metalloproteinases (MT-MMPs), are secreted in the latent form 
which requires extracellular processing to the active form (reviewed by Nagase, 1997)^. 
MMPs are multi-domain structures composed of the N-terminal pro-region which is lost 
during activation, followed by the Zn^+- and Ca^+-binding catalytic domain. The C- 
terminal domain is composed of a 4-bladed p-propeller which shows strong sequence 
similarity to the hemopexin family of proteins. The C-terminal domain is connected to 
the catalytic domain by a hyperflexible linker, or hinge, of variable length (fig.3; 
Birkedal-Hansen, 1995). The propeptide region occupies the active site cleft of the 
catalytic domain by ligation of an invariant Cys residue in the propeptide sequence to 
the zinc ion. Stepwise activation of the MMP is achieved by initial proteolytic cleavage 
which destabilizes the Cys-Zn^+ interaction, which then allows further proteolysis to 
the fully active form (Springman et al., 1990; Van Wart and Birkedal-Hansen, 1990). 
The serine proteinase,^plasmin, is thought to be involved in the initial catalytic step 
necessary during autocatalytic activation of many of the MMPs including; stromelysin- 
1, and -2 (SL-1 and -2; Nagase et al., 1990), gelatinase-B (GL^B; Ogata et al., 1992)
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and collagenase-1 (CL-1; Gavrilovic and Murphy, 1989). Other active MMPs may 
greatly increase the activity of plasmin-activated MMPs for example, incubation of SL-1 
with plasmin-activated CL-1 elicits a 10-fold increase in collagenase activity at a molar 
ration of 1:100 (Murphy et al., 1987). Both fibroblast and neutrophil collagenases are 
superactivated by stromelysin-1, and neutrophil collagenase has also been shown to be 
activated by stromelysin-2 (Knauper et al., 1996c).
Pro gelatinase A (pGLA) has been found to be activated at the surface of cells treated 
with concanavalin A (Con-A) (Murphy et al., 1991). A recently identified membrane- 
bound MMP, (MT-1 MMP; Sato et al. 1994), is thought to mediate GLA activation by 
partial cleavage of the pro-GLA to an intermediate form, which is then processed to the 
mature form by autolytic cleavage of the GLA itself (Atkinson et al., 1995). This 
proteolytic cascade activation mechanism has a similar function to the stepwise 
activation observed for other MMPs, representing mutiple opportunities for regulation 
of MMP activity at the cell surface (reviewed by Basbaum and Werb, 1996). A futher 
level of complexity to the GLA activation pathway is the involvement of tissue inhibitor 
of metalloproteinases-2 (TIMP-2). TIMP-2 has been isolated from the plasma 
membrane of Con-A treated HT1080 cells and was found to be in a complex with MT-1 
MMP and GLA. GLA activation was enhanced by the addition of low levels of 
exogenous TIMP-2 but inhibited at higher doses of the TIMP (Strongin et al., 1995). 
TIMP-2 forms a complex with pro-GLA via the N-terminal domain of the TTMP and the 
C-terminal domain of pro-GLA, leaving the N-terminal domain of GLA free to interact 
with MT-1 MMP. The importance of the C-terminal domain of GLA during GLA 
activation has been demonstrated (Murphy et al., 1991; Ward et al., 1994), loss of this 
part of the molecule prevented pGLA binding to the cell surface and activation of the 
enzyme . It is possible that TIMP-2 acts an "anchor" protein during GLA activation, 
binding free pGLA and holding it in position in close proximity to the cell surface, 
thereby enabling MT-MMP interaction with GLA to initiate activation. However, the 
exact role of TIMP-2 in the GLA activation mechanism has yet to be elucidated.
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Interestingly, CL-3 has also been shown to be activated at the cell surface by MT-1 
MMP and gelatinase A (Knauper et al., 1996b). Similarly to gelatinase A activation, 
cell-surface activation of collagenase-3 is also dependent on its C-terminal domain 
(Knauper et al., 1997b).
MT-1 MMP, along with SL-3, has been shown to be activated intracellularly by the 
Golgi-associated subtilisin-like proteinase, furin (Pei and Weiss, 1995; Pei and Weiss, 
1996). Due to the transmembrane domain of the MT-MMPs, the active enzymes are 
anchored at the cell surface, unlike SL-3 which is fully secreted as a soluble, active 
enzyme. The activation mechanism of the other MT-MMPs has not yet been published, 
however, since these also contain the furin recognition motif it is likely that these too 
will be activated prior to insertion into the cell membrane.
(c) Inhibition of MMPs
Once activated, MMPs are regulated in vivo by specific inhibitors of MMPs, the tissue 
inhibitors of metalloproteinases (TIMPs). Four TIMPs have been identified to date 
(Stetler-Stevenson et al., 1989; Uria et al., 1994; Leco et al., 1997) and these are often 
coexpressed with MMPs by cells, therefore allowing tight regulation of matrix 
degradation (reviewed by Edwards et al., 1996). The four TIMPs are distinct gene 
products and are composed of two structurally distinct domains. TIMP-1 is a 30 kDa 
glycoprotein which forms high-affinity, non-covalent, complexes with active MMPs in 
a 1:1 stoichiometry. TIMP inhibition of MMPs does not cause permanent changes in 
MMP conformation and therefore the interaction is in theory reversible, although the 
affinity of the inhibitor for the MMP is so great that very stable complexes are formed 
(Murphy et al., 1994b). Some specificity of TIMP interactions with MMPs is possible 
as it has been shown that TIMP-1 does not completely inhibit MT-1 MMP activity but 
that TIMP-2 does (Atkinson et al., 1995). Of interest is the fact that TIMP-1 binds to
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proGLB and TIMP-2 binds to proGLA, which is of importance to the activation of the 
latter, as discussed above.
Both TIMP-1 and TIMP-3 expression can be induced by growth factors such as EGF 
and TGF-P 1, whereas TIMP-2 expression is more constitutive (reviewed by Edwards 
et al., 1996). However, TIMP-3 is different from all other TIMPs described to date in 
that subsequent to secretion, it becomes bound to the ECM. This may reflect an 
additional level of cell regulation of MMP activity, since restriction of TIMP-3 to an 
area proximal to the cell surface may allow TIMP-3 the greatest mfluence on pericelluar 
ECM proteolysis. Point mutaions in the TIMP-3 gene have been shown to be present in 
patients suffering from Sorsby's fundus dystrophy (SFD), a condition which effects 
the retina and leads to irreversible blindness (Weber et al., 1994). The significance of 
synthesis of dysfunctional TIMP-3 protein and the SFD disease is not yet known, 
although increased MMP activity due to TIMP-3 malfunction is unlikely since 
thickening and vascular penetration of Bruch's membrane is a feature of the disease.
An imbalance between MMP and TIMP production where levels of secreted MMP 
exceeds the available extracellular TIMP has been postulated to be the cause of many 
instances of pathological tissue destruction, for example during tumour cell metastasis. 
The current model of the role of MMPs and TIMPs in tumour growth and invasion is 
examined in more detail later in this chapter.
(x) The AD AMs: Cell Surface Proteins Possessing a Metalloproteinase 
and an Adhesion Receptor Domain
A novel family of cell surface proteins with A Disintegrin And Metalloproteinase 
domain, the AD AMs, have recently been described. These proteins have a unique 
domain organisation consisting of a proteolytic domain, an adhesion domain, a fusion 
domain and a signaling domain. The proteinase and cell adhesion domains of the
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AD AMs share ~30% sequence homology with the snake venom metalloproteinases, 
which are soluble proteins, unlike the membrane-bound AD AMs. Despite all the known 
AD AMs possessing the same four domains, sequence analysis of the proteins suggests 
that not all domains in all ADAMs are functional. At least 15 vertebrate AD AMs have 
been identified to date, of these, 1-6 have been implicated in sperm-egg fusion during 
fertilization. Others have been identified on macrophages, myeoblasts, brain and some 
tumour cells (reviewed by Wolfsberg and White, 1996).
Seven of the full-length vertebrate ADAMs contain an extended active-site sequence 
motif which is sim ila r to that found in the catalytically active metalloproteinase domain 
of the snake venom metalloproteinases. This suggests that these ADAMs can be 
catalytically active in the pericellular environment and it has recently been demonstrated 
that a new member of the ADAM familiy processes the precursor of tumour necrosis 
factor a  (TNF-a), to allow release of the mature cytokine from the cell surface (Black 
et al., 1997; Moss et al., 1997). Since cytokines and growth factors have such an 
important role during normal and neoplastic cell proliferation and motility, this finding 
suggests that ADAMs may be involved in mediating processes such as induction of 
tumour growth and metastasis.
The disintegrin domains of the ADAMs are similar to those found on snake venom 
proteins, which have been demonstrated to bind to the platelet anbPs integrin and 
disrupt platelet aggregation (reviewed by Wolfsberg and White, 1996). The integrin- 
binding region of the snake venom disintegrin is thought to be a 13-14 amino acid loop 
which contains and RGD sequence at the tip. The RGD-containing loop projects out 
from the rest of the disintegrin and probably binds to a pocket in the anbp3 integrin 
heterodimer. Much less is known about the disintegrin domains of the ADAMs, 
however, the sequence of the predicted 14-amino acid loop is much more degenerate 
amongst the ADAMs than the snake venom disintegrins, which might indicate that not 
all ADAM disintergins are able to bind to the integrins or other surface receptors.
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The first two ADAMs identified were originally isolated from guinea pig sperm, and 
their roles in the reproductive process has been the subject of intense research (reviewed 
by Wolfsberg and White, 1996; Bigler et al., 1997). It was originally thought that the 
metalloproteinase domain of fertillin a  (ADAM-1), might be important for spermatid 
cell migration through the seminiferous tubules during early spermatogenesis. 
However, a recent report suggesting that the human fertilin a  gene is non functional 
casts some doubt on the role of this ADAM during reproduction (Jury et al., 1997). The 
role of fertilin P (ADAM-2), which forms a heterodimer with fertilin a  on guinea pig 
and bovine sperm, during sperm-egg interactions is better understood. The major 
functional domain of fertilin P is thought to be its disintegrin domain, which has been 
postulated to be involved in sperm-egg binding via interations with an egg integrin.
The cytoplasmic tails of the ADAMs have been postulated to be involved in signal 
transduction (reviewed by Wolfsberg and White, 1996). This is due to the fact that 
several of the ADAM cytoplasmic domains, such as meltrin gamma, are rich in proline 
which may allow binding of signaling molecules (Weskamp cl al., 1996). Others are 
rich in lysine and serine, and some have consensus sites for phosphorylation. 
However, the cytoplasmic domains of the ADAMs are not well conserved across 
mammalian species and therefore the importance of ADAMs as signal transducing 
molecules has yet to be elucidated.
(xi) Mechanism and Regulation of Cell Motility
Migration of cells can occur via three different processes; chemotaxis, haptotaxis and 
chemokinesis. Chemotaxis is the directional movement of cells towards a gradient of a 
specific, soluble attractant (reviewed by Albini et al., 1985). Haptotaxis is cell 
movement guided by an immobilized attractant, and chemokinesis is the random 
migration of cells caused by factors which stimulate motility.
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Cell motility is achieved by a fine balance of cell attachment and detachment (reviewed 
by Huttenlocheret al., 1995; Opas, 1995; Adams, 1997). A well studied example of this 
is the "rolling mechanism" employed by leukocytes to move along the vascular 
endothelium (Dunon et al., 1996). Integrins have a central role in potentiation of cell 
motihty over extracellular matrix, enabling cells to maintain simultaneous interactions 
with both the extracellular matrix and the actin cytoskeleton. Initiation of cell 
locomotion involves a directional protrusion of the leading edge of the cell to form a 
lamellipodium, a structure which is firmly linked to the ECM via focal adhesion 
complexes. These focal adhesions also serve to link the substratum and the actin 
cytoskeleton which is essential to provide the traction required to drag the cell in the 
direction of the lamellipodium. Ligand occupancy of Pi integrins has been shown to 
lead to retrograde movement of the ligand-bound integrins mediated by attachment of 
the pi integrin cytoplasmic tail to the cytoskeleton, thereby generating the contractile 
force necessary for cell locomotion (Felsenfeld et al., 1996).
Ill Older to permit cell movement, integrin attachments to the ECM at the rear of the cell 
must be released. Most integrins at the trailing edge have been shown to be recycled to 
the leading edge of the ceU (Lawson and Maxfield, 1995; Palecek et al., 1996), 
however, integrins and other cells surface proteins have been found to be deposited on 
the ECM at the rear of the cell (Friedl et al., 1997), indicating that the recycling process 
is not 100% efficient.
Cell migration is regulated by a number of external factors. These include growth 
factors, cytokines and ECM components (reviewed by Huttenlocher et al., 1995). Anti­
adhesive ECM components such as tenascin, thrornbospondin and SPARC can induce 
cell migration by promoting detachment from the substratum and possibly by induction 
of MMP expression (Tremble et al., 1993; Tremble et al., 1994), leading to degradation 
of the ECM and consequently cell detachment. Growth factor signaling has been shown
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to stimulate ttyps integrin-mediated carcinoma cell migration on vitronectin. However, 
in the absence of the growth factor stimulus, carcinoma cells migrated over collagen 
using tt2pi integrin, and ttyps integrin was only found to be involved in carcinoma cell
adhesion to vitronectin (Klemke et al., 1994).
Cell motility is also regulated by the strength of the adhesions formed by integrins to the 
ECM (Palecek et al., 1997). At low adhesive strength cells will not be able to generate 
sufficient traction to permit migration, however, at higher adhesive strength cells will 
not be able to relax their adhesions to permit migration, effectively trapping the cell on 
the substratum. Variations in the substrate concentrations and cell surface integrin 
expression can effect the rate of cell migration, intermediate levels of both receptor and 
substrate tending to lead to maximal migration (DiMilla et al., 1991). A second way in 
which the strength of cell attachment can be regulated is by modulation of integrin 
activation states. As has been previously explained, this is mediated by the cytoplasmic 
domains of the integrins and is effected by inside-out signaling. Thus, cells have 
several levels of opportunity for regulating cell motility, which is tightly controlled in 
normal tissue, but deregulation of which can lead to tumour cell metastasis.
(xii) The Role of MMPs in Tumour Invasion and Metastasis
Tumour transformation from the benign to the malignant state involves interactions 
between the primary tumour and the ECM. These involve breakdown of the basement 
membrane by metastatic cells derived from the primary tumour, invasion of these 
through the connective tissue stroma, lymph vessels or basement membranes of small 
blood vessels, (intravasation), and transport in the bloodstream to a distant site. 
Metastatic cells must then adhere to the internal surface of blood vessels and extravasate 
into the new site, and finally degrade the stroma at the new site to allow expansion of 
the metastatic lesion and infiltration of blood vessels (reviewed by Hart and Saini,
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1992). AU these processes require proteolysis of the ECM and tissue remodeling, 
which could be potentially mediated by MMPs.
MMP-mediated hydrolysis of basement membrane has been thought to be a critical step 
during tumour cell intravasation into the bloodstream and extravasation into a new 
tissue. The involvement of MMPs in tumour progression has been noted for many 
years, however, a clear picture of the precise role of MMPs during this process has yet 
to be conclusively drawn. Many studies have found upregulation of MMPs and/or 
downregulation of TIMPs associated with tumours or the surrounding stroma 
(reviewed by Stetler-Stevensoi^t al., 1993; MacDougaU and Matrisian, 1995b; Sato 
and Seiki, 1996; Basset et al., 1997; Parsons et al., 1997). More direct evidence for the 
importance of MMP activity during metastasis has been the downregulatory effect of 
TIMPs and synthetic MMP inhibitors on tumour ceU invasion and metastasis, both in 
vitro and in vivo (reviewed by Chambers and Matrisian, 1997; Docherty et al., 1997; 
Parsons et al., 1997).
Despite upregulation of MMP activity around invasive tumour cells, degradation of 
ECM must be under some degree of control, otherwise tumour cells would be unable to 
gain sufficient adhesion to the substratum to permit movement towards the bloodstream 
and target organs. This may be regulated by TIMP production by stromal cells or even 
the tumour cells themselves, as TIMPs have occasionally been found to be upregulated 
in malignant tumours (Grignon et al., 1996). Positive regulation of MMP production by 
stromal cells surrounding the tumour may be achieved by production of growth factors 
and cytokines by tumour cells. MMPs are also not the only proteinases capable of ECM 
degradation and it has been demonstrated that enzymes of the plasminogen-activator 
system cooperate with MMPs during tumour progression (reviewed by DeClerck and 
Laug, 1996). This is particularly significant as plasmin has already been shown to 
activate several MMPs in vitro, and this may represent a highly sensitive mechanism for 
regulation of MMP activity. Signal transduction via integrin receptors has also been
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shown to effect MMP production in normal and tumorous cells (DeClerck and Laug, 
1996), suggesting that the extracellular environment may provide another level of 
regulation of MMP-mediated tumour cell invasion (Sudbeck et al., 1997).
An interesting report by Koop et al. (1996) showed by using the techmque of intravital 
videomicroscopy that normal and malignant, ras-transformed NIH 3T3 fibroblasts were 
equally well able to extravasate, however, the difference in normal versus transformed 
phenotypes was manifest during postextravasation growth. Although the MMP profile 
of the normal versus transformed fibroblasts was not explored in this study, MMP 
synthesis and activation has often found to be a feature of associated with mahgnant 
transformation. Upregulation of MMP activity in the tissue surrounding tumours was 
thought to be important for permission of tumour cell metastasis (reviewed by Stetler- 
Stevenson et al., 1993; Powell and Matrisian, 1996), although another study by Koop 
et al. (1994), found that overexpression of TIMP-1 in B16F10 melanoma cells had no 
effect on the rate of cell extravasation into chick embryo chorioallantonic membrane. 
However, this study showed that overexpression of TIMP-1 markedly suppressed 
post-extravasatory tumour growth. Therefore, MMPs may be capable of influencing 
neoplastic cell growth and growth of metastatic lesions (reviewed by Chambers and 
Matrisian, 1997). This suggests a more subtle role for MMPs during metastasis than 
had been previously ascribed. MMP facilitation of tumour growth may be indirect, 
possibly by release of sequestered growth factors from the ECM by MMP degradation 
and/or by degradation of the surrounding matrix to increase the space available for the 
tumour to occupy. MMPs have also been implicated in angiogenesis. Studies using 
synthetic inhibtiors of MMPs have found angiogenesis to be downregulated by MMP 
inhibition (Galardy et al., 1994). It is possible MMPs are acting in concert with growth 
factors such as vascular endothelial cell growth factor (VEGF), which have an 
estabüished foie in angiogenesis (Kim et al., 1993).
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The abundance of data concerning MMPs and tumour progression confirms their 
relevance to the metastatic process. New reports concerning more the subtle influence 
of MMPs during metastasis are now appearing in the literature, and comprehensive 
elucidation of the role of MMPs during tumour growth and metastasis will hopefully 
lead to novel tumour-suppressant drugs and and more specific targets for theraputic 
intervention.
(xii!) In Summary
The role of MMPs during tumour cell proliferation and metastasis remains to be clearly 
defined. It is apparent from previous work that MMP production and activation by 
tumour and stromal cells comprises a single aspect of tumourigenicity, although this 
area may still offer a potential target for theraputic treatment. A more detailed 
knowledge of the co-ordination of cytokine signaling and ECM signaling which bring 
about changes in cell behaviour, such as MMP expression, is vital to the design of 
effective treatments. Therefore, studies which focus on a particular aspect of the 
proposed metastatic cascade are important for elucidating the effects of a single event, 
such as MMP cleavage of a substrate. It is hoped that by defining individual issues 
during tumour progression that a detailed understanding of the whole, complex process 
can be built up.
This study focuses on the role of CL-3 in regulation of « 2pl integrin-mediated cell 
interactions with type I collagen. By presenting cells with either native coUagen or 
coUagenase-cleaved collagen fragments, it is possible to clearly evaluate the effects of 
CL-3 cleavage on cell attachment to, and invasion through, coUagen-1. The majority of 
published data to date concerning tt2pi integrin-mediated cell-collagen interactions, 
relates to cell binding to non-physiological, cyanogen bromide fragments of type I 
coUagen, often assayed below 37®C. This study is designed to address the apparent 
absence of information regarding the physiological significance of coUagenase cleavage
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of type I collagen. Since collagenolytic cleavage of fibrillar collagens may be an 
instance of in vivo generation of gelatin (denatured collagen) it is important to evaluate 
the effects of collagenase activity on cell-collagen interactions at physiological 
temperature.
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T a b l e  1
S ubun it Subunit Ligands and Counter Receptors
Pi a i
collagens, laminin
«2 collagens, laminin
«3 fibronectin, laminin, collagens
«4 fibronectin, VCAM-1
«5 fibronectin
«6
a?
laminin
laminin
a s not known
tty vitronectin, fibronectin
P2 OtL ICAM-1, ICAM-2
OtM fibrinogen, factor X, ICAM-1, complement (C3b)
a x fibrinogen, complement (C3b)
P3 «Ilb
a  Y
fibrinogen, fibronectin, von Willebrand factor, vitronectin, 
thrombospondin
vitronectin, fibronectin, fibrinogen, von Willebrand factor, 
thrombospondin, osteopontin, denatured collagens
P4 a6 laminin
P5 a^f vitronectin
P6 a y fibronectin
P? a4 fibronectin, VCAM-1
OtIEL not known
P8 ay not known
ICAM: intercellular adhesion molecule; VCAM: vascular cell adhesion molecule
T a b l e  2
Enzyme
Collagenases
Collagenase-1
Collagenase-2
Collagenase-3
Collagenase-4 (Xenopus) 
Gelatinases  
Gelatinase A
Gelatinase B
Strom elys ins  
Stromelysin-1
MMP S u b stra tes  
num ber
Stromelysin-2
stromelysin-3
Membrane-type
MMPs
MTl-MMP
MT2-MMP
MT3-MMP
MT4-MMP
Others
13
18
2
10
11
14
15
16 
17
collagens I, II, III, VII and X, aggrecans, 
serpins, a 2 -macroglobulin ( a 2 M), gelatins 
(limited)
collagens I, II and III, aggrecans, serpins, 
tt2 M, gelatins (limited)
collagens I, II, III, IV, IX, X and XIV, 
gelatins, serpins, aggrecan, fibronectin, 
laminin, tenascin, N-telopeptides 
collagen I
denatured fibrillar collagens, collagens V, VII 
and XI, Œ2 M, tenascin, elastin 
denatured fibrillar collagens (I-III), collagens V, 
VII, XI and XIV, « 2 M, elastin
aggrecan, fibronectin, nidogen, laminin, 
proteoglycan core protein, collagen IX, gelatins 
(limited), elastin (limited), nonhelical X-links of 
collagen IV
aggrecan, fibronectin, non-helical X-links of 
collagen IV, proteoglycan core protein, collagen 
IX, laminin, gelatins (limited), elastin (limited) 
a  1-proteinase inhibitor, limited activity on 
fibronectin, laminin, collagen IV, aggrecan, 
gelatins
collagens I, II, III, fibronectin, laminin,
vitronectin, dermatan sulphate proteoglycan,
proMMP-2, proMMP-13
not known
proMMP-2
not known
Matrilysin (PUMP)
Metalloelastase
(Unnamed)
12
19
aggrecan, fibronectin, laminin, gelatins, non­
helical X-links of collagen IV, elastin, entactin, 
collagen IX, proteoglycan core protein, 
vitronectin 
elastin 
not known
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Chapter 2
Materials and General Methods
The majority of chemicals and reagents used in this study were purchased from Sigma 
Chemical Company, and are not specifically listed in this section. Specialist materials 
and manufacturers are listed below.
Antibodies and Peptides
5E8 mouse monoclonal anti-a2 integrin antibody (Chen et al., 1991) was a kind gift of 
Dr. R. Bankert, Roswell Park Cancer Institute, Buffalo, NY, USA; 6F1 mouse 
monoclonal anti-a2 integrin antibody (Coller et al., 1989) was a kind gift of Dr. B.S. 
Coller, Mount Sinai Hospital, New York, NY, USA; LM609 mouse monoclonal anti- 
ttvPs integrin antibody (Wayner et al., 1991) was purchased from Chemicon, USA; 
mouse IgG (Sigma) was used as an antibody control. ROD and RYD (single letter 
amino acid code) containing-peptides were purchased from Sigma.
Cell Lines and Tissue Culture
HT1080 K2P fibrosarcoma cells were a kind gift of C. Marshall, Institute of Cancer 
Research, London, UK. A375M melanoma cells were obtained from the European Cell 
and Culture Collection. Cells were maintained at 37oC, 5% CO2, in Dulbecco's 
Modified Eagle's Medium (DMEM; GibcoBRL, UK) supplemented with 10% heat- 
inactivated foetal calf serum (PCS; Globepharm, USA) and the antibiotics penicillin and 
streptomycin (1000 iu/ml-1000 pg/ml, GibcoBRL, UK). Cells were passaged 24-48 
hours prior to experimentation and harvested at 80% confiuency using trypsin/EDTA 
solution (Sigma).
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Electrophoresis, Silver Staining and Gelatin Zymography
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Proteins were analysed by SDS-PAGE (Laemmli and Favre, 1973), using acrylanude 
solution, ammonium persulphate and potassium persulphate from BioRad Laboratories. 
SDS was purchased from Serva. Gels were formed and electrophoresed using BioRad 
mini-protean II equipment. (40% acrylamide, 0.01% Bis aciylamide solution)
Proteins were visulaized using silver nitrate solution. Briefly, gels were fixed in 40% 
methanol, 10% acetic acid solution for 30 minutes. The fix was removed and the gels 
rinsed with distilled water , A small pinch of 61.5% Na2S2Û3.5H20, 38.5% 
K3Fe(CN)6 mixture was added to ~20 mis water and added to the gel to reduce any 
proteins present. After 5 minutes this solution was removed and the gels washed with 
several changes of water until they became colourless. Silver nitrate solution (0.012M) 
was added to the gels and incubated for 20 minutes at room temperature with constant 
agitation. The silver nitrate solution was removed and the gels washed several times 
with water, prior to a single rinse in 2.5% Na2C0 3  solution. Gels were developed with 
100 pi of 38.5% paraformaldehyde solution in 100 mis of 2.5% Na2C0 3  until bands 
appeared. Development was stopped using 5% acetic acid solution. Gels were dried in 
10% glycerol, 5% acetic acid solution and preserved in porous actetate.
To analyse samples for gelatinase activity, heat-denatured (20 minutes at 60°C) type I 
calf skin collagen (0.5 p,g/ml) was incorporated into 8% polyacrylamide SDS-PAGE 
gels (Heussen and Dowdle, 1980). Non-reduced samples were separated by 
electrophoresis and the gels washed twice with 2.5% Triton X-100 for 15 minutes per 
wash. Excess Triton was rinsed off with water and the gels incubated for 16 hours at 
room temperature (or 37°C) in lOOmM Tris pH 7.9, 30 mM CaCl2, 0.04% Brij 35, 
0.02% sodium azide. Gels were stained with Coomassic Brilliant Blue and then 
destained slightly to reveal bands of gelatin lysis. Zymograms were dried and preserved 
as for silver stained gels
34
.K--
Generation and Purification of Type I Collagen 3/4 and 1/4 Fragments
Rat skin type I collagen was isolated and purified as described by Cawston and Barrett 
(1979). Recombinant human collagenase-3 was expressed by stable transfection of
I
: NSO mouse myeloma cells and purified from serum-free conditioned cell culture
medium (Knauper et al., 1996a). Collagenase-3 was activated with p- 
aminophenyhnercuric acetate (APMA) for 30 minutes at 37®C (Knauper et al., 1996a).
Type I collagen (5 mg) in 50 mM Tris pH 7.4, 150 mM NaCl (Tris buffered saline, 
TBS) with 60 mM CaCl2 was incubated with activated collagenase-3 (18 p,g) for 16 
hours at 25®C. Isolation of 3/4 and 1/4 type I collagen fragments from this cleavage 
mixture was performed essentially as described by Fitzsimmons et al. (1986) with 
minor modifications. The cleavage mixture was placed on ice at 4®C and solid 
anunonium sulphate added to 12% saturation to precipitate any uncleaved type I 
collagen. The mixture was stirred constantly for 1 hour on ice and centrifuged at 15,(X)0 
g for 1 hour at 4°C. The supernatant was removed, ammonium sulphate added to 18% 
I saturation to precipitate the 3/4 fragment and stirred for 1 hour on ice. The 12% pellet
I was washed by resuspension in TBS containing 12% ammonium sulphate and
ii repeUeted by centrifugation at 15,000 g for 1 hour at 4®C. The peUet was solubhzed in 
I 0.2 M acetic acid and dialysed for 16 hours into TBS. The precipitate produced by 18%
I anunonium sulphate precipitation was centrifuged as before, washed with TBS
■f
i containing 18% anunonium sulphate, and solublized and dialysed as above. The
■i ammonium sulphate concentration of the supernatant was raised to 25% to precipitate 
j the 1/4 fragment and purified as above. The protein concentration of each solution was
I estimated by bicinchoninic acid (BCA) assay (Smith et al., 1985) (see below),
j following the manufacturers instructions (Pierce). A known concentration of each
sample was analysed with uncleaved type I collagen by 5-15% polyacrylamide gradient 
gel electrophoresis and stained with silver reagent.
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Adsorption of the fragments to plastic at room temperature stabilized the triple helical 
fragment conformation even when the fragment-coated plastic was later placed at 37®C 
for the duration of the assay (usually 30 minutes, as revealed by cell attachment assays 
performed at 37®C, see Chapter 5). It was therefore necessary to heat denature the 
collagen fragments for 16 hours at 35®C prior to assay at 37®C.
The presence of CL-3 on the collagen fragments was probed by ELISA using a sheep 
anti-human CL-3 polyclonal antibody produced in this laboratory (L29/6; Cowell,S., 
Knauper,V., Stewart,M., d'Ortho,M.-P., Stanton,H., Hembry,R.M., L6pez-Otin,C., 
Reynolds,JJ. and Murphy,G., paper in preparation). No detectable level of CL-3 was 
found in association with fragments adsorbed to ELISA plates (Maxisorp, Nunc), 
although a positive control of 10 ng/well CL-3 adsorbed alongside the fragments was 
readily detected by this method.
Immunolocalization
Cells were grown in DMEM supplimented with 10% PCS on glass coverslips coated 
with 20 jig/ml substrate (type I collagen, fragments of type I collagen or fibronectin; 
adsorbed to the glass for 16 hours at 4°C). Cells were then washed with serum-free 
DMEM and fixed with 4% paraformaldehyde in 0.5x PBS pH7.4, for 5 minutes. 
Coverslips were washed with fresh PBS and incubated with 0.1% Triton X-100 in 
PBS for 5 minutes to permeabHse cells. Cells were washed and incubated with 200 pi 
per/covershp of 5 pg/ml primary, monoclonal antibody in PBS with 50 pg/ml blocking 
serum, (same species as the secondary antibody was raised in), for 30-60 minutes at 
room temperature. Cells were washed and incubated with appropriate fluorescent-labelled 
secondary antibodies diluted 1:200 (donkey-anti-mouse IgG Texas Red-conjugated 
antibody, Jackson Immunoresearch Ltd (Texas Red is a registered trade mark of 
Jackson Immunoresearch Ltd.); rabbit anti-rat IgG FTTC-conjugated antibody, Dako) in
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PBS for 30 minutes at room temperature. Cells were washed and mounted in Citifluor 
(City University, London) and examined under a fluorescence microscope (Zeiss 
Photomicroscope HI; Carl Zeiss, New York). Photographs were taken using Kodak 
Panther 1600 ASA film.
MMP Activity Assays
Gelatinase activity was measured using the method of Murphy et al. (1981b). Briefly, 
i^C-acetylated rat skin type I collagen (1 mg/ml) was denatured at 60°C for 20 minutes 
and placed in tubes, (100 pl/tube), with samples and 100 mM Tris pH 7.6, 10 mM 
CaCl2, 0.02% NaN3, 0.04% Brij 35 (TCAB) to a total volume of 250 pi for 16-18 
hours at 37°C. Undegraded gelatin was precipitated with 30% trichloroacetic acid (50 
pl/tube) for 30 minutes on ice. The precipitate was pelleted by centrifugation for 15 
minutes at 12,000 g and 4°C, and the radioactivity of 200 pl/sample determined by 
scintillation counting. Incubation of 100 pi of gelatin with either 16 pg bacterial 
collagenase or 10 pg trypsin, controlled for total lysis of the gelatin and gelatin integrity 
respectively. The gelatinase activity of tlie samples was converted into the linear range 
of the assay (20-75% of total lysis) and expressed as units/ml of enzyme activity.
Stromelysin activity was detected using 1 mg/ml I4c-acetylated casein (100 pl/tube) by 
the method of Murphy et al. (1981b), essentially as described for gelatinase assays. 
However, undegraded casein was precipitated using 50 pl/tube 3% trichloroacetic acid 
on ice for 30 minutes prior to pelleting by centrifugation. Bacterial collagenase controls 
were omitted from these assays and total lysis of the casein determined using 10 
pg/tube trypsin, as described above. Results were analysed and expressed as described 
for gelatinase assays.
Collagenase activity was detected by the method of Cawston and Barrett (1979), which 
is similar to the gelatinase assay detailed above. Briefly, 100 pi of 1 mg/ml ^^C-
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acetylated rat skin type I collagen was incubated with samples and TCAB in a total 
volume of 300 pl/tube. The tubes were incubated for 16-18 hours at 35°C and 
uncleaved collagen pelleted by centrifugation for 15 minutes at 12,000g at 4®C. The 
radioactivity of 200 pi of each sample was determined by scintillation counting. Control 
lysis with bacterial collagenase and trypsin were performed as descibed for gelatinase 
assays. Results were analysed and expressed as described for gelatinase assays.
All samples were assayed in triplicate for all MMP assays, and one unit of enzyme 
degrades 1 pg of substrate in 1 minute at 37°C.
Protein Estimation
The concentration of protein sangles was estimated using the bicinchoninic acid method 
(Smith et al., 1985) according to the manufacturers (Sigma) instructions. Briefly, 
bicinchoninic acid (50 parts) was mixed with copper (H) sulphate (1 part) to produce 
the protein determination reagent. 2 mis of protein reagent was mixed with known 
volumes of prulciu Standard diluted in water (to form a calibration curve), and with the 
unknown protein sample. The total volume of each tube did not exceed 2.1 mis. 
Samples were incubated at 37°C for 30 minutes then allowed to cool to room 
temperature. Once cool, the absorbance of the samples at 562 nm was determined using 
a spectrophotometer. The absorbance of known quantities of protein standard were 
plotted to give a standard curve, from which the concentration of the unknown samples 
was determined. In all cases, 1 mg/ml BSA was used as the protein standard.
Recombinant Human Matrix Metallproteinases and Inhibitors
Procollagenase-3 was a kind gift from Dr. Vera Knauper (University of East Anglia, 
Norwich, UK). Progelatinase A (Crabbe et àl., 1993), progelatinase B (O'Connell et 
al., 1994), procollagenase-1 and stromelysin-1 (Murphy et al., 1992b) were kind gifts
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from Prof. Gillian Murphy (University of East Anglia, Norwich, UK]u TIMP-2 
(WiUenbrock et al., 1993) was a gift from Dr. Mike Hutton (University of East Anglia, 
Norwich, UK). Full length MT-1 MMP and MT-2 MMP were gifts from Dr. Horst 
Will (In Vitek GmbH, Berlin-Buch, Germany).
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Chapter 3
Interaction of Isolated tt2pi Integrin With Type I Collagen and Collagen 
Fragments
Introduction
To study effect of collagenase-degradation on cell-surface receptor interactions with 
monomeric type I collagen, sohil^ised collagen was incubated overnight with active 
collagenase-3 to produce the classical 3/4 and 1/4 length fragments. These fragments 
were purified from the residual, uncleaved collagen, thereby ensuring that all receptor- 
coUagen interactions could be attributed to the collagen fragments. In order to facilitate 
the detailed study of tt2Pi integrin mediated interactions with type I collagen and the 
collagenase-3 derived fragments of collagen, « 2Pl integrin was isolated from outdated 
human platelet preparations. These cells were chosen because tt2pi integrin mediates 
platelet adhesion to monomeric type I collagen (Staatz et al., 1989; Santoro and Zutter, 
1995), and because suitable quantities of outdated preparations were readily available.
Most reports of cell interactions with collagen fragments have concentrated on location 
of tt2pi integrin-binding sites within the type I collagen molecule. This has been 
principally been studied using peptide fragments generated by cyanogen bromide 
(CNBr) cleavage of type I collagen (Fitzsimmons et al., 1986; Staatz et al., 1990; 
Gulberg et al., 1992; Morton et al., 1994), although Fitzsimmons et al. (1986) also 
used collagenase- 1 generated collagen fragments.
Whilst the small peptides generated by CNBr cleavage of collagen are useful in 
attempting to pinpoint regions of the collagen molecule involved in receptor binding, 
they do not represent a physiological substrate for cell-surface receptors such as tt2Pi
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integrin. Collagenases. such as collagenase-3 (CL-3), are synthesised and secreted by 
many cell types in vivo, and are therefore more useful tools than CNBr for analysing 
the effects of degradation of the collagen molecule on cell-collagen interactions. As 
discussed in chapter 1, ECM remodeling has been shown to have a significant effect on 
cell behaviour. However, few studies on the effects of physiological proteolysis of 
fibrillar collagens on cell-matrix interactions have been published to date. The data 
presented in this chapter analyses the interactions of isolated collagen fragments and the 
tt2Pi integrin receptor, and compares these with a 2pi integrin interactions with native 
type I collagen.
Methods
Reagents
Mouse monoclonal antibodies to human (%2 integrin (6F1 and 5E8) and a rat 
monoclonal to human pi integrin (mAb 13) were obtained as described in Chapter 2. 
Rat skin type I collagen and gelatin was prepared as described in Chapter 2.. 
Collagenase-3 generated fragments of rat skin type I collagen were purified as described 
in Chapter 2.
Purification of a 2pi Integrin From Outdated Human Platelets
This was carried out essentially as described by Vanderberg et al. (1991) with some 
modifications. Briefly, outdated human platelet concentrate apheresis packs of single 
ABO blood group were combined and centrifuged at 1,500 g for 20 minutes at 4°C. 
The supernatant was discarded and the pellets resuspended in 13 mM sodium citrate, 
120 mM NaCl, 30 mM glucose pH 7.0 at 4^C. The suspension was centrifuged at 
1,500 g for 20 minutes at 4°C and the washing procedure repeated as above. The 
resulting pellets were resuspended in 10 mM Tris pH 7.4, 5 mM sodium citrate, 100
41
pM pepstatin A, 5 |iM trans-epoxysuccinyl-L-leucylamido(4-guajiidino)butane (E-64), 
2 pg/ml leupeptin, 1 mM 4 -(2-aminoethyl)-benzenesulphonyl fluoride (AEBSF) and 
sonicated at 30% output for 3x10 seconds on ice. The sonicates were centrifuged at 
100,000 g for 30 minutes at 4°C and the supernatant discarded. The platelet membrane 
preparations were then either stored at “80°C until needed or lysed directly by 
resuspending in a small volume of 50 mM Tris pH 7.4, 150 mM NaCl, 2 mM MgCl2,
1 mM MnCl2, 100 mM n-octyl p-p-glucopyranoside (OG), 100 pM pepstatin A, 5 pM 
E-64, 2 pg/ml leupeptin, 1 mM ABBSF (extraction buffer) for 30 minutes on ice. The 
lysate was centrifuged at 100,000 g for 30 minutes at 4°C and the supernatant collected 
and loaded directly onto a prepared collagen-Sepharose column.
Type I collagen (2.25 mg/ml) was coupled to 6 -aminohexanoic acid n- 
hydroxysuccinimide ester linked, cyanogen bromide activated Sepharose 4B (Sigma) 
according to the manufacturers instructions. This was washed alternatively with three 
washes of: (a) O.IM sodium acetate pH 4.0, 0.5M NaCl and (b) 0.1 M Tris pH 8.0, 
0.5 M NaCl. The gel was washed with 50 mM Tris pH 7.4, 150 mM NaCl (TBS) and 
packed into a column. The column was equilibrated with two column volumes of TBS,
2 mM MgCl2, 1 mM MnCl2, 25 mM OG (equihbration buffer) followed by two column 
volumes of extraction buffer at a flow rate of 30 milliliters/hour. The platelet membrane 
supernatant was loaded onto the column at 10 milliliters/hour and the mnoff reapplied to 
the column. One column volume of extraction buffer was then run through the column 
followed by at least two column volumes of equilibration buffer. Bound a 2pi integrin 
was eluted off the colunrn with TBS, 25 mM OG, 20 mM EDTA at a flow rate between 
3-10 milliliters/hour. Protein eluted in the presence of EDTA were monitored by 
spectrophotometry at 280nm. Fractions containing protein were combined and dialysed 
into TBS, 2 mM MgCl2 , 1 mM MnCl2 , 0.02% sodium azide, and the protein 
concentration determined by BCA assay (Chapter 2). The purified integrin was 
sometimes biotinylated using a protein biotinylation kit (Amersham Life Sciences)
42
according to the manufacturer's instructions. All integrin preparations were aliquoted 
and stored at "80°C.
Characterization of the Purified Platelet a%Pl Integrin
The purity of the affinity-purified collagen receptor was analysed by SDS-PAGE. 
Proteins were visualized by staining with silver nitrate (described in Chapter 2). 
Immunoprécipitation of the integrin with P1E6 anti-tt2 integrin antibody (Carter et al., 
1990) was carried out esentially as described by Adams and Watt (1988). Briefly, 
biotinylated a 2 0 i integrin was incubated with the antibody, then the integrin-antibody 
mixture incubated with protein A coupled to Sepharose matrix. Unbound protein was 
washed off the matrix and bound protein released by boiling with x2 reducing sample 
buffer. The sample was subjected to 6% SDS-PAGE and transfered onto Hybond ECL 
(Amersham Life Sciences) nitrocellulose membrane. The membrane was blocked with 
5% non-fat milk powder in PBS with 0.1% Tween X-100 (PBS-Tween), washed in 
milk-ffee PBS-tween solution and incubated for 1 hour with streptavidin-horseradish 
peroxidase (Amersham Life Sciences: 1:1500 dilution) in PBS-Tween. Unbound 
streptavidin-peroxidase was washed off with PBS-Tween, and bound proteins 
visualized onto ECL Hyperfilm (Amersham Life Sciences) using SuperSignal 
Chemiluminescent Substrate and SuperSignal Stable Peroxidase solutions (Amersham 
Life Sciences).
Western blotting of the purified « 2^1 integrin was performed essentially as described 
by Towbin et al. (1979). Briefly, a 2pi integrin was subjected to 6 % SDS-PAGE and 
tranferred onto Hybond ECL (Amersham Life Sciences) nitrocellulose membrane. 
Unbound membrane was blocked by incubation for 1 hour at 37°C with 5% non-fat 
milk powder in Western wash buffer. The blocked membrane was incubated for 16 
hours at 4°C with mAb 13 anti-tt2 integrin antibody (Akiyama et al., 1989). Unbound 
primary antibody was washed off with wash buffer and the membrane blocked for a
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second time at 37°C with 5% milk powder solution. The membrane was then incubated 
with horseradish-peroxidase conjugated, rabbit-anti-rat IgG secondary antibody in 
wash buffer for 1 hour at room temperature. Unbound secondary antibody was washed 
off with wash buffer and the membrane-bound proteins visualized with ECL solutions, 
as described for the immunoprécipitation protocol above.
Solid-phase Ligand Binding Assays
Experiments in which the tt2Pi integrin receptor was adsorbed to 96 well ELISA plates 
(Maxisorb, Nunc), and biotinylated ECM ligands were added are termed "receptor- 
immobilized" ligand binding assays and were performed as described by Kern et al.
(1993). Briefly, 100 jil/well of tt2pi integrin (1.75 pg/ml) in TBS, 1 mM MgCl2 , 1 
mM MnCl2 , 0.02% sodium azide (buffer A) was adsorbed to ELISA plates for 16 
hours at 4°C and unbound plastic was blocked by incubation with buffer A containing 
1% BSA (buffer B, 100 pl/well) for 1 hour at room temperature. Where antibodies 
were used, these were added to washed wells in buffer B at a total volume of 100 
pj/well and incubated for 1 hour at room temperature. Wells were washed 3 times with 
buffer B and 100 jil/well of biotinylated type I collagen and type I collagen fragments 
were incubated with the immobilized integrin for 2 hours at room temperature, with or 
without 10 mM EDTA. After washing the wells three times with buffer B, bound 
proteins were detected by incubation with streptavidin-horseradish peroxidase 
(Amersham Life Sciences; 1:1500 dilution) in buffer B (100 pl/weU) for 1 hour at room 
temperature. Unbound streptavidin was washed off the wells three times with buffer A 
and bound peroxidase activity was measured by incubation with 3,3',5,5'- 
tetramethylbenzidine-peroxidase (TMB) substrate mixed 1:1 with H2O2 (100 pl/well). 
The colour reaction was stopped using 50 pl/well 2.5 M H2SO4 and the absorption of 
the solution in the wells was measured at 450 nm using an ELISA reader.
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Due to the difference in size of the whole collagen molecule and the 3/4 and 1/4 collagen 
fragments, it was necessary to determine the degree of biotinylation of each of these 
ligands. Serial dilutions of biotinylated proteins were dotted onto Hybond ECL 
nitrocellulose membrane (Amersham Life Sciences) and incubated with streptavidin- 
horseradish peroxidase (Amersham Life sciences; 1:1500) in TBS for 30 minutes at 
room temperature. Peroxidase activity was detected using SuperSignal 
Chemiluminescent Substrate and Stable Peroxidase (Amersham Life Sciences) ECL 
reagents and the blot exposed to Hyperfilm (Amersham Life Sciences) ECL film for 15- 
30 seconds. The film was developed and scanned into a Leica Q500+ image analyser 
(in collaboration with Dr. Richard Famdale, Department of Biochemistry, University of 
Cambridge, Cambridge, UK) and the density of each dot of protein measured by the 
image analyser. Values were corrected against the background and mean values for each 
protein compared. OD values obtained during "receptor-immobilized" ligand binding 
assays were then corrected for the degree of biotinylation of each ligand.
Experiments in which type I collagen and type I collagen fragments were adsorbed to 
ELISA plates and then biotinylated a 2pi integrin added are termed "ligand binding 
assays". For experiments carried out at room temperature, type I collagen and the 
fragments in TBS (100 pl/well) were allowed to bind to the ELISA plates for 1 hour at 
room temperature and uncoated plastic blocked with 50 mg/ml BSA in TBS (100 
|Lil/well) under the same conditions. Wells were washed three times with TBS, 1 mM 
MgCl2, 1 mM MnCl2 (buffer C) and incubated with biotinylated tt2Pi integrin in 1 
mg/ml BSA in buffer C (buffer D; 100 pl/well) for 2 hours at room temperature. Where 
antibodies or EDTA were used, these were added to the wells at the same time as the 
integrin. Unbound integrin was removed and wells washed three times with buffer C. 
Wells were incubated with streptavidin-horseradish peroxidase (1:1500 dilution) in 
buffer D (100 |il/well) for 15-20 minutes at room temperature and bound protein 
visualised as described for the "receptor-immobilized" ligand binding assays.
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For studies of a 2Pi integrin interactions with the denatured fragments, ligand binding 
assays at 37°C were performed essentially as described above. However, the 
biotinylated collagen fragments were incubated at 35°C for 16 hours prior to coating to 
wanned ELISA plates for 1 hour at 37°C. Blocking and wash stages were performed at 
37°C using the buffers described above, warmed to 37°C. Incubation with biotinylated 
ligands was carried out at 37°C for 30 minutes. Washed wells were incubated with 
streptavidin-horseradish peroxidase for 15 minutes at 37°C and bound proteins were 
visualised as described for the "receptor-inunobihzed" ligand binding assays.
Results
The purity of the type I collagen fragments generated by CL-3 cleavage of native type I 
collagen was determined by 6% SDS-PAGE followed by silver staining. Each fragment 
was found to be essentially free of contamination with uncleaved collagen or the other 
fragment (fig.3.1)
The purity of the human platelet tt2pi integrin preparation was determined by 6% 
polyacrylamide gel electrophoresis and silver staining. Two bands were resolved on the 
gel, of approximate molecular mass of 150 kDa and 120 kDa (fig.3.2), which 
correspond to the published molecular mass of the tt2 and Pi integrin subunits 
respectively analysed under reducing conditions (Takada and Hemler, 1989; 
Vanderberg et al., 1991). The bands were further characterized by immunoprécipitation 
with P1E6 anti-« 2  integrin antibody (Carter et al„ 1990), Two bands were visualized 
by immunoprécipitation, (of approximate mass of 150 kDa and 125 kDa), as the 
integrin a  and p subunits form a tight complex which precipitates both subunits when 
probed with an antibody to a single subunit (fig.3.3). Western blotting using mAb 13 
anti-pi integrin antibody (Akiyama et al., 1989) located a single band of approximate 
molecular mass of 125 kDa (fig.3.4), corresponding to the described molecular mass of 
the Pi subunit.
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Biotinylated type I collagen bound to immobilized a iP i integrin in a dose-dependent 
manner (fig.3.5). Collagen binding to a 2pi integrin was inhibited by incubation of the 
immobilized integrin with 6F1 anti-tt2 integrin and mAb 13 anti-Pi integrin antibodies 
prior to addition of the collagen, whereas a control IgG had no effect (fig.3.6). This 
result demonstrated the specificity of the biotinylated collagen binding to the a 2Pi 
integrin. Collagen binding to the immobilized integrin could also be completely 
inhibited by 10 mM EDTA (fig.3.6), confirming the that this was a cation-dependent 
interaction. Biotinylated 3/4 and 1/4 type I collagen fragments were found to bind to 
immobilized a 2pi integrin approximately 67% and 15% as well as full length collagen 
respectively when coated at the same molar concentration (fig.3.7). The correction for 
the degree of biotinylation with respect to each collagenous ligand was determined from 
densitometric analysis of a serial dilution of each ligand (fig.3.8).
Biotinylated tt2Pi integrin bound to immobilized type I collagen in a dose-dependent 
marmer (fig.3.9). tt2pi integrin binding to immobilized collagen and fragments was 
compared at room temperature and it was found that « 2Pi integrin bound equally well 
to native collagen and the native 3/4 fragment of type I collagen. Less integrin binding 
to the 1/4 fragment was observed at lower ligand concentrations, however, binding 
increased to approximately 60% of that observed to native collagen at the highest ligand 
concentration tested (fig.3.10). The tt2pi integrin binding to the native type I collagen 
and the fragments was completely inhibitable by 10 mM EDTA, indicating that the 
binding was most likely to be integrin-mediated (fig.3.10).
The a 2Pi integrin binding to native collagen and the native fragments which was 
observed at room temperature could be significantly reduced by addition of 6F1 and 
5E8 anti tt2 integrin antibodies, but a control IgG had no effect on integrin ligand 
binding (fig.3.11). This confirmed the specificity of the biotinylated tt2pi integrin 
interaction witli the collagen fiagnients.
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tt2pi integrin binding to native collagen and denatured collagen fragments at 37°C was 
also tested. The results showed the necessity for retention of the collagen fragment 
triple-helical stmcture to maintain a 2pi integrin interactions, since heat-denaturation of 
the fragments completely inhibited tt2pi integrin binding (fig.3.12). Heat-denaturation 
of type I collagen also inhibited tt2Pi integrin binding at 37°C compared to integrin 
binding to native collagen, although at the highest gelatin concentration a low level of 
tt2Pi integrin was observed (fig.3.13).
Discussion
The data presented in this chapter strongly indicate that tt2pi integrin binding to type I 
collagen fragments, generated by in vitro degradation by collagenase-3, is totally 
dependent on retention of the collagen triple-helix. The implications of this result for 
tt2pi integrin interactions with collagen fragments generated in vivo are profound, as 
these fragments might be expected to denature at 37°C as soon as they were formed, 
leading to abolition of tt2pi integrin binding.
Two types of ligand-binding assays were employed to test isolated a 2pi integrin
interactions with type I collagen and the 3/4 and 1/4 fragments. Pfaff et al. (1994)
found that stronger integrin-ligand binding was observed when the isolated integrins
were immobilized on ELISA plates and the ligands added in solution than when the
ECM ligands were coated onto ELISA plates and the integrins added in solution. This is
possibly due to integrin conformation being optimised when adsorbed onto plastic 
4ke. conformation
conq)ared to^in solution, therefore allowing the integrins to function more readily as ECM 
protein receptors. A study by Kem et al. (1993), which used platelet tt2pi integrin 
purified in a similar manner as described below, analyzed the coating efficiency of this 
integrin using iodinated integrin and found that 50-60% of the integrin coated in 
solution was immobilized on the ELISA plates by adsorption.
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Due to complications in analysing the data generated from this type of "receptor- 
immobilized" assay, ligand binding assays were also performed using immobilized type 
I collagen and fragments and biotinylated tt2Pi integrin. This allowed direct 
comparison of integrin binding to each substrate without correction for degree of 
biotinylation of the substrates, and also permitted less variation in results between 
integrin and fragment preparations.
The majority of biotinylated tt2pi integrin binding to collagen fragments was supported 
by the native 3/4 fragment of type I collagen. This was essentially the same level of 
binding as was observed to the whole collagen molecule. Since tt2Pi integrin only 
appeared to interact with the 1/4 fragment of type I collagen at high coating 
concentration at room temperature, it is possible that this fragment does not contain 
many tt2pi integrin binding sites. This is in agreement with data with cyanogen 
bromide derived fragments of type I collagen (Morton et al., 1994). The 1/4 fragment 
generated by collagenase cleavage of type I collagen is equivalent to a small section of 
al(I)CN Br 7 and all of CNBr 6b (Gross et al„ 1980; see Chapter 1, fig, 1,3). No 
human platelet adhesion to CNBr 6b via « 2pl integrin was observed, and although 
CNBr 7 was found to support platelet adhesion, the collagenase-generated 1/4 fragment 
may not contain enough of the CNBr 7 region to actively support 0 .2  integrin 
interactions. However, it is possible that the 1/4 fragment was partially denatured 
during the assays at room temperature, thus reducing any integrin-mediated 
interactions. This is unlikely as the published melting temperature of this fragment 
(29°C; Stark and Kiihn, 1968a) is several degrees higher than the assay temperature. 
Binding to the triple helical fragments was significantly reduced by anti-a2 integrin 
antibodies at the concentrations used, and completely abrogated by EDTA, confirming 
that binding to collagen and the fragments was specifically mediated by tt2pi integrin.
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Studies bÿ -Stark-andiQihir(t968a) showed that the 1/4 and 3/4 fragments of type I 
collagen lose their triple helical structure below physiological temperature. Thus, 
collagenase cleavage of type I collagen may be an instance of in vivo generation of 
gelatin. The results presented above show that tt2pi integrin was able to bind to the 
triple helical 3/4 and 1/4 fragments of collagen, but not to the heat-denatured fragments, 
which were essentially gelatin. The results extend the data published by Morton et al.
(1994), where the authors found that tt2Pi integrin-mediated platelet adherence to 
CNBr fragments was ablated at 37®C. These data underscore the need for native, triple 
helical collagen conformation as a prerequisite for tt2pi integrin mediated binding, and 
strongly suggest that tt2pi integrin does not mediate cell interactions with cleaved type I 
collagen in vivo.
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Chapter 4
a 2 In teg rin  A -dom ain B inding to Type I Collagen and  Collagen 
Fragm ents 
In troduction
The OL2 integrin is one of several alpha integrin subunits (a i, « 2 , otL» otM, a x  and ag)
which have been found to contain a - 2 0 0  amino acid inserted domain (I-domain) between
repeats II and III of the seven-fold repeated N-terminal domain structure (Hughes,
1992; Shaw et ah, 1994). This region is similar in sequence to the collagen binding
the
motif found in the A-domain of von Willebrand factor (Pareti et ah, 1987) and^A- 
domain-like sequences found in type VI collagen, complement factor B and cartilage 
matrix protein (Colombatti et ah, 1993). The (%2 integrin A-domain has been shown to 
the collagen-binding region of the a 2 pi integrin (Kamata and Takada, 1994; Tuckwell 
et al, 1995), and it was therefore of interest to study the effects of collagenase-cleavage 
of collagen on A-domain binding. It is unclear whether divalent cations such as Mg2+ 
or Mn^+ are essential for all A-domain function, however, the (%2 integrin A-domain 
requires divalent cations to interact with type I collagen (Tuckwell and Humphries, 
1996b). The purpose of this investigation was to confirm and extend the data generated 
during the study of whole a 2 Pi integrin interactions with type I collagen and type I 
collagen fragments in their native and denatured conformation.
M ethods 
Antibodies and Reagents
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Mouse monoclonal antibodies to human Œ2  integrin (6F1 and 5E8) were obtained as 
described in Chapter 2. Recombinant human Œ2  integrin A-domain was a kind gift from 
Dr. Danny Tuckwell, School of Biological Sciences, University of Manchester, 
Stopford Building, Oxford Road, Manchester, UK. Rat skin type I collagen was 
prepared as described in Chapter 2. Collagenase-3 generated fragments of rat skin type 
I collagen were purified as described in Chapter 2.
Generation and Labelling of Recombinant In tegrin  A-domain
Recombinant « 2  integrin A-domain was produced by D. Tuckwell at Manchester 
University, as described by Tuckwell et al. (1995a). Briefly, human « 2  integrin A- 
domain cDNA was generated by reverse transcription/PCR from HT 1080 cell RNA, 
cloned into the pGEX-2T vector (Smith and Johnson, 1988) and transfected into E. coli 
DH5aF' bacteria. Induction of bacteria that carried the plasmid with 0.1 mM isopropyl- 
p-D-thiogalactoside led to production of « 2  integrin A-domain-glutathione-S-transferase 
(GST) fusion protein, which was purified from bacterial lysates on a glutathione- 
affinity column. The fusion protein was dialysed into TBS to remove the glutathione 
and cleaved with thrombin (Sigma; 1:100 (w/w) enzyme:fusion protein). The cleavage 
mixture was reduced with dithiothreitol (DTT) and passed a second time down a 
glutathione agarose column to remove GST. The purified Œ2  integrin A-domain was 
dialysed into TBS and stored at ’80°C.
Recombinant « 2  integrin A-domain was biotinylated using a protein biotinylation kit 
(Amersham Life Sciences). Briefly, A-domain was dialysed in to PBS and incubated 
with biotinylation reagent for 1 hour at room temperature, following the manufacturer's 
instructions. Unbound biotin was removed by extensive dialysis into TBS, 1 mM 
MgCl2  (at least 3 changes of buffer over 48 hours) and the protein concentration of the 
solution determined by BCA assay as described in Chapter 2.
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Solid-phase Ligand Binding Assays
These were performed essentially as described by Tuckwell et al. (1995a). For 
experiments carried out at room temperature, type I collagen, gelatin or type I collagen 
3/4 and 1/4 fragments (100 pl/well) were coated to 96 well ELISA plates (Maxisorb, 
Nunc) by adsorbtion for 1 hour at room temperature. Unbound substrate was flicked 
off and the wells blocked with 100 pl/well of 50 mg/ml ESA in TBS for 1 hour at room 
temperature. Wells were washed three times with TBS, 1 mM MgCh and biotinylated 
A-domain was added to wells in the presence or absence of antibodies or 10 mM EDTA 
(total volume: 100 pl/well) for 3 hours at room temperature. Unbound A-domain was 
flicked off and wells washed three times as described above. Wells were incubated with 
100 |il/well streptavidin horseradish peroxidase (1:1500; Amersham Life Sciences, part 
of the biotinylation kit) for 2 0  minutes at room temperature, washed as before and 
bound streptavidin visualised using TMB reagents. The colour reaction was allowed to 
develop until the positive control was a strong blue colour then stopped with 50 pl/well 
2.5 M H2 SO4 . Data directly comparing ligands coated on an equimolar basis was 
calculated as percentage of the positive control (A-domain binding to native type I 
collagen), to take into account the slight variability in colour development.
For experiments carried out at 37°C, type I collagen and the fragments were coated and 
blocked at room temperature prior to assay at 37°C. In some experiments, type I 
collagen fragments were incubated for 16 hours at 35®C prior to coating to ELISA 
plates to ensure that they were completely denatured. Denatured fragments were coated 
directly following dénaturation alongside native type I collagen for 1 hour at 37°C. 
BSA (50 mg/ml) in TBS was used to block unbound plastic for 1 hour at 37°C and 
wells were washed with TBS, 1 mM MgCh as before. Both the block and wash buffer 
were warmed to 37°C prior to use. Biotinylated A-domain was diluted in warmed 
buffer and added to wells with and without antibodies or EDTA for 30 minutes at 37°C. 
This optimized time point was determined by time course assay (data not shown).
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Unbound A-domain was flicked off and wells washed with warmed buffer. Wells were 
incubated with streptavidin-horseradish peroxidase (Amersham Life Science) in 
warmed buffer for 20 minutes at 37°C, washed as before and the bound streptavidin 
visualised as described above.
Since it was noted that mixing of the A-domain solution and EDTA a few minutes prior
to addition to the assay resulted in a decrease in the EDTA-mediated inhibition of A-
domain binding to type I collagen (data not shown), all reagents were added
blocking
immediately to the assay upon mixture. Optimal antibody^concentrations were 
determined by serial dilution (data not shown) and concentrations which gave maximal 
inhibiton of binding using blocking antibodies and minimal non-specific inhibition 
using a control IgG were used in all subsequent experiments.
R esults
Biotinylated, recombinant human a ]  integrin A-domain was analysed by 7% SDS 
PAGE and silver stained to confirm that the protein was intact (fig.4.1). Biotinylated ot2  
integrin A-domain bound to type I collagen in a dose-dependent manner (fig.4.2) The 
optimimum A-domain concentration for these experiments was determined to be 0.5 
|ig/ml, and all subsequent assays were carried out at this concentration. When A- 
domain binding to the native type I fragments was compared to A-domain binding to 
native type I collagen at room temperature, it was found that essentially the A-domain 
bound equally well to native type I collagen and the native 3/4 fragment (fig.4.3). No 
A-domain binding to the native 1/4 fragment of collagen was observed, even at the 
highest ligand concentration tested. A-domain binding to native collagen and the 3/4 
fragment was completely ablated by addition of 10 mM EDTA, suggesting that the
binding was likely to be of the same specific nature as binding of the intact integrin to 
collagen and the % fragment (fig.4 .3 ).
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A-domain binding to native collagen and the 3/4 fragment was inhibited by inclusion of 
inhibitory 6 Fl or 5E8 anti-tt2  integrin antibodies as well as EDTA. Inclusion of a non­
specific IgG control antibody had significantly less effect on A-domain binding to 
native collagen or fragments at room temperature (fig.4.4), confirming the specificity of 
a 2 Pi integrin A-domain interactions with native type I collagen and the 3/4 fragment.
Dénaturation of the collagen fragments completely ablated A-domain binding to the 3/4 
fragment when assayed at 37°C, although this temperature was permissive for A- 
domain binding to native type I collagen (fig.4.5). This result suggests that the 
integrin A-domain is responsible for recognition of the triple-helical form of the type I 
collagen 3 / 4  fragment by the whole a 2 Pi integrin, but that dénaturation of the 
fragments prohibits their interaction with Œ2  integrin A-domain and therefore the whole 
integrin molecule.
D i s c u s s i o n
These data confirm that monomeric type I collagen is a ligand for the « 2  integrin A- 
domain, and show that the A-domain binding regions are located within the N-terminal, 
3/4 fragment of triple-helical type I collagen. The inability of the « 2  integrin A-domain 
to bind to the heat-denatured collagen fragments confirms that collagen triple-helical 
conformation is essential for support of tt2 pi integrin binding.
These data are in agreement with and extend previous studies of « 2  integrin A-domain- 
type I collagen interactions. Recombinant human « 2  integrin A-domain bound strongly 
to native momomeric type I collagen at room temperature and 37°C. Interestingly, 
although very little binding to the 1/4 fragment was observed, the A-domain was able to 
interact with the native 3/4 fragment of type I collagen at room temperature. A-domain 
binding to the 3/4 fragment at room temperature was as strong as to native collagen. 
This suggests that all the a 2 pi integrin A-domain binding sites are located within the
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3/4 fragment of type I collagen, but that the C-terminal quarter of the molecule contains 
none of these binding sites.
Dénaturation of the collagen fragments resulted in total abrogation of A-domain binding 
to both the 3/4 and the 1/4 fragments, although A-domain binding to native collagen 
was still possible at this temperature. These results clearly demonstrated the necessity of 
the collagen triple-helical conformation to support «2 integrin A-domain binding to type 
I collagen and its cleavage products. In addition, these data confirmed results obtained 
studying whole a 2 Pi integrin interactions with the same substrates, are supported by 
published data concerning the importance of collagen CNBr fragment conformation for 
a 2 Pi integrin-mediated platelet adhesion (Morton et al., 1994). Collagenase 
degradation of type I collagen is likely to prevent a 2 Pi integrin binding by generating 
collagen fragments which denature at physiological temperature, thereby altering cell 
attachment to a type I collagen substrate.
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Chapter 5
Cell A ttachm ent to Type I Collagen and CL-3 Derived Fragm ents 
In troduction
Studies using isolated a 2 pi integrin, and «2 integrin A-domain are useful to determine 
the ability of collagenase-generated type I collagen fragments to support receptor 
binding at, or below, physiological temperature. However, the information to be gained 
from this type of experiment is limited because integrins have been shown to do more 
than simply anchor cells to the ECM. As has been described in Chapter 1, integrins are 
signaling molecules which transduce both "outside-in" and "inside-out" signals. These 
signals can lead to major changes in cell activity and are crucial to maintaining dynamic 
interactions between a cell and its extracellular environment.
From the results of the solid-phase ligand binding assays using purified a 2 pi integrin, 
and its A-domain, collagenase cleavage of type I collagen might be predicted to lead to a 
significant reduction in a 2 Pi integrin-mediated cell attachment to the denatured 
fragments. HT 1080 cells express a single fibrillar collagen receptor, a2pl integrin 
(Grenz et al., 1993), and antibodies such as 6F1 (Coller et al., 1989) and 5F8 (Chen et 
al., 1991), which are specific to the «2 integrin subunit, can completely inhibit cell 
attachment to type I collagen via this integrin.
A375M cells express low levels of a2 bi integrin and also an RGD-dependent integrin, 
ayb] (Marshallet al., 1991), which has been shown to be a receptor for denatured 
collagen on some cell types (Davis, 1992; Montgomery et al., 1994). RGD-dependent 
integrin adhesion can be blocked by function-blocking antibodies directed at the
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individual integrins or by short, RGD-containing peptides which bind to the integrins 
and compete with the normal substrate.
In this chapter, the ability of HT 1080 cells cxnci A373H oe]\5 to attach to native, 
triple-helical type I collagen and the 3/4 and 1/4 fragments was studied, and the 
integrins responsible for cell attachment to each substrate determined using function- 
blocking anti-integrin antibodies and peptide ECM-ligand mimics. Cell interactions with 
heat-denatured type I collagen fragments were also examined, to begin to elucidate 
possible in vivo effects of collagenase degradation of type I collagen on cell-collagen 
interactions.
M ethods 
Cell Culture
HT 1080 K2P fibrosarcoma cells and A375M melanoma cells were obtained and 
maintained as described in Chapter 2. Cells were passaged 24-48 hours prior to 
experimentation and harvested at 80% confluency using trypsin/EDTA solution 
(Sigma). Cells were suspended in serum-free DMEM and centrifuged at 15(X) g for 5- 
10 minutes to remove the trypsimEDTA solution. The cell pellet was resuspended in 
serum free DMEM, cells counted using a haemocytometer and diluted in DMEM to the 
desired concentration.
Antibodies, Peptides and Substrates
Mouse monoclonal antibodies to human a ]  integrin (6F1 and 5E8), ttyps integrin 
(LM609) and mouse IgG were obtained as described in Chapter 2. All antibodies were 
used at 2.5-5.0 pg/ml. GRGDS and GRYGS peptides were purchased from Sigma and
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used at 20 |ig/ml. Rat skin type I collagen and purified type 1 collagen fragments were 
produced as described in Chapter 2. The mixture of 3/4 and 1/4 collagen fragments 
produced by collagenase cleavage was initially used as a substrate for cell attachment 
and is referred to as "cleaved collagen".
A ttachm ent Assays
Since type I collagen fragments denature below physiological temperature, it was 
appropriate to test their adhesive capacity before and after dénaturation. Attachment 
assays were performed essentially as by Gamble et al. (1993) with some modifications. 
Type I collagen, gelatin, cleaved collagen fragment mixture and isolated collagen 
fragments in TBS were plated onto 96 well tissue culture plates (Corning) for 1 hour at 
room temperature or 16 hours at 4®C and blocked with 1% heat-denatured BSA in TBS 
(Sigma) for 1 hour at room temperature or 2 hours at 4°C. Where it was necessary to 
prevent renaturation, these steps were performed at 37°C with warmed reagents. Wells 
were washed with tissue culture medium and cells plated for the required time at the 
desired temperature. Unattached cells were removed at the end of the assay by a sharp 
flicking motion (HT 1080 cells) or by draining (A375M cells). Wells were washed three 
times with tissue culture medium and attached cells fixed with 4% paraformaldehyde in 
PBS for 30 minutes at room temperature. Fixed cells were stained for 30 minutes at 
room temperature with 1% methylene blue in 0.01% sodium tetraborate, washed 
thoroughly under running water and lysed with ethanol/IM HCl (50:50 mixture). 
Released dye was gently mixed and the colour intensity measured by spectrophotmeter 
at 630 nm wavelength.
Cell A ttachm ent at Room Tem perature
In order to assess cell attachment at room temperature (approximately 21°C), cells were 
harvested in DMFM, washed in an air buffered tissue culture medium (L-15; Sigma,
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USA) and resuspended in L-15 medium. Cells were plated onto type I collagen in 100 
pi of L-15 medium at 6x10^ cells/ml for up to 2 hours at room temperature. The optimal 
time for assay at this temperature was determined to be between 1 and 1.5 hours. 
Where antibodies were used, cells were incubated with these for 30 minutes in L-15 
medium at room temperature prior to use in the assay.
Cell A ttachm ent at 37«C
Cell attachment to type I collagen and fragments was tested at physiological temperature 
in two ways. Adsorption of gelatin, cleaved collagen and isolated fragments to tissue 
culture plastic at room temperature appeared to stabilize the substrates and encourage 
adoption of the triple helical conformation by the denatured substrates. Therefore, collagen, 
gelatin, cleaved collagen and fragments were adsorbed to 96 well plates at room 
temperature and 37°C, to allow comparison of cell attachment to native and denatured 
substrates at physiological temperature. Collagen fragments were denatured by 
incubation at 35°C for 16 hours. This temperature was chosen because it is above the 
fragment's melting temperature but below the melting temperature of monomeric type I 
collagen. Collagen was denatured to gelatin by heating to 60°C for 20 minutes. To 
ensure neither the fragments or gelatin had opportunity to renature during the adsorption 
process, these were coated onto warmed 96 well plates at 37®C. Blocking and washing 
stages were also performed at 37°C using warmed reagents. Cells were harvested, 
washed and resuspended in DMEM and plated in 100 pi of DMEM at 6x10^ cells/ml for 
up to 2 hours at 37°C. Optimal attachment was found to occur between 30 minutes and 
1 hour at this temperature. Where antibodies were used, cells were incubated with these 
for 30 minutes in DMEM at 37^C prior to use in the assay.
Im m unolocalization of Integrins
-.X'
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HT 1080 cells were sparsely seeded onto glass coverslips which had been coated by 
adsorption of type I collagen and collagen fragments for 16 hours at 4°C. Cells were 
cultured in DMEM in the presence of 10% ECS for 48 hours prior to washing with 
PBS. Cells were washed 3 times for 5 minutes each time and then fixed with 4% 
paraformaldehyde in PBS, pH7.4 for 5 minutes. Cells were washed as before and 
incubated with anti-integrin antibodies (5.0 pg/ml) in PBS, in the presence of 0.5% 
serum (species dependent on the species of the secondary antibodies), for 2 hours at 
room temperature. The primary antibody solution was removed and cells washed three 
times as above. Cells were incubated with immunofluorescence-conjugated secondary 
antibodies for 1 hour at room temperature and then washed as before. The coverslips 
were mounted cell-side-down onto glass slides and sealed. Cell-surface staining was 
observed using an immunofluoresence microscope (Ziess) at x600 magnification. 
Photographs were taken using Panther colour film (Kodak) and processed at 1600 
ASA.
R esults 
HT1080 Cell A ttachm ent a t Room Tem perature
The duration of the assay at room temperature and the collagen concentration was 
optimised by time course and serial dilution of the substrate (fig.5.la  and 5.1b). When 
HT 1080 cell attachment to native collagen and the cleavage mixture of fragments was 
compared, it was found that collagenase cleavage had made no difference to the ability 
of cells to attach to collagen (fig.5.2). Attachment was mediated by a 2 pi integrin, as 
6F1 anti-tt2  integrin antibody greatly reduced cell attachment to native or cleaved 
collagen (fig.5.3).
A375M Cell A ttachment at Room Tem perature
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Assay duration was determined by time course (fig.5.4a) and optimum collagen 
concentration was determined by concentration curve (fig.5.4b). No difference in 
attachment was observed when cells were plated onto native collagen or the cleavage 
mixture of fragments when these were plated at room temperature (fig.5.5).
HT1080 Cell A ttachm ent at 37oC (adsorption at room tem perature)
The optimal duration of the assay at 37°C was estimated to be between 30-60 minutes 
(Gamble et al., 1993). Optimum collagen concentration was determined by 
concentration curve (fig.5.6). Reduced HT 1080 cell attachment to low concentrations 
of the cleavage mixture of collagen fragments, compared to attachment to native 
collagen at the same concentrations was observed (fig.5.7). When HT1080 cell 
interactions to isolated collagen fragments was analysed, it was found that these cells 
were only utilising binding sites within the 3/4 fragment (fig.5.8), and attachment to the 
isolated 3/4 fragment closely mirrored attachment to the cleavage mixture and 
gelatinized collagen. HT 1080 cell attachment to native collagen and the 3/4 fragment 
could be inhibited by anti-a2  integrin antibodies but not by a control IgG, an RGD- 
containing peptide or its control RYD-containing peptide (fig.5.9).
HT1080 and A375M Cell A ttachm ent at 37®C (adsorption a t 3 7 ^ 0
Serial dilutions of native type I collagen and denatured fragments showed that heat- 
denaturation of the fragments completely ablated HT 1080 cell attachment to the 3/4 
fragment (fig.5.10) and gelatin (fig.5.11).
HT 1080 cell attachment to native collagen could still be inhibited by preincubation of 
cells with 6F1 anti-a2  integrin antibody, and occasional low levels of cell attachment to 
gelatin could also be completely inhibited by 6F1 (fig.5.12). As a control for collagen, 
gelatin and fragment adsorption to the tissue culture plastic, A375M melanoma cell
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attachment was also assayed under these conditions. These cells adhered equally well to 
gelatin and the denatured fragments, although slightly more attachment to native 
collagen was observed. A375M cell attachment to collagen could be inhibited by 
incubation with 6F1 anti-a2  integrin antibody, however, attachment to gelatin and the 
fragments was inhibited by LM609 anti-ttyps integrin antibody. 6F1 had little effect on 
A375M attachment to gelatin or denatured fragments and LM609 had little effect on cell 
attachment to native collagen (fig.5.13).
Imm unolocalization of Integrins
The integrin profile of HT 1080 cells grown on native type I collagen and type I collagen 
fragments was compared. HT 1080 cells expressed high levels of a 2 pi and a s  Pi 
integrin when grown on all three substrates (fig.5 .14a and b). Virtually no ayPs 
integrin could be detected by immunofluorescent staining using LM609 anti-Œypg 
integrin antibody on cells grown on any of the substrates (fig.5.14a). The suitability of 
LM609 for use in immunolocalization studies was confirmed by the bright staining of 
ttvPs integrin on the surface of A375M cells (see Chapter 8). These results suggest that 
HT 1080 cells may not modulate their integrin repertoire in response to the triple-helical 
fragments, however, the effects of dénaturation of the collagen fragments on HT 1080 
cell integrin profile was not tested.
D iscussion
Two cell surface receptors for type I collagen have been identified and confirmed to 
date, a i P i  and o^Pi integrins. HT 1080 cells express a 2 pi integrin but not a i p i  
integrin, therefore all cell attachment to type I collagen was likely to be mediated by this 
integrin. The a2pi  integrin binding sites on native type I collagen are reversibly 
destroyed upon unwinding of the collagen triple helix but cooling to physiological 
temperature allows renaturation of the triple helix (Stark and Kiihn, 1968a) and
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restoration of a2 bi integrin binding sites (Morton et al., 1994). Since the 3/4 and 1/4 
collagen fragments denature below 37°C, it was unlikely that these would be able to 
support cell attachment via a 2 Pi integrin if maintained in the denatured conformation. 
However, it is interesting to note that if the 3/4 fragment is adsorbed to tissue culture 
plastic at room temperature prior to assay at 37°C, association with the plastic appears 
to stabilize the triple-helical conformation sufficiently to allow a 2 Pi integrin-mediated 
cell attachment. The data confirms the hypothesis that triple-helical collagen 
conformation is essential for a2Pi  integrin-mediated cell attachment but also 
demonstrates that in native collagen conformation, all a 2 pi integrin-mediated binding 
sites are within the 3/4 N-terminal portion of the molecule. The data supports published 
observations using cyanogen bromide (CNBr) fragments of type I collagen, showing 
that «2pl integrin-mediated attachment of human platelets occurs to native CNBr 
fragments derived from the N-terminal of the collagen molecule and that heat- 
denaturation of the fragments containing binding sites ablates platelet adhesion (Morton 
et al., 1994).
ttvPs integrin has been postulated to be a cryptic receptor for gelatin which is only 
exposed when the collagen triple helix is unwound during heat-denaturation and 
degraded by proteinases (Montgomery et al., 1994). HT 1080 cells are not thought to 
express any ay integrins (fig. 15 and K. Yamada, personal communication), so it was 
not unexpected that gelatinized collagen could not support HT 1080 cell attachment. It 
was interesting to find that the heat-denatured collagen fragments were also unable to 
provide binding sites for HT 1080 cells, suggesting that these might well provide a good 
model for in vivo generation of gelatin. A375M melanoma cells express both ttyPs 
integrin and a 2 pi integrin, explaining why these cells adhere as well to native collagen 
as they do to gelatin and denatured 3/4 and 1/4 collagen fragments. LM609 anti-otypg 
integrin antibody inhibited A375M cell attachment to the denatured substrates, lending 
support to the hypothesis of cryptic ttyPs integrin-binding sites being exposed upon 
dénaturation of type I collagen. It is very interesting to note that there is at least one of
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these binding sites on both the 3/4 and the 1/4 collagen fragment as these supported 
A375M adhesion equally well, in contrast to a 2 pi integrin-mediated adhesion which 
only occurs within the 3/4 fragment.
These findings demonstrate that cleavage of type I collagen has a profound effect on cell 
adhesion to this substrate. Cells which are able to adhere to native, triple-helical type I 
collagen may not be able to form stable attachments to cleaved, denatured collagen 
fragments. Loss of adhesion or reduction in attachment can lead to dramatic changes in 
cell morphology and function, even prompting apoptotic cell death (reviewed by 
Ruoslahti and Reed, 1994; Metcalfe and Streuli, 1997) or tumour cell metastasis 
(Juliano and Varner, 1993; Varner and Cheresh, 1996). Even cells which are able to 
utilize another integrin receptor to remain attached to a cleaved substrate may be 
subjected to changes directly brought about by interactions with the modified substrate 
(reviewed by Sage, 1997). Integrin signaling information about the new extracellular 
environment may lead to alteration of cell responses to other stimuli such as growth 
factors (Sundberg and Rubin, 1996), thereby leading to localized disruption of an area 
of tissue and tumour cell invasion and metastasis.
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FigJ.la  : HT1080 cell (6x10  ^ cells/ml) attachment to 
native type I collagen at room temperature at 0.5 pg/ml and 
0.25 pg/ml collagen concentration increased with time up to 
90 minutes after plating, but decreased after this time. Values 
shown arc the mean of triplicates, +/ standard deviation. 
Where error bars are not shown, bars are smaller than the 
point markers.
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Fig^.lb : HT1080 cell attachment to native type I 
collagen at room temperature increased with increasing 
collagen concentration over 1 hour. Values shown are the 
mean of triplicates +/- standard deviation. Where error 
bars are not shown, bars are smaller than the point 
markers.
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Fig.2 : Collagenase-3 cleavage of type I collagen had no
effect on HT1080 cell (6x10  ^ cells/ml) attachment at 
room temperature. Native and cleaved collagen were 
plated and assayed at room temperature for 1.5 hours at 
1.0 and 0.5 pg/ml. Values shown are the mean of 
triplicates, +/- standard deviation.
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Fig.53 : HT1080 cell (6x10  ^ cells/ml) attachment to 
native and cleaved collagen coated and assayed at room 
temperature at 0.5 and 0.25 pg/ml, was inhibited by 6F1 
anti-tt2  integrin antibody (2.5 pg/ml). Values shown are the
mean of triplicates, +/- standard deviation. Where error bars 
are not shown, bars are too small to be visible on this scale.
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Fig^.4a : A375M cell attachment at room temperature 
to type I collagen plated at 10.0 and 5.0 pg/ml reached 
maximtmi at approximately 90 minutes after plating. No 
further increase in cell attachment was observed after this 
time. Values shown are the mean of triplicates, +/- 
standard deviation.
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Fig^.4b : A375M cell (6x10  ^ cells/ml) attachment at 
room temperature to type I collagen increased with 
increasing collagen concentration. Values shown are the 
mean of triplicates, +/- standard deviation. Where error bars 
are not shown, bars are smaller than the point markers.
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Fig^^ : Collagenase-3 cleavage of type I collagen had 
no effect on A375M cell attachment to collagen plated 
and assayed at room temperature at 1.0 and 0.5 p.g/ml. 
Values shown are the mean of triplicates, +/- standard 
deviation.
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Fig.5.6 : HT1080 cell attachment to collagen at
37®C for 1 hour increased with increasing collagen 
concentration. Values shown are the mean of 
triplicates, +/- standard deviation. Where error bars 
are not shown, bars are smaller than the point 
markers.
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Fig^.7 : Attachment of HT1080 cells (6x10 
cellsAnl) to cleaved type I collagen was generally 
lower than cell attachment to native collagen. 
Substrates were plated at room temperature and cell
attachment assayed for 1 hour at 37 ®C. Values
shown are the mean of triplicates, +/- standard 
deviation. Where error bars are not shown, bars are 
smaller than the point markers.
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Fig.5.8 : HT1080 cell (6x10  ^ cells/ml) attachment to 
native type I collagen was already near maximal at 0.1 
}xg/ml collagen coating concentration, however, at least 1.0 
p,g/ml coating concentration of 3/4 fragment was required 
to reach half maximal cell attachment. Virtually no cell 
attachment to the 1/4 fragment was observed. Substrates 
were plated at room temperature and cell attachment assayed
for 1 hour at 37 °C. Values shown are the mean of 
triplicates, +/- standard deviation. Where error bars are not 
shown, bars are smaller than the point markers.
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Fig.5.9 : HT1080 cell (6x10^ cells/ml) attachment to native collagen
and the isolated 3/4 collagen fragment at 3fC was inhibited by 6F1 and 
5E8 anti- « 2  integrin antibodies but not by control IgG or RGD/RYD
peptides. No cell attachment to the 1/4 fragment was observed at this 
concentration (0.5 pg/ml). Collagen and fragments were compared on an 
equimolar basis. Antibodies used at 5.0 pg/ml, peptides used at 20.0 
p,g/ml. Values shown are the mean of triplicates, +/- standard deviation. 
Where error bars are not shown, bars are too small to visualize on this 
scale.
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Fig^.lO : HT1080 cell (6x10 ^/ml) attachment to 
type I collagen increased with increasing collagen 
concentration, however, cells were not able to attach to 
either denatured collagen fragment even at high 
fragment coating concentrations. Values shown are the 
mean of triplicates, +/- standard deviation. Where error 
bars are not shown, bars are smaller than the point 
markers.
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F ig^ .ll : HT1080 cell (6x10 ^cells/ml) attachment to 
native collagen increased with increasing collagen 
concentration, however, cells were not able to attach to 
gelatin (heat-denatured collagen), even at high coating 
concentrations. Values shown are the mean of triplicates, 
+/- standard deviation. Where error bars are not shown, 
bars are smaller than the point markers.
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Fig.5.12 : HT1080 cell attachment to type I collagen was 
inhibited by 6F1 anti- « 2  integrin antibody but not by LM609 
antictyPg antibody or control IgG. Resdiual HT1080
attachment to gelatin and the denatured 3/4 fragment were also 
inhibited by 6F1. No cells attached to the denatured 1/4 
fragment. All substrates were used at 10.0 {Xg/ml, all 
antibodies used at 5.0 pg/ml. Values shown are the n^an of 
triplicates, +/- standard deviation. Where error bars are not 
shown, bars are too small to be visualized on this scale.
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Fig.5.13 : A375M attachment to type I collagen was inhibited 
by 6F1 anti-tt2  integrin antibody but not by LM609 anti- 
integrin antibody. In constrast, A375M cell attachment to gelatin 
and the denatured collagen fragments was inhibited by LM609 
but not by 6F1. A control IgG had little effect on A375M cell 
attachment to the substrates. All substrates were used at 10.0 
pg/ml, all antibodies were used at 5.0 pg/ml. Values shown are 
the mean of triplicates, +/- standard deviation. Where error bars 
are not shown, bars are too small to visualize on this scale.
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Fig.5.14a; HT1080 cells highly express a jP i integrin when grown on native type 
I collagen and the 3/4 and 1/4 collagen fragments, however, these cells apparently 
expressed very little OLyPg integrin when grown on any of the collagenous substrates. 
5E8 anti-a^ integrin antibody, LM609 anti-o^Pj integrin antibody and control mouse 
IgG were used at 5.0 micrograms/ml.
0 SOjum
Collagen 3/4 Fragment 1/4 Fragment
mAb 16
Rat IgG
Fig.5.14b: HT1080 cells highly expressed integrin when grown on native type 
I collagen and the 3/4 and 1/4 collagen fragments. mAh 16 anti-a^ integrin antibody 
and control rat IgG were used at 5.0 micrograms/ml.
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Chapter 6
Cell Invasion Through Collagen and Cleaved Type I Collagen Fragm ents 
In troduction
The role of MMPs during cell invasion through ECM proteins was studied by 
investigating the effects of prior in vitro cleavage of type I collagen on HT 1080 
fibrosarcoma cell ' invasion. To ensure that the ECM
substrate was completely degraded, purified type I collagen fragments (generated by 
collagenase-3 cleavage of type I collagen) were coated to the filters and cell invasion 
was compared to invasion through native collagen. The role of a 2 Pi integrin
in cell invasion through these ECM proteins was also explored using function-blocking 
anti-integrin antibodies and RGD-containing peptides. The roles of MMPs and serine 
proteinases in cell motility through native and cleaved collagen were investigated with 
TIMP-2 and a synthetic MMP inhibitor CT1746 of metalloproteinases, as well as the 
serine proteinase inhibitor, aprotinin.
Mlethods 
R eagents
Anti- tt2  integrin antibodies and a control IgG were obtained as described in
Chapter 2. BSA and RGD/RYD containing peptides were purchased from Sigma as 
described in Chapter 2. A synthetic MMP inhibitor, CT1746, was donated by Celltech, 
UK. Aprotinin was purchased from Sigma.
Tissue Culture
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HT 1080 cells were obtained and maintained as described in Chapter 2. Cells were 
passaged 24-48 hours prior to experimentation and removed from tissue culture flasks 
using trypsin:EDTA as described in Chapter 2. Cells were suspended in serum-free 
DMEM and centrifuged at 1500 g for 5-10 minutes to remove the trypsin:EDTA 
solution and cells resuspended in DMEM. Cells were counted using a haemocytometer 
and diluted to the required concentration in DMEM, with or without 
antibodies/inhibitors.
NIH 3T3 cells were obtained from the ETACC and maintained in DMEM supplemented 
as described in Chapter 2.
Development of a Serum -Free C hem oattractant
NIH 3T3 conditioned medium (CM) was generated essentially as described by Fridman 
et al. (1990). The cells were supplemented with 5 pg/ml insulin, 0.2% lactalbumin 
hydrolysate (LH) and 50 pg/ml ascorbic acid for 24 hours. Ascorbic acid was later 
omitted. Excess CM was stored at "20^C until needed.
Gelatinases were removed from NIH 3T3 CM by batch affinity chromatography using 
gelatin-Agarose. Briefly, CM was swirled gently with gelatin-coupled Sepharose 
(prepared as instructed by the manufactures. Sigma) for 2 hours at room temperature. 
The mixture was centrifuged at 500 g for 2 minutes and the CM supernatant removed. 
The presence of residual gelatinases was checked by gelatin zymography but the 
purified CM was found to be gelatinase-free (data not shown). Gelatinases were 
removed from commercial preparations of human plasma fibronectin (FN) by passing 
the FN preparation over a zinc-chelated Sepharose (Sigma) column as described by 
Smilenovet al. (1992). Purified FN was checked for residual gelatinase presence by 
gelatin zymography but no evidence of pro or active gelatinases was found. Protein 
concentration was determined by BCA assay as described in Chapter 2.
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Although a trend towards less invasion/migration can be seen during the course of the 
experiments using gelatinase-depleted FN as the sole chemattractant, it was felt that the 
purified FN had sufficient chemotactic ability to use in the system. However, when FN 
was tested in the 6 hour invasion assay, an unacceptably high degree of variablity in cell 
migration and invasion from assay to assay was recorded (data not shown). Serum was 
found to stimulate a consistant level of cell invasion and therefore was used during 
short (6 hour) assays.
The possibility of using growth factors (GFs) as chemoattractants was briefly explored. 
These had advantages over the CM system because the quantity of each GF was defined 
and was not subject to fluctuations due to the state of the conditioning cells. It was 
decided to focus on the chemotactic ability of scatter factor (hepatocyte growth factor), 
as this has proven ability to attract hepatocytes (Gherardi et al., 1989) and is produced 
by NIH 3T3 cells (Rong et al., 1994). This was compared to the chemotactic effect of 
3T3 CM and found to be substantially less able to attract HT 1080 cells than the 3T3 CM 
(data not shown).
Invasion Assays
The invasion system chosen, (Transwell, Costar), has been extensively used by other 
researchers and consists of an 8 jim pore-sized filter at the bottom of a 0.5 ml volume 
disposable plastic insert (upper well) which is suspended above a 1.5 ml volume lower 
well (fig. 1-). Cells in unsupplemented culture medium are placed into the upper well 
which is then placed into the lower well containing tissue culture medium and a 
chemoattractant. The filter may be coated with ECM proteins prior to the addition of 
cells to provide a barrier to invasion. This system provides a simple in vitro model of 
cell invasion through ECM and is easily adapted to allow study of the effects of 
antibodies and exogenously added proteinases or inhibitors.
68
The invasion assay method was based on the protocol of Albini et al. (1987). Type I 
collagen was cleaved as described in Chapter 2 and air-dried onto filters for 16 hours at 
room temperature. Filters were washed and rehydrated as described above. Type I 
collagen fragments were prepared as described in Chapter 2 and air-dried onto filters 
either as for the cleaved collagen mixture or overnight at 37°C. Gelatin was prepared as 
described in Chapter 2 and air-dried onto filters for 16 hours at 37°C. Cells were 
removed with trypsin/EDTA, spun down in the absence of serum and resuspended in 
DMEM. Two xlO^ cells/well were placed in the upper well of each chamber and cells 
allowed to invade through the matrix towards a chemoattractant in the lower chamber 
for 6-18 hours at 37°C. If antibodies were to be included, cells were incubated in the 
presence of antibody for 30 minutes at 37°C prior to assay. Medium in upper and lower 
chambers was harvested and invasive cells were trypsinised off the lower chambers and 
the bottom of the filters, placed in DMEM-i-10% ECS, spun down and resuspended in 
DMEM4-10% FCS (50-100 |il/well). Cells were counted using a haemocytometer. 
Medium collected from upper and lower chambers was analysed by 8% gelatin 
zymography and 11% reverse gelatin zymography (see Chapter 2) to assess cells 
production of gelatinases and TIMPs.
R esults
To avoid contaminating the 24 hour invasion system with MMPs and TIMPs it was 
necessary to devise a serum-free chemoattractant. Ideally, this would be tissue culture 
medium with defined supplements. Initially 3T3 CM was assessed because other 
groups (Albini et al., 1987; Fridman et al., 1990) found it to contain powerful 
chemoattractants, although these could not be defined. Upon gelatin zymography of the 
CM generated, it was found that this too contained gelatinases (data not shown) and 
once these were removed by gelatin agarose purification, chemotactic ability was lost.
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Addition of gelatinase-free FN back to the CM restored this ability. As FN can also be 
purified over gelatin agarose it is likely the FN content of the CM was removed at the 
same time as the GLA and GLB. Although the purified CM + FN was a reasonably 
good chemoattractant when compared to serum, (10-50% of cells which migrated 
towards 10% serum would migrate towards CM + FN), there were many unknown 
factors also present in the CM which could also be influencing invasion/migration. 
However, FN proved to be a chemoattractant in its own right, migration of HT 1080 
cells towards DMEM+20 pg/ml gelatinase-free FN was approximately 25% of that 
towards DMEM-i-10% serum, and roughly equal to that towards CM 4- FN. A summary 
of the results obtained using the various chemoattractants tested in the development of a 
serum-free system is shown in Table 1.
Following purification over a zinc-chelate Sepharose column, the sample of the 
fibronectin was checked for gelatinase activity by gelatin zymography (method 
described in Chapter 2). To maximise the chance of gelatinolytic enzymes degrading the 
substrate the zymogram was incubated in assay buffer for 16 hours at 37°C prior to 
staining the gel. The starting material was found to contain both gelatinise A and B, 
however, no gelatinase activity was detected in the zinc-purified fibronectin by this 
assay (fig.6.1).
The optimum coating concentration for type I collagen to form a substantial barrier to 
HT 1080 cell invasion towards 10% serum over 24 hours was determined by serial 
dilution (fig.6.2), however, cells invaded more readily through CL-3 cleaved type I 
collagen when coated at the same concentration as native type I collagen (fig.6.3). 
Zymographic analysis of the conditioned medium from these experiments revealed an 
increase in active gelatinase A production by cells invading through collagen coated 
filters compared to cells migrating through uncoated filters, but no difference in 
gelatinase levels or activity between cells invading through native or cleaved collagen 
(fig.6.4). The degree of collagen cleavage was assessed on each occasion by SDS
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PAGE analysis to ensure that cells were presented with a clear difference in substrate 
(data not shown).
HT 1080 cell invasion through type I collagen and the 3/4 and 1/4 fragments of type I 
collagen was assessed during 6 hour assays. The substrates were coated onto the filters 
on an equimolar basis to ensure a fair comparison, however, HT 1080 cells invaded 
more readily through the cleaved fragments than through the intact collagen (fig.6.5). In 
order to check that any increase in cell invasion through the fragments was not due 
simply to a reduction in protein coating the filters, BSA was added back to the fragment 
solutions prior to coating the filters to bring the final protein concentration to equal that 
of native type I collagen. No significant difference in cell invasion through fragments 
alone and fragments + BSA was found (fig.6.5), so BSA was excluded from future 
experiments.
In order to check that the cleaved collagen fragments were adhering to the plastic filters in a similar ratio 
to the native collagen, native and CL-3 cleaved '^’C-labelled collagen was air-dried onto the filters 
overnight at room temperature, as described earlier in this chapter for unlabelled collagen. The residual 
liquid after the rehydration stages of the protocol (prior to addition of cells) was collected from both the 
filters coated with ^^C-labelled collagen, and the filters coated with the cleavage mixture of ^^C-labelled 
collagen, and separately analysed in a scintillation counter. The percentage of native or cleaved collagen 
adhering to the filters at the end of the rehydration stages was estimated from the number of counts 
released into the wash liquid during rehydration, compared to the number of counts folBaoed‘by|j^ie 
. starting volume of ^'^C-labelled collagen. Samples were analysed in duplicate. The total counts per minute 
*Oteloaoed-by 100 pi of ^'^C-labelled collagen (100 pg/ml), the starting volume of collagen, was 6,630 and 
7,617. The total counts released by the uncleaved ^"C-labelled collagen during rehydration of the collagen 
film was 120 and 122 counts per minute. The total counts released by the CL-3 cleaved '^’C-labelled 
collagen during rehydration of the film was 570 and 542 counts per minute. Althougli more counts were 
released by the cleavage mixture of collagen fragments compared to the uncleaved collagen, these were 
still less than 5% of the total available counts. Therefore, it was estimated that 95% of the collagen 
fragments remained stuck to the plastic filters during rehydration.
The increase in HT 1080 cell invasion through type I collagen fragments compared to 
native type I collagen was not affected by preineubation of cells with an anti-ot2  integrin 
antibody (fig.6.6) or an RGD-eontaining peptide (fig.6.7). However, the number of 
cells invading through the fragments eould be reduced by a small but statistically
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significant amount if TIMP-2 was added to the cells at the start of the invasion assay. 
Interestingly, addition of TIMP-2 had no effect on the number of cells migrating 
through uncoated filters. Inclusion of the serine proteinase inhibitor aprotinin to the 
cells with TIMP-2 had no additive effect on reduction in cell invasion (fig.6.8) although 
it completely ablated activation of GLB secreted by cells. The reduction in HT 1080 cell 
invasion through the collagen fragments when a synthetic MMP inhibitor, (CTI746), 
was added to the invasion assay was comparable to the level of cell inhibition caused by 
TIMP-2 (data not shown).
Gelatinized type I collagen was compared to native type I collagen as a barrier to cell 
invasion. It was found that a greater number of cells were able to invade through the 
denatured substrate but that less cells invaded through gelatin than through the cleaved 
fragments (fig.6.9). Cell invasion through gelatin or the collagen fragments was not 
inhibited by an anti-ai integrin antibody (fig.6.10) or an RGD-eontaining peptide (data
not shown).
Laminin-1, used at high concentrations (100 pg/ml or more), was also found to be a 
chemoattractant for HT 1080 cells. In one experiment laminin-I was used as a 
chemoattractant to investigate if HTI080 cells were using a fibronectin-bridge 
mechanism to move more readily through the collagen fragments than through intact 
collagen. However, many more cells invaded through the cleaved fragments towards 
the laminin, compared to cell invasion through the native collagen (fig.6 .11). Since the 
ratio of cells invading through the fragments relative to uncleaved collagen in response 
to laminin-1 or serum was very similar, the possibility that HT 1080 cells were using a 
fibronectin bridge to faeilitate movement through the fragments was discounted.
D iscussion
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. . .y:These data clearly show that collagenase-cleavage of type I collagen dramatically affects 
HT 1080 cell invasion through this substrate. Cell motility towards at least two 
chemotactic proteins was consistently upregulated through the collagen fragments 
relative to cell motility through uncleaved type I collagen during the assay periods. This 
suggests that HT 1080 cells can detect the change in extracelular environment following 
collagenase degradation of the substrate and modify their behaviour accordingly.
Plasma fibronectin was found to be a chemoattractant for HT 1080 cells during the 24 
hour invasion assays but the number of cells invading moving towards FN during 
invasion assays was found to be very variable. Due to the inconsistency of FN as a 
chemoattractant, 10% serum was used in its place for cell invasion through type I 
collagen. Analysis of the medium from upper wells of these experiments showed that 
gelatinase A activation was upregulated by cells confronted by native or cleaved type I 
collagen compared to cells migrating through uncoated filters. Type I collagen has been 
shown to upregulate GLA activation by these cells (Azzam and Thompson, 1992), 
although GLA is not generally considered to be a collagenolytic enzyme. Interestingly, 
the was no obvious difference in GLA production or activation in response to native or 
collagenase-cleaved collagen. Cleaved collagen can be considered as gelatin (as both 
fragments produced melt below 37°C), so this would be a likely target for active GLA 
produced by invading cells. This may have been the case during the 24 hour assays 
performed here as there was an increase in HT 1080 cell invasion through the cleaved 
type I collagen.
HT 1080 cells invaded significantly more readily through the cleaved fragments than 
through native collagen when compared on an equimolar basis, and this was not simply 
due to a reduction in protein coating the filters. Cell invasion through gelatin was also 
upregulated compared to invasion through native collagen but due to renaturation of the 
gelatin, the number of cells invading through gelatin was not as high as through cleaved 
type I collagen fragments.
73
.r-
Incubation of cells with 6F1 anti-ot2  integrin antibody had no effect on cell invasion 
through the cleaved collagen fragments. Because the level of HT 1080 cell invasion 
through type I collagen coated at 100 jig/ml was so low it was not possible to detect 
whether the antibody or peptide had any effect on cell invasion, although since HT 1080 
cells use a 2 pi integrin to attach firmly to native collagen, reduction in cell attachment 
by 6FI may be speculated to have led to an increase in cell motility.
It is well known that fibronectin binds to denatured fibrillar collagens with higher 
affinity than it does to the native proteins (reviewed by Kuhn, 1987), and cells have 
been found to interact with denatured collagen via a fibronectin-bridge (Tuckwell et al., 
1994). Sinee HT 1080 cells express asPi integrin, which is a RGD-dependent receptor 
for fibronectin, the possibility that cells were using such a mechanism to facilitate cell 
motility through the cleaved type I collagen fragments was tested. However, inclusion 
of an RGD-eontaining peptide into the serum-containing assays had no effect on cell 
motility through the fragments, and neither did use of laminin-I as a chemoattractant. 
These results suggest that HT 1080 cells probably do not use fibronectin as a 
mechanism to interact with collagenase-generated type I collagen fragments, particularly 
since cell interactions with laminin-I are likely to be via an RGD-independent receptor 
(such as (X6pi integrin).
Addition of TIMP-2 to the invasion assay caused a small but signifieant decrease in 
HT 1080 cell invasion through the collagen fragments. This reduction of motility was 
recorded using a relatively high dose of TIMP-2 (2 pM), although this concentration 
was still within physiological range. Clearly, TIMP-2 did have minor part to play in 
reducing cell motility through the cleaved collagen fragments, possibly by inhibiton of 
endogenous MMPs produced by HT 1080 cells. Inhibiton of serine proteinases also had 
no effect on cell motility, but did completely inhibit activation of GLB (data not 
shown). This data lend support to the hypothesis that active MMPs may facilitate cell
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invasion, but these are not the only factors involved in mediating cell motility through 
cleaved type I collagen.
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Table 1
C hem oattractant M ean N um ber Cells M igrated in 
24h +/- S tandard  Deviation
CM 95,000 4-/- 34,559
CM* 10,000 4-/- 8,049
CM* 4- FN 181,000 +/- 22,053
FN 4- insulin 42,000 +!- 14,292
GLA 4- GLB 4- insulin 795 -k/- 524
FN* 27,000 +!- 10,894
K ey: CM = 3T3 cell conditioned medium; CM* = condtioned medium after 
purification over gelatin-âgarose; FN = plasma fibronectin (20 pg/ml); insulin = 5.0 
pg/ml; GLA and GLB = 1.0 pg/ml; FN* = fibronectin after purification over zinc- 
chelated Sepharose.
NIH 3T3 cell conditioned medium (CM) was an efficient chemoattractant for HT 1080 
fibrosarcoma cells, however, the CM contained gelatinases. These were removed by 
batch affinity chromatography using a gelatin-agarose matrix. However, this had the 
effect of dramatically reducing HT 1080 cell migration towards the CM. Fibronectin is 
also binds to gelatin-agarose, therefore, purified human plasma fibronectin was added 
back to the CM to try to restore the chemotactic ability of the CM. This proved to be a 
success, so the chemotactic ability of fibronectin was tested with insulin in DMEM. A 
significant number of HT 1080 cells migrated towards the fibronectin and insulin 
solution, however, it was noted that the purified fibronectin also contained gelatinases. 
The possibility that the gelatinases could be chemoattractants was tested, however, 
these proteins did not stimulate many cells to migrate during the assay period. 
Gelatinases were removed from fibronectin using a zinc-chelated Sepharose column. 
The ultra-pure fibronectin was tested for chemotactic ability and found to retain most of 
its chemotactic properties for HT 1080 cells.
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Fig.6.2: HT1080 cell invasion through type I
collagen after 24 hour assay decreased with 
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Fig.6.3 : More HT1080 cells invaded after 24 
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Fig.6.5 : Addition of BSA to the 3/4 and 1/4 
fragments to increase the coating concentration to 
equal that of native collagen (100 |ig/ml) had no 
effect on HT1080 cell invasion after 6 hours. Cell 
migration through uncoated filters is denoted by 
"control". Values shown are the mean of triplicates, 
+!- standard deviation.
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Fig.6 .6  : Addition of an anti<%2 integrin antibody
(6F1; 10.0 |4g/ml) had no effect on HT 1080 cell 
invasion through native type I collagen and 
collagen fragments over 6 hours. Cell invasion in 
the absence of antibodies is denoted by "control". 
Values are the mean of triplicates, +/- standard 
deviation. Where error bars are not shown, bars are 
too small to visualize on this scale.
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Fig.6.7 : Addition of an RGD-containing peptide 
or an RYD peptide control (20.0 |4g/ml) had no 
effect on HT1080 cell invasion through native type 
I collagen and collagen fragments over 6 hours. 
Cell invasion in the absence of peptide is denoted 
as "control". Values are the mean of triplicates, +/- 
standard deviation. Where error bars are not shown, 
bars are too small to visualize on this scale.
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Fig.6.8 : HT1080 invasion over 6 hours was 
significantly inhibited by addition of TIMP-2 
(*p<0.05). Inclusion of aprotinin had no additive effect 
on the decrease in cell invasion. Values shown are the 
mean of triplicates, +/- standard deviation.
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Fig.6.9 : Fewer HT 1080 cells were able to invade 
through gelatin over 6 hours than through type I 
collagen fragments. Migration of cells through uncoated 
filters is denoted by "control ". Values shown are the 
mean of triplicates, +/- standard deviation. Where error 
bars are not shown, bars are too small to be visualized 
on this scale.
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Fig.6.10 : HT1080 cell invasion through type I 
collagen and gelatin over 6 hours was not affected 
by addition of an anti- tt2 integrin antibody (10.0 
pg/ml). More cells invaded through both collagen 
and gelatin in this assay compared to Fig.6.9, 
however, the proportion of cells invading through 
the native and denatured substrate remained the 
same. Invasion of cells in the absence of antibody 
is denoted by "control". Values shown are the mean 
of triplicates, +/- standard deviation.
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Fig.6.11 : Laminin-1 was chemotactic for HT1080 cells 
invading through gelatin and the collagen fragments. Cell 
invasion through gelatin and the fragments was not 
downregulated compared to invasion through native collagen, 
suggesting that cells probably do not use a fibronectin-bridge 
mechanism to invade through the fragments towards serum. 
Migration of cells through uncoated filters is denoted by 
"control". Values shown are the mean of triplicates, +/- 
standard deviation.
C hapter 7
Integrins as Novel Substrates for MMP degradation 
In troduction
Several groups have reported increased human platelet (Pidard et al., 1991; Si-Tahar et 
al., 1997) and human melanoma cell (Fujii and Imamura, 1995) adhesion to ECM 
molecules after incubation of the cells with serine proteinases such as trypsin or 
plasmin, possibly due to proteolytic activation of integrin or exposure of sequestered 
integrin.
In contrast, Ray and Stetler-Stevenson (1995) reported that preineubation of A2058 
human melanoma cells with active gelatinase A resulted in decreased cell attachment to 
fibronectin and vitronectin. Addition of recombinant human TIM? allowed increased 
binding of these cells to both substrates. The authors interpreted their results to mean 
that gelatinase A can directly modulate cell attachment and spreading. It was of great 
interest to further investigate this hypothesis using HT 1080 human fibrosarcoma cells, 
A375M human melanoma cells and A2058 human melanoma cells. Cells were 
incubated with various MMPs prior to attachment to type I collagen and fibronectin. 
Attachment assays were performed essentially as described in Chapter 4.
The direct degradative effect of active MMPs on integrins was also tested in a controlled 
system. Purified integrins were incubated with active MMPs and serine proteinases at 
known enzyme-substrate ratios, sinee proteolytic modification of integrins could 
account for the increased cell adhesion described by other authors.
M ethods
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Cell Lines and Tissue Culture
A2058 human melanoma cells were purchased from the American Tissue Culture 
Collection. Human HT 1080 fibrosarcoma cells and A375M melanoma cells were 
obtained as described in Chapter 2. Cells were maintained in DMEM supplemented with 
10% foetal calf serum as described in Chapter 2. Cells were passaged 24-48 hours prior 
to assay and harvested at approximately 80% confluency. Cells were suspended in 
serum-free DMEM and centrifuged at 1500 g for 5-10 minutes to remove the 
trypsiniEDTA solution. The cell pellet was resuspended in serum free DMEM, cells 
counted using a haemocytometer and diluted in DMEM to the desired concentration.
Purified Integrins
Human platelet a 2 pi integrin was purified as described in Chapter 3. Chimeric a?pi 
integrin was isolated from human 293 kidney cells producing pi integrin and 
transfected with mouse a? integrin (Echtermeyer et al., 1996), and was a kind gift of 
Dr. Helga Von der Mark, Institute of Experimental Medicine, Friedrich-Alexander 
University, Erlangen-Nuremberg, Germany. Human ayp3 and ttyps integrins were 
isolated from human placenta, and were kind gifts of Dr. David Simmons, University 
of Oxford, Oxford, UK and Dr. Simon Goodman, Merck Laboratories Ltd, Darmstadt, 
respectively.
MMP Activation
MMPs were activated essentially as described by Murphy et al. (1991), with minor 
modifications. Briefly, pGLA was activated by incubation with 2 mM amino phenyl 
mercuric acetate (APMA) for 1 hour at 25°C, pGLB was activated by incubation with 1 
mM APMA for 1 hour at 37«C. The cytotoxic APMA was removed from the gelatinase
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solution by size-separation using Sephadex (Sigma) spin columns. Activated GLA and 
GLB could be stored at -20°C for up to one week without losing proteolytic activity as 
determined by gelatinase assay as described in Chapter 2.
pSL-1 was activated by incubation with trypsin (5.0 pg/ml) for 30 minutes at 25°C, the 
reaction was quenched by addition of 50 P-g/ml soyabean trypsin inhibitor (SBTI) and 
incubation at 4°C for 30 minutes. pCL-1 was activated by incubation with trypsin (5.0 
pg/ml) and pSL-1 (0.2 p.g/ml) for 30 minutes at 25°C. The reaction was quenched as 
for SL-1 activation. Activated SL-1 and CL-1 could also be stored at -20°C for up to 
one week, as determined by stromelysin assay and collagen diffuse fibril assay.
The specific activities of the active enzymes were determined by radio-labelled substrate 
assay in conjunction with each cell attachment assay. Collagenase diffuse fibril assay 
was performed as described by Cawston and Barrett (1979), Gelatinase and 
Stromelysin assays were performed as described by Murphy et al. (1981b), see Chapter 
2. The specific activities of each enzyme upon each activation was calculated and is 
expressed in units/mg (one unit of each enzyme degrades one microgram of substrate in 
one minute at 37®C).
Cell A ttachm ent
The methods of Ray and Stetler-Stevenson (1995) were followed as closely as 
possible, however their exact methodology was not clear from the paper. Therefore, 
attachment assays were carried out as described in Chapter 4, with some modifications. 
After trypsin/EDTA treatment, cells were pelleted in serum-free DMEM and 
resuspended in DMEM. Cells were allowed to recover from trypsin treatment for 30 
minutes at 37°C in serum-free DMEM prior to MMP treatment. Recovered cells were 
pelleted and resuspended in DMEM containing activated MMPs (250-500 ng/ml) and 
incubated at 37°C for 30 minutes. Cells (6xl0^/well) were plated onto BSA-blocked
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substrates and incubated for 35 minutes at 37°C. Unattached cells were washed off and 
attached cells fixed and stained as described in Chapters. Other modifications included 
addition of BSA to the cell-MMP incubation and longer assay periods. MMPs were 
generally included in the attachment assay as removal by centrifugation resulted in 
uneven loss of cells from each MMP incubation, rendering comparison of the final data 
difficult.
MMP integrin-degradation Assays
Recombinant human trypsin, plasmin and plasminogen were purchased from Sigma, 
USA. Plasminogen was activated by incubation witb streptokinase (Kabi Ltd, UK) at 
100:1 plasminogen:streptokinase ratio at 37°C for 15 minutes. Gelatinase A and B, 
stromelysin-1 and collagenase-1 were activated as described earlier in this chapter. 
Collagenase-3 was activated by incubation with 1 mM APMA for 30 minutes at 37°C 
(Knauper et al., 1996a). MMP activity was assessed in parallel to the integrin assays by 
^"^C-labelled substrate assay as described in Chapter 2. Plasmin activity was assessed 
using the l^C-labelled casein assay also used for detection of stromelysin activity.
Activated MMPs in dilution buffer (10 mM Tris pH7.5, 10 mM CaCl2 , 0.05% Brij, 
0.02% sodium azide) were added to integrins in TBS, 1 mM MgCl2 , 1 mM MnCh (0.5 
pg integrin/tube, 100:1 and 10:1 integrin:MMP molar ratio) and incubated for 16 hours 
at 37°C. The cleavage mixtures were analysed by 7% SDS PAGE followed by silver 
staining.
R esults
In the absence of MMPs, HT 1080 cells attach to native type I collagen under the assay 
conditions described above. Therefore these were the initial cell line and substrate of 
choice to test the hypothesis. Cells were incubated with active GLA, GLB, SL-1 or CL-
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1 at 500 pg/ml (fig.7.1) or 250 pg/ml (data not shown), however, no reduction in 
HT 1080 cell attachment to type I collagen was observed.
A human melanoma cell line was utilised by Ray and Stetler-Stevenson (1995), so the 
effects of MMP incubation on A375M cells was tested next. After establishing that 
more of these cells adhered to fibronectin than to laminin-1 under the assay conditions 
(data not shown), A375M cell attachment to fibronectin after incubation with MMPs 
(500 ng/ml) was examined. A small decrease in cell attachment after MMP-incubation 
was reeorded in one out of two experiments (fig.7.2). MMP-incubation did not have 
any effect on cell attachment on the other occasion (data not shown). Although a small 
decrease in cell adhesion (approximately 10%) had been observed on one occasion, this 
was not as significant as the dramatic reduction in cell adhesion recorded by Ray and 
Stetler-Stevenson (approximately 80%). Therefore, it was decided to make use of the 
same cell line that these researchers had used and introduce some subtle variations in the 
assay procedure in an attempt to mimic these researchers methods.
A2058 human melanoma cells adhere almost as well to laminin-1 as to fibronectin under 
the above assay conditions in the absence of MMPs (data not shown), however, as Ray 
and Stetler-Stevenson had recorded a decrease in adhesion to fibronectin it was decided 
to use only fibronectin. Four out of five experiments recorded no effects on cell 
attachment to fibronectin after incubation with MMPs, although addition of BSA (1.0 
mg/ml) into the cell-MMP incubation slightly increased the overall levels of cell 
attachment (fig.7.3). A single experiment showed a small reduction (approximately 
10%) in cell attachment following MMP-incubation, however the result of the positive 
control for this experiment was mueh lower than anticipated and therefore this 
experiment was discounted (data not shown).
Human platelet a 2 pi integrin was incubated with active GLA, GLB, SL-1 and CL-1 at 
10:1 and 100:1 integrin:MMP molar ratio and the cleavage mixtures analysed on 7%
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polyacrylamide gels (fig.7.4); specific activities (SA) of the MMPs; GLA=8615, 
GLB=10813, SL-1 =342, CL-1=699 units/mg). No obvious a 2 Pi integrin degradation 
was detected as the result of several assays. Further experiments examined the effects 
of CL-3, MTl-MMP and MT2-MMP on this integrin (fig.7.5 and 7.6). Again, hardly 
any integrin degradation was visible by protein gel analysis. The proteolytic effects of 
the serine proteinases plasmin, plasminogen and trypsin on a2pl integrin were also 
tested (fig.7.7); SA plasmin=120 units/mg). Trypsin was found to efficiently degrade 
(X2 P 1 integrin at both 10:1 and 100:1, integrin:proteinase ratio, however, neither 
plasmin or plasminogen had any detectable effect on a 2 pi integrin structure.
Human ttyps integrin was incubated with active GLA, GLB, SL-1, CL-1 and CL-3 and 
analysed on 7% polyacrylamide gels (fig.7.8; SA GLA= 13026, GLB=8144, SL- 
1=117, CL-1=192 and CL-3=1694 units/mg). None of these proteinases appeared to 
degrade ayp3 integrin. Human a?Pi integrin was also included in this experiment but 
no MMP degradation was recorded (data not shown). Finally, human ttyps integrin 
was incubated with GLA and GLB and analysed on a 5-15% polyacrylamide gradient 
gel (fig.7.9). This integrin was also found to be resistant to gelatinase degradation.
D iscussion
Ray and Stetler-Stevenson (1995) reported that incubation of A2058 melanoma cells 
with activated GLA resulted in a dramatic decrease in cell adhesion to fibronectin. The 
aim of this study was to determine if their results were due to MMP degradation of one 
type of cell-surface receptors for ECM components, the integrins. Initially, the effect of 
cell incubation with various active MMPs, including gelatinase A, on cell attachment to 
ECM ligands was assessed. However, the ability of three different human cell lines, 
including A2058 cells, to attach to type I collagen or fibronectin did not appear to be 
inhibited by pre-incubation of cells with activated MMPs. This may be due to
-w*-
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differences in the methodology used in these experiments, as the exact method used by 
the above authors to produce their results is not clearly documented in their paper.
MMPs degradation of ECM proteins is well documented (reviewed by Murphy and 
Reynolds, 1993). These enzymes may have a direct role to play in modulation of cell 
adhesion and motility during processes such as tumour progression, at the level of 
substrate cleavage and subsequent disruption of cell-substrate interactions (Mignatti and 
Rifkin, 1993; Crawford and Matrisian, 1994; Stetler-Stevenson, 1994; Heino, 1996). 
However, it would not be inconceivable for MMPs to have more subtle roles, for 
example by cleavage of cell-surface receptors for ECM proteins, which could also lead 
to reduction in cell adhesion. Reinartzet al. (1995) reported that incubation of a human 
keratinocyte cell line with plasmin abrogated avPs integrin-mediated cell attachment to 
vitronectin. However this group could find no evidence that plasmin had a direct effect 
on the integrin receptors and concluded that degradation of the ECM substrate eaused 
the reduction in cell attachment. Therefore, it cannot be ruled out that the reduction in 
cell attachment could be due to proteolytic degradation of other cell-surface proteins, 
such as syndecans.
The possibility that integrins might be novel substrates for MMPs and/or serine 
proteinases was tested directly by incubation of isolated integrins with excess active 
enzymes. It would have been preferable to test the effects of MMPs on the classical 
fibronectin receptors (such as aqpi and a^Pi integrins) in order to relate the isolated 
protein assays with the data from the eell attachment to FN assays. However, these 
integrins were not readily available and therefore the effeet of MMPs on another FN 
receptor, a^P] integrin, was tested along with tt2 pi, (X7 P 1 and ayp5 integrins. Trypsin 
was able to efficiently cleave a 2 pi integrin under the assay conditions described above, 
however, another serine proteinase, plasmin, did not show any degradative ability 
towards this integrin. None of the MMPs tested appeared to have any proteolytic effect 
on human tt2 Pi, a?P i, ttvp3 or avp5 integrins in solution. This was an interesting
-.rf-
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observation, as the transmembrane and cytoplasmic domains of these integrins that 
would not normally be exposed to active MMPs in the extracellular environment, were 
available to the MMPs in the test-tube but were not degraded. However, a recent report 
by von Bredowet al. (1997) showed that matrilysin can degrade human P4  integrin 
subunit transfected into human prostate carcinoma cells, both in cell lysates and on the 
surface of cells grown on glass coverslips. This same study showed that receptor- 
degrading activity of matrilysin was specific for the P4 integrin, as the p] integrin 
subunit was resistant to degradation by this MMP. The authors note that the sequence 
of the p4 integrin subunit (as listed in the EMBL protein database) contains two 
candidate matrilysin cleavage sites, but the Pi subunit does not contain any appropriate 
sequences at which matrilysin could cleave.
The inability of MMPs to degrade the integrin class of cell-surface ECM receptors is 
likely to be of great significance to cell-matrix interactions in areas of tissue undergoing 
active remodelling, particularly in relation to their function as signal-transducing 
proteins able to relay information about a cell's extracellular environment. Integrin 
resistance to proteinase degradation during ECM remodeling may facilitate cell detection 
of, and reaction to, changes in pericellular conditions (Auer and Jacobson, 1995; Clark 
and Brugge, 1995; Richardson and Parsons, 1995; Dedhar and Hannigan, 1996). Loss 
of these information channels could lead to inappropriate cell behaviour in an altered 
cellular environment, potentially leading to catasrophic events such as apoptotic cell 
death or even gain of invasive capacity.
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Fig.7.1 : preincubation of HTl 080 cells (6x10 cells/well) 
with active MMPs had no effect on cell attachment to type I 
collagen, but preincubation with 10 mM EDTA completely 
inhibited cell attachment. Data denoted as "control" refers to 
cell attachment in the absence of MMPs. Values shown are 
the mean of triplicates, +/- standard deviation. Where error 
bars are not shown, bars are too small to visualize on this 
scale.
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Fig.7.2 : Preincubation of A375M cells (6x10 cells/ml) 
with active SL-1 had a small hut sigificant effect on cell 
attachment to fibronectin (*p<0.05). No effect was observed 
after incubation with the other MMPs tested. However, 
incubation of cells with 10 mM EDTA completely 
inhibited cell attachment. Data denoted as "control" refers to 
cell attachment in the absence of MMPs. Values shown are 
the mean of triplicates, +/- standard deviation. Where error 
bars are not shown, bars are too small to visualize on this 
scale.
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Fig.7.3 : Preincubation of A2058 cells (6x10 ^
cells/ml) with active MMPs had no effect on cell 
attachment to fibronectin in the presence of 1 mg/ml 
BSA, but incubation with 10 mM EDTA completely 
inhibited cell attachment. Data denoted as "control" 
refers to cell attachment in the absence of MMPs. 
Values shown are the mean of triplicates, +/- standard 
deviation. Where error bars are not shown, bars are too 
small to visualize on this scale.
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Chapter 8
Gelatinase A Interaction With Integrin ayp 3  
In troduction
Previous studies have shown that integrin expression and GLA production are 
upregulated by cells during events such as angiogenesis (Brooks et al., 1994; Cornelius 
et al., 1995; Friedlander et al., 1995) and tumour progression (Seftor et al., 1992; 
Crawford and Matrisian, 1994; Stetler-Stevenson, 1994; Danen et al., 1995a), 
suggesting that there may be a correlation between expression of these two proteins. 
Ray and Stetler-Stevenson (1995) reported that melanoma cell adhesion to vitronectin 
and fibronectin was significantly reduced following incubation of cells with active 
GLA, but did not investigate whether this was due to GLA cleavage of cell surface 
receptors for ECM or competitive binding of GLA to the ECM receptors. This latter 
possibility was substantiated by Brooks et al. (1996) and Deryugina et al. (1997) who 
reported that human integrin Œyp] was able to interact directly with gelatinase A via its 
C-terminal domain. Brooks et al. (1996) reported co-localization of the integrin and 
MMP on the surface of human melanoma cells in cryostat sections, and reduction of 
human melanoma cell attachment to vitronectin (VN) after incubation of cells with 
chicken gelatinase but not by the C-terminal truncated mutant of chicken GLA. These 
authors also found by ELISA technique that chicken GLA or human VN bound to 
immobilized human ttyPs integrin, and SDS-stable complexes of chicken GLA and 
human aypg integrin were formed as analysed by SDS-PAGE.
It was of interest to expand these observations to include human gelatinase A 
interactions with human ayPa integrin. Although chicken GLA shares a very high 
sequence homology to human GLA, subtle changes in proteinase-integrin interactions 
might occur due to species differences. Therefore, this study aimed to mimic the
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methods used by Brooks et al. (1996) using recombinant human GLA, to compare and 
contrast these results with the published data using chicken GLA.
M aterials and Methods 
Purified Integrins and MMPs
Human ttvp 3  integrin purified from placenta was kindly donated by Dr. David 
Simmons, Oxford, UK, and Dr. Simon Goodman, Merc Laboratories, Darmstadt. Dr. 
Goodman also provided human avp 5  integrin. Integrins were solublized in buffers 
containing 25-40 mM OG, 1 mM MgCl] and 1 mM CaCl2  and stored at -20^0. 
Recombinant chicken GLA in 0.2 M NaCl, 0.05 M Tris pH 7.5, 0.01 M CaCl2 , 0.05% 
Brij, 10% DMSG, and rabbit-anti-chicken GLA polyclonal antibody were kindly 
provided by Prof. James Quigley, School of Medicine, State University of New York, 
Stony Brook, NY, USA. Chicken GLA and antibody were stored at 4°C and used 
immediately. 23C6 anti-avPs integrin antibody was kindly provided by Prof. Michael 
Horton, Department of Medicine, Sir Jules Thorn Institute, UCL Medical School, The 
Middlesex Hospital, London, UK. Recombinant human GLA was kindly provided by 
Prof. Gillian Murphy, as described in Chapter 2.
Tissue Culture
A375M cells were obtained and maintained as described in Chapter 2. Cells were 
pasaged 24-48 hours prior to experimentation and removed from the^issue culture 
plastic using trypsin:EDTA as described in Chapter 2. Cells were suspended in serum- 
free DMEM and centrifuged at 1500 g for 5-10 minutes to remove the trypsiniEDTA 
solution. The cell pellet was resuspended in serum free DMEM, cells counted using a 
haemocytometer and diluted in DMEM to the desired concentration.
-Vf
85
Inhibition of Cell A ttachm ent by Preincubation With GLA
This was performed essentially as described by Brooks et al. (1996). Briefly, 
vitronectin (1.0 pg/ml; lOOpl/weli) was adsorbed onto 96 well tissue culture plates 
(Corning) for 16 hours at 4°C. Wells were then washed with sterile PBS and blocked 
with 1% heat-denatured BSA in PBS for 1 hour at room temperature. Cells were 
removed from tissue culture flasks and incubated with and without gelatinase A in 
DMEM, 0.2 M MnCh for 30 minutes at 37«C, prior to plating onto the washed 96 well 
plate. Cells were allowed to attach to the vitronectin for 15 minutes at 37°C in the 
presence of 0.2 mM MnC^. Unbound cells were washed off at the end of the assay 
period, and attached cells were detected as described for the cell attachment assays in 
Chapter 5.
Form ation of SDS-stable Complexes
This was performed as described by Brooks et al. (1996). Briefly, purified integrins 
(0.5 fxg) were incubated with APMA activated gelatinase A (see Chapter 7) in 50 mM 
Tris pH 7.5, 200 mM NaCl, 10 mM CaCl2 , 0.2 mM MnCl2  (total volume of 50 pi), for 
4 hours at 37®C. Reactions were stopped by addition of 4 x Laemmli sample buffer 
(Laemmli and Favre, 1973), (without mercaptoethanol), and analysed on 6 % SDS- 
PAGE gels followed by silver staining. Samples were left unreduced and unboiled to 
maximise the stability of any protein-protein complexes during SDS-PAGE analysis. 
Since pro-GLA is likely to be associated with TIMP-2 in vivo, it was interesting to add 
TIMP-2 into the protein mixtures on some occasions, to study if this had any effect on 
complex formation.
GLA Binding to Immobilized av p 3 Integrin
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ELISA techniques were employed to determine if there was any direct interaction 
between isolated ttvPs integrin and GLA. Briefly, binding of anti-chicken GLA 
antibody and anti-human GLA to chicken GLA was compared and the anti-chicken 
GLA antibody concentration optimized prior to the main assay. ttvPs integrin (1.0 
pg/ml) in TBS, ImM CaCh, 1 mM M gC^, 1 mM M nC^ (binding buffer) was 
immobilised onto ELISA plates (Maxisorb, Nunc) by adsorption for 16 hours at 4«C. 
Unbound plastic was blocked by incubation with 50 mg/ml BSA in TBS for 1 hour at 
3 7 0 c  and washed off with binding buffer. Chicken GLA or human VN were plated 
onto the integrin or blocked plastic at 200 ng/ml for 1 hour at 37oC. Unbound ligand 
was flicked off and the wells washed with binding buffer prior to addition of rabbit- 
anti-chicken GLA or rabbit-anti-human VN (Chemicon) at 5.0 pg/ml and 1:500 dilution 
respectively in binding buffer and 1.0 mg/ml BSA for 1 hour at 37°C. Unbound 
primary antibodies were flicked off and wells washed as before. Donkey-anti-rabbit 
horseradish peroxidase-conjugated secondary antibody (Jackson Labs) was added at 
1:500 dilution in binding buffer and 1.0 mg/ml BSA for 1 hour at 37°C and removed as 
described above. Bound ligands were detected by addition of TMB reagents and the 
colour reaction allowed to develop. The reaction was stopped by addition of 2.5 M 
H2 SO4  and the optical density of the wells analysed using a spectrophotometer set at 
450 nm.
Immunolocalization of GLA and ayPa integrin
A375M melanoma cells were plated sparsely onto glass coverslips coated with 20 pg/ml 
fibronectin and allowed to grow in DMEM in the presence of 10% ECS for 48 hours. 
Cells were washed with PBS and fixed for 5 minutes with 4% paraformaldehyde in 
PBS and permeabilized with 0.1% Triton X-100 in PBS for 5 minutes. Permeabilized 
cells were washed with PBS and incubated in primary antibodies (LM609 (Chemicon) 
or 23C6 (Prof. M. Horton) mouse-anti-human ayp 3  integrin antibodies, VB3 mouse- 
anti-human GLA antibody (Celltech, UK), and control mouse IgG (Sigma)) at 5.0
•A-
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pg/ml in PBS with 50.0 pl/ml donkey serum (Sigma) for 30 minutes at room 
temperature. Cells were washed with PBS to remove the primary antibodies and 
incubated in 2 0 0  pi donkey-anti-mouse texas red conjugated secondary antibody 
(Jackson Labs) in PBS at 1:200 dilution for 30 minutes at room temperature. Cells were 
washed with PBS, mounted onto glass slides and sealed. Slides were stored in the dark 
at 4°C prior to photography.
R esults
The purified human integrins were first run under reducing conditions on a 3-10% SDS 
gradient gel to establish their purity and confirm that they were intact (fig.8.1). Both 
avp3  integrin preparations contained protein bands of approximately 125 kDa and 115 
kDa, which correspond to the reduced tty and pg subunits respectively (Pytela et al., 
1985). The purified ttyps integrin preparation contained two major bands, of 
approximate molecular weight of 125 kDa and 110 kDa under reducing conditions (Kim 
et al., 1994).
The purified integrins (0.5 pg/tube) were incubated with activated human GLA (200 
ng/tube) according to the method of Brooks et al. (1996), immediately following 
APMA activation of the GLA (as described in Chapter 7). These authors reported a high 
molecular weight, SDS-stable GLA-Œypg integrin complex of approximately 200 kDa 
weight, following GLA-integrin incubation. However, after incubation of the «yPg 
integrin and ayp 5  integrin with human GLA under the conditions described in this 
paper, no evidence of such complexes was found using either ay  integrin. 
Interestingly, one ŒyPg integrin preparation also contained a significant band of protein 
of approximately 125 kDa. The ay integrin is composed of two chains of 125 kDa and 
25 kDa which are disulphide-bonded (Suzuki et al., 1986). The major band visualised 
on the gel corresponds to the larger chain of the ay integrin subunit, suggesting that this 
preparation may have been less stable than the other. Major protein bands of
approximately 170 kDa, 125 kDa and 80 kDa were detected for the ayp3  integrin-GLA 
mixture, and 140 kDa and 80 kDa for the ayPs integrin-GLA mixture (fig.8.2).
Brooks et al. (1996) reported that incubation of a hamster melanoma cell line 
(transfected with human p 3  integrin) with chicken gelatinase A prevented cell 
attachment to vitronectin. Ray and Stetler-Stevenson (1995) had previously reported 
that human melanoma cells attach firmly to both vitronectin and fibronectin, but that 
incubation of these cells with human GLA reduced cell attachment to either substrate. 
The observation of these authors was extended by studying the effect of incubation of 
A375M human melanoma cells with human GLA prior to cell attachment to FN. Since 
the activation state of the GLA used by Brooks et al was not obvious, GLA was added 
at two different concentrations in pro and active forms. The results of these experiments 
are summarised in table 1 .
Table 1
FN conc. GLA Activation s ta te  of N um ber D u ra t io n  P ercen t
(p g /m l)  conc .  the GLA
1.0
o f  o f  a ssa y  reduction
c e l l s /w e l l  (m in u tes )  in
APMA activated 
350 ng/ml (APMA removed) 4x10^ 15
a t tac h m e n t
16%
1.0 350 ng/ml pro-GLA/GLA mix 4 x 1 0  ^ 15 10%
1.0 350 ng/ml pro-GLA/GLA mix 4 x 1 0  ^ 15
1.0 5 pg/ml pro-GLA/GLA mix 4 x 1 0  ^ 15
-20%
T2%
.â'
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These results show that preincubation of A375M melanoma cells with human gelatinase 
A had very little effect on subsequent cell attachment to a fibronectin substrate. 
However, the effect of GLA-incubation on melanoma cell attachment to a vitronectin 
substrate was not tested during this study, and remains to be elucidated.
Immunolocalization of ttvPs integrin and GLA expression by A375M melanoma cells 
was performed. Cells were found to highly express ŒyPg integrin and this could be 
localized to focal adhesion complexes (fig.8.3, see arrow head). However, these cells 
produced low levels of endogenous GLA and this was always located within the golgi 
apparatus, never on the cell surface (fig.8.3). Control antibody showed almost no 
staining (fig.8.3).
Since little evidence for human GLA interaction with ayp 3  integrin could be found, a 
small amount of recombinant chicken GLA (as used by Brooks et al. (1996)) was 
obtained. This was used to check that the methods used in these experiments were 
correct and to confirm the data reported by Brooks et al. (1996). Analysis of isolated 
ttyP3  integrin interactions with chicken GLA by ELISA technique showed a very low 
level of GLA binding to immobilised ttyp3 integrin (fig.8.4). This was proportionally 
much lower than binding of VN to the same receptor but was just above the 
background. Insufficient chicken GLA prevented repetition of this experiment under 
exactly the same conditions, however, it would be necessary to repeat the experiment 
several times to determine if the low level of binding observed on this single occasion 
was consistently above background binding, and therefore significant.
D iscussion
The data presented by Brooks et al. (1996) showed that chicken GLA was able to form 
stable interactions with purified human Œyp3  integrin, both in the isolated form and 
with human integrin transfected into ttyp3 integrin-negative hamster melanoma cells.
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The formation of SDS-stable complexes of human GLA with ayp 3 integrin and ayp5 
integrin was tested using the conditions described by Brooks et al, but no high 
molecular weight complexes were observed. TIMP-2 was also included in some 
incubations to allow for the possiblity that the chicken GLA used by Brooks et al was 
already complexed to TlMP-2. An example of an SDS-stable MMP-TIMP complex is 
reported in the literature, where Blaser et al. (1991) found that collagenase-2 was co­
precipitated with TlMP-1 following Western blotting. Therefore, it was necessary to 
explore the possibility that the high molecular weight "ayP3 integrin-GLA" complexes 
observed were in fact due to GLA-TIMP-2 complexing. However, no role for TIMP-2 
was found in this study, as inclusion of TIMP-2 into the protein mixture had no effect 
on the formation of SDS-stable, human GLA-ttyP3 integrin complexes.
Although the melanoma cell line used by Brooks et al was not available, another human 
melanoma cell line, A375M, which was known to highly express ttyp3  integrin 
(Marshall et al., 1991) was used to test the hypothesis that preincubation of cells with 
GLA reduced ttyP3  integrin-mediated cell attachment to an ECM substrate. However, it 
was not clear form the methods of Brooks et al. (1996) whether pro or active GLA or 
inactive C-terminal truncated GLA (NGL) were present during the cell attachment assay 
or whether these were removed prior to assay. Therefore, to maximise the probability 
of GLA effecting A375M cell adhesion to ECM proteins, cells were allowed to attach in 
the presence of active and pro-MMPs. A small reduction in the percentage of cells 
attaching to FN after incubation with GLA compared to attachment of untreated cells 
was observed, but this only amounted to 10-20% of the total cell attachment. Since 
melanoma cell attachment to vitronectin after incubation with GLA was not tested, it is 
not possible to compare these results with the work of Brooks et al. (1996), although 
both fibronectin and vitronectin are ligands for ttyp3 integrin. Nevertheless, since GLA 
had very little effect on cell attachment to fibronectin, it might be suggested that GLA 
does not interact with the fibronectin receptor on A375M cells. A375M cells express at 
least three fibronectin receptors, a 4 pi, ttsPi and ttyP3  integrins, but ttyP3 has been
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reported to be the more abundantly expressed of the these integrins (Marshall et al., 
1991). In order to speculate further on the role of GLA interactions with ayp3 integrin 
during cell attachment to fibronectin, it would be necessary to determine which of the 
three integrin receptors mediate A375M cell binding to this substrate.
Since A375M cells express high levels of avP 3 integrin, the difference in substrate 
(fibronectin rather than vitronectin) should not have had any effect on the 
immunolocalization of avP 3 integrin and GLA on the surface of A375M cells. This 
experiment failed to demonstrate a spatial link between GLA and ayP 3  integrin, GLA 
was observed in the golgi apparatus whereas ayp 3 integrin was observed on the cell 
surface and in focal contacts. However, this experiment would have been better 
conducted using cells which produce high levels of GLA as A375M cells produced low 
levels of endogenous GLA on this occasion. Deryugina et al. (1997) also suggested that 
LM609 anti-avP3  integrin antibody may not be able to bind to avP3 integrin when the 
integrin is bound to ligands. Since a second anti-ayp3 integrin antibody (23C6) was 
used alongside LM609 during the immunolocaliztion experiments it might be hoped that 
this problem had been overcome, although it is possible that 23C6 may also bind to 
ttyp3 integrin in a similar position to LM609.
Since no reliable demonstration that human GLA was able to interact with ttyp3 integrin 
was recorded during these studies, it was considered necessary to move back to 
recombinant chicken gelatinase A, as used by Brooks et al. (1996). A solid-phase 
ligand binding assay using chicken GLA and human ttyP3 integrin demonstrated a very 
low level of GLA binding to ttyP3 integrin above background readings. This was 
significantly lower than VN binding to ttyp3  integrin but of a corresponding level to 
that reported by Brooks et al. Given that the CD readings were so small (-0.1 unit), it is 
difficult to attach much relevance to these findings in a physiological context, where the 
ECM ligands might be expected to preferentially bind to free integrin rather than GLA, 
for which the integrin shows such low affinity.
-w«-
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The data presented here tends not to support the theory that GLA is localized to the cell 
surface by binding directly to ttyps integrin, however GLA has been shown to be 
activated at the cell surface by MT-1 MMP (Sato et al., 1994; Atkinson et al., 1995; Pei 
and Weiss, 1996). TlMP-2 is thought to interact with proGLA in order to localise 
proGLA in close proximity to MT-1 MMP prior to MT-1 MMP activation of GLA, 
thereby forming a trimolecular complex of TIMP-2, proGLA and MT-1 MMP. 
Although ttyp3 integrin is not thought to be involved in the GLA activation process, it 
is possible that once activated a cell might be able to sequester GLA at the cell surface 
by ligation of GLA to cell surface receptors such as integrins.
Previous studies have shown that the urokinase plasminogen activator receptor (uPAR) 
colocalizes with ttyps integrin on a human keratinocyte cell line (Reinartz et al., 1995) 
and with Pi and P3  integrins on HT 1080 fibrosarcoma cells (Xue et al., 1997). 
Urokinase plasminogen activator (uPA) has also been colocalized with vinculin in focal 
adhesion plaques (Pollanen et al., 1988), therefore suggesting that urokinase 
plasminogen binds to its receptor and is activated in very close proximity to this 
integrin. A novel familiy of cell surface molecules designated ADAMS which possess 
both an integrin binding domain and a metalloproteinase catalytic domain have been 
identified (Wolfsberget al., 1995), and this raises the possiblity that metalloproteinase 
activity may be positionally-linked to integrin function for this group of cell surface 
proteins.
However, apart from the work by Brooks et al, no other data concerning MMPs as 
novel ligands for integrins has been conclusively demonstrated. A recent paper by 
Deryugina et al. (1997) suggested that a glioma cell line was able to attach to the C- 
terminal domain of GLA and that this attachment was inhibited by function-blocking 
anti-Œyp3 integrin antibody. However, in this study the cells were allowed to attach for 
24 hours, during which time they might be able to synthesize a provisional matrix to
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which cells could attach via ttvPs integrin, and therefore cannot be taken as direct 
evidence that GLA binds to ttvPs integrin. Further studies are required before firm 
conclusions concerning the role of integrins as cell surface receptors for MMPs can be 
drawn.
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Chapter 9
D iscussion
In addition to its structural role, the ECM is an information processing medium that 
controls cell position, identity, proliferation and fate. This is achieved through direct 
cell-ECM interactions and by acting as the contextual framework for the interactions of 
growth factors and cytokines with their signaling receptors. Despite the profound 
effects the ECM can exert on cell behaviour, cells are able to modulate their responses 
to the ECM, even to the extent of proteolytic remodeling of the local matrix. Thus, a 
dynamic, bidirectional flow of information between the cells and the ECM allows 
individual cells to continually react and adapt to variations in their function and 
extracellular environment. This ability to react to change is essential for maintenance of 
tissue homeostasis, as all tissues constantly undergo some degree of turnover. 
Deregulation or blockade of this flow of information has been suggested to be a feature 
of pathological situations, for example tumour formation, where tumour cells lose 
adhesion-dependency for survival.
The results of this study clarify and advance our knowledge of « 2 ^ 1  integrin-mediated 
cell interactions with type 1 collagen following proteolytic degradation of the substrate. 
It was of great importance to utilize a physiological enzyme to generate type I collagen 
fragments, as previous studies have concentrated primarily on non-physiological 
cyanogen bromide-derived fragments (Staatz et al., 1990; Gulberg et al., 1992; Morton 
et al., 1994). Studies have mainly been aimed at elucidating the sites of integrin binding 
within the type I collagen molecule and have not dealt with the physiological 
significance of degradation of collagen in vivo. The approach of this study has been to 
present cells with native or degraded substrate in order to explore any differences in 
subsequent cell adhesion and migration. Such a mechanistic approach was utilized to 
ensure that complete degradation of type I collagen had occured, prior to use in any of
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the assays. An additional benefit of this approach was that the cleavage products of 
collagenase degradation of collagen could be purified, allowing initial characterization 
of cell interactions with the individual fragments. Type I degradation could have been 
achieved using cells which produce high levels of collagenolytic enzymes and which 
could therefore degrade the substrate during the assay periods. However, it was felt that 
the precleaved substrate represented a more measured route, and was more suitable for 
these studies.
This is thought to be a novel study of cell attachment to, and invasion through 
fragments of type I collagen generated by a physiological enzyme, using cells other than 
human platelets. Since retention of the triple-helical conformation of type I collagen 
CNBr fragments has been shown to be vital to the support of platelet adhesion (Morton 
et al., 1994), it was of great interest to study the effects of temperature on HT 1080 cell 
interactions with the collagenase-3 fragments of type 1 collagen. Although the 
conformation of the collagen fragments generated in this study were not directly 
assessed, Sakai and Gross (1967) and Stark and Kiihn (1968a) showed by optical 
rotatory dispersion that the 3/4 and 1/4 fragments of monomeric, tadpole or bacterial 
collagenase-treated calf skin collagen retained their triple-helical conformation below 
their melting temperatures (32°C and -29°C respectively). These authors also 
demonstrated that both native type 1 collagen and collagenase-derived fragments of 
collagen renatured into triple-helical conformation if cooled to below melting 
temperature, with approximately 50% recovery of optical rotation in all cases (Stark and 
Kiihn, 1968a). This report also showed by disc electropherogram analysis of the 
renatured fragments that these were mainly composed of a l  chains. In view of the 
above observations, the work of all these authors is of significance in relation to 
interpretation of the results of this study. Future studies using optical rotatory 
dispersion could confirm the triple-helical conformation of the collagen fragments used 
at temperatures below 29®C.
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Another aspect of the experimental models used in this system is the use of thin layers 
of monomeric collagen. Although cells may adhere to and invade through such films, 
the same cells may well behave differently when cultured in thicker, 3-dimensional 
collagen lattices. An example of this altered response to a 3-dimensional matrix was 
demonstrated by Seltzer et al. (1994). These authors showed that gelatinase A produced 
by normal fibroblasts cultured in collagen gels was both in the pro and active forms, 
compared to gelatinase produced by fibroblasts cultured on collagen films, which was 
always in the proenzyme form. Nevertheless, collagen gels may not be the best in vitro 
model for studying the effects of an encapuslating matrix on cell behaviour.
Collagen gels consisting of polymerized monomeric collagen do not truely reflect the in 
vivo morphology of a type I collagen fibrils, which are highly cross-linked. 
Interestingly, an early study of the effect of chemical cross-linking agents demonstrated 
that cross-linking of type I collagen fibrils protected the fibrils from degradation by 
vertebrate collagenase, both in vitro and in vivo (Harris and Farrell, 1972). This 
suggests that physiological cross-linking of a mature collagenous matrix may also 
render it resistant to collagenase cleavage. However, during deposition of the 
provisional matrix produced by fibroblasts during events such as wound healing, newly 
formed fibrillar collagen matrices are likely to be susceptible to collagenase degradation. 
Type III and type 1 collagen are synthesized at high levels by fibroblasts relatively early 
on during wound healing, and are thought to be crucial for providing the healing tissue 
with stiffness and tensile strength. Although collagen synthesis is downregulated 
approximately two weeks after injury, remodelling of the provisional matrix continues 
for some weeks after this time (reviewed by Clark, 1996b). Thus, it is probable that a 
newly deposited collagen matrix is not so resistant to collagenase activity and therefore 
may become remodelled. This hypothesis is supported by the study of transgenic mice 
carrying a mutation in the type 1 collagen gene which prevents collagenase cleavage at 
the classical triple-helical site. Mice are able to develop normally due to the ability of 
rodent collagenase to degrade collagen at the N-telopeptide site, however in later life the
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mice develop marked fibrosis of the dermis (Liu et al., 1995). This suggests that 
collagenase degradation of type I collagen in the triple-helical domain is necessary for 
normal matrix remodelling, especially in the skin.
a 2 pi integrin is one of the better characterized cell-surface ECM receptors. Its principal 
ligands have been determined to be type I collagen, type IV collagen (Vanderberg et al., 
1991) and/or laminin-1 (Elices and Hemler, 1989; Kirchhofer et al., 1990), depending 
on the type of cell expressing it. Other ECM ligands such as tenascin (Sriramarao et al., 
1993) and laminin-5 (A. Messent, J. Gavrilovic, P. Roussell and P. Simon-Assmann, 
unpublished observations) have also been suggested for a 2 pi integrin. As has already 
been mentioned, the type 1 , type 11 and type 111 collagen binding site has been 
determined to be in the A-domain of the (%2 integrin subunit, although it is not known if 
this region is involved in binding to any of the other a 2 Pi integrin ligands.
As has already been mentioned in Chapter 1, generation of gelatin by heat-denaturation 
of type 1 collagen does not occur. Therefore, the only physiological mechanism for 
gelatinization of collagen must be by proteolytic degradation into peptides which are 
thermally unstable at 37°C. Using the purified a 2Pi integrin, its ligand-binding domain 
and collagenase-generated collagen fragments, (either melted at 37°C, or in triple-helical 
conformation at room temperature), this study has shown the importance of type 1 
collagen conformation for support of (%2Pi integrin interactions.
Integrin and A-domain binding to the native 3/4 fragment of type 1 collagen at room 
temperature confirmed previous reports using non-physiological peptides, showing that 
a 2 Pi integrin interacts with binding sites within this region of the collagen molecule. 
The reduction or ablation of integrin and A-domain binding to the native 1/4 fragment 
can be explained in at least two ways. Since some integrin but no A-domain interaction 
was observed at high 1/4 fragment concentrations, it may be possible that this fragment 
contains (X2 pi integrin binding sites of lower affinity for the integrin than the binding
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sites within the 3 / 4  fragment, which require the whole integrin conformation to bind. 
Collagenase cleavage of type I collagen at the triple-helical cleavage site occurs near to 
the C-terminal region of the al(I)CNBr 7 peptide, and the 1/4 fragment generated by 
collagenase cleavage is equivalent to a small section of al(I)C N B r 7 and all of 
al(I)CNBr 6 b (Gross et al., 1980). Morton et al. (1994) reported that CNBr 6 b was 
unable to support human platelet adhesion, and although CNBr 7 was found to support 
platelet adhesion, the collagenase-generated 1/4 fragment may not contain enough of the 
CNBr 7 region to support « 2  integrin-mediated interactions (see fig. 1.3). However, a 
second possibility is that the 1/4 fragment denatured during the assays at room 
temperature, thus ablating any integrin-mediated interactions. This would not be 
expected during assays performed at room temperature (23°C or below) as the 
published melting temperature of this fragment (~29°C; Sakai and Gross, 1967; Stark 
and Kiihn, 1968a) is several degrees higher than the assay temperature.
The significance of these results was explored by the study of HT 1080 cell interactions 
with the native and denatured fragments. The major integrin receptor for type 1 collagen 
expressed by these cells is tt2 pi integrin. Integrin involvement in cell attachement to 
collagen was confirmed using the divalent metal ion-chelator, EDTA, which removes 
Mg2 '  ^ from integrins and therefore renders cation-dependent integrins (such as tt2 Pi
A
integrin) inactive. Function-blocking anti-tt2  integrin antibodies also prevented HT 1080 
cell attachment to the native collagen fragments, verifying the role of a 2 pi integrin in 
mediating HT 1080 cell attachment to the type I collagen triple helix.
Heat-destahlization by melting the collagen fragments at 37°C completely ablated 
HT 1080 cell attachment. This result was in complete agreement to the observations 
made regarding isolated « 2 Pl integrin and A-domain binding to the melted fragments. 
These cells were also unable to attach to collagen denatured at 60®C (conventional 
gelatin), confirming the likelihood that the collagenase fragments were in the heat- 
unwound, denatured conformation during these assays.
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The possihlity of collagenase-cleavage of type I collagen leading to the exposure of 
cryptic RGD sequences on the surface of the denatured fragments was investigated 
using A375M melanoma cells. These cells express ayp3 integrin which, as has already 
been mentioned, is postulated to be a receptor for heat-denatured collagen. Since 
A375M cell attachment to either denatured collagen fragment could be inhibited by a 
function-blocking anti-ttvPs integrin antibody, collagenase degradation of type I 
collagen may potentiate cell-collagen interactions via alternative integrin receptors, 
possibly leading to divergent signaling and modulation of cell activity. This was not 
possible for HT 1080 cells as these cells did not apperently express ayp3 integrin. 
Therefore, in the absence of any other substrate, collagenase degradation of type I 
collagen resulted in loss of HT 1080 cell attachment. This too has profound implications 
for cell behaviour, as loss of appropriate cell adhesion has been shown to lead to 
apoptotic death of some normal cells, such as mammary epithelial cells, in a matrix- 
dependent manner (reviewed by Metcalfe and Streuli, 1997). Adhesion-independent 
survival and proliferation has also been shown to be a feature of tumour cell phenotype 
(reviewed by Varner and Cheresh, 1996).
A very interesting finding of this study was that collagenase degradation of type I 
collagen upregulated HT 1080 cell motility through thin layers of collagen fragments 
relative to motility through native type I collagen. This was not dependent on overall 
protein concentration, as addition of BSA to fragment solutions to equal the 
concentration (w/w) of native collagen did not reduce the number of invading cells over 
the assay period. The accepted model of fibroblast migration involves some degree of 
adhesion to a substrate to allow generation of contractile forces (Palecek et al., 1997). 
HT 1080 cells did not apparently adhere to the denatured collagen fragments. However, 
it may be that t t 2 Pi integrin undergoes sufficient transient and/or low affinity 
interactions with denatured collagen fragments to permit cell motility, but these 
interactions may not be stable enough to be detected by the attachment and binding
.41-
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assays used in this study. The most definitive method for testing this hypothesis would 
be use of a BIAcore apparatus to study the kinetics of a iP i integrin interactions with 
native and denatured collagen fragments (discussed in more detail later in this chapter).
However, an alternative explanation for the differences in cell invasion through native 
and cleaved type I collagen can be suggested. The observation that HT 1080 cell 
invasion through type 1 collagen fragments was upregulated relative to invasion through 
intact collagen, could imply that HT 1080 cells plated on the collagen fragments 
responded differently to chemotactic ligands in the serum, compared to cells plated on 
native collagen. Potential ligands would include fibronectin, laminin-1 and vitronectin, 
which could act haptotactically, since these molecules are likely to coat the underside of 
the filters shortly after commencement of the assay.
Since preincubation of HT 1080 cells with 6F1 anti-tt2  integrin antibody had no effect 
on the number of cells invading through either of the denatured collagen fragments, it is 
possible that this integrin may not be involved in HT 1080 cell motility through native or 
denatured collagenous matrices. «2^1 integrin has been clearly shown to mediate 
HT 1080 cell attachment to type I collagen, however, it does not necessarily follow that 
this receptor is also responsible for regulating cell motility. This idea is supported by 
the findings of Liebersbach and Sanderson (1994), who showed that loss of expression 
of syndecan-1, a cell-surface proteoglycan receptor for type I collagen, dramatically 
upregulated B lymphoid cell invasion through type I collagen gels. Transfection of the 
syndecan-negative cells with cDNA for syndecan led to surface expression of this 
receptor and almost complete ablation of cell invasion. Since the level of HT 1080 cell 
invasion through native collagen in this study was too low to investigate the role of 
a 2 pi integrin, future studies are required to elucidate the role of this integrin during 
HT 1080 cell motility through native collagen. The possibility of other classes of ECM 
receptors mediating HT 1080 cell motility through type I collagen should also be 
investigated.
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Cells have been shown to be able to modulate expression of integrins in response to 
ECM and growth factor-induced signals, leading to changes in cell adhesion and 
motility (Chen et al., 1993; Beauvais et al., 1995; Jones et al., 1996b). Although 
culture of HT 1080 cells on collagen-fragment coated coverslips did not apparently lead 
to induction of ttyps integrin (as determined by immunolocalization experiments), it is 
possible that they may utilize another integrin to interact with denatured type I collagen. 
As has already been mentioned, a small number of published studies suggest that agpi 
integrin may be a collagen receptor for some cells. Yamamoto and Yamamoto (1994) 
reported the initial attachment of rabbit arterial smooth muscle cells to heat-denatured 
type I collagen was inhibited by an anti-ag integrin antibody. Since HT 1080 cells 
express this integrin (Grenz et al., 1993), it is possible that these cells may upregulate 
ocgpi integrin in response to the melted fragments, however this requires further study.
Interestingly, Xue et al. (1997) found that HT 1080 cells expressed a low level of «ypg 
integrin when plated onto vitronectin. This integrin co-localized with uPAR in focal 
contacts formed on vitronectin, but the interaction was substrate-specific as uPAR co­
localized principally with a^pi integrin when cells were plated on fibronectin. The fact 
that these authors could detect expression of Œypg integrin by HT 1080 cells when 
others have not, suggests that expression of this integrin may be influenced by the ECM 
substrate with which cells are in contact. Adhesion to vitronectin may induce and/or 
upregulate synthesis or cell-surface expression of Œypg integrin, while attachment to 
other substrates, such as denatured type I collagen, may not induce the same 
upregulatory signal. HT 1080 cells grown on collagen fragments did not apparently 
express ttyps integrin. It would be of interest to determine the expression of Œypg 
integrin by cells grown on vitronectin, since serum that was used as a chemoattractant 
in the invasion assays contains vitronectin.
..A '
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Tuckwell et al. (1994) showed that HCS-2/8 human chondrosarcoma cells were able to 
adhere to denatured type II collagen via an as pi integrin-fibronectin bridge mechanism. 
The possibility of HT 1080 cells using such a mechanism to mediate cell invasion 
through type I collagen (a similar fibrillar collagen) was tested using two approaches, 
aspi integrin is an RGD-dependent integrin and therefore a synthetic, RGD-containing 
peptide was added to the invasion assay system. No reduction in cell invasion was 
observed at the concentration of RGD peptide used in these experiments. In addition, 
laminin-1 as well as fibronectin was found to be a chemoattractant for HT 1080 cells. 
Therefore, the invasion of these cells through denatured type I collagen fragments was 
examined using laminin-1 in place of serum. Mouse laminin-1 is known to contain an 
RGD site, however, since this has been shown to be cryptic (Aumailley et al., 1990) it 
is unlikely that cells would have interacted with laminin-1 via RGD-dependent integrins 
on this occasion. Since cells invaded through the collagen fragments to a similar extent 
when either laminin-1 or fibronectin were used as chemoattractants, it is unlikely that a 
fibronectin-bridge is involved in these experiments. However, it would be of interest to 
investigate whether laminin-1 binds to the collagenase-generated type I collagen 
fragments.
The results of this study demonstrating the inability of cells to adhere to collagenase- 
cleaved collagen fragments is very likely to be relevant to in vivo situations such as 
tumour cell migration or wound healing. Pilcher et al. (1997) demonstrated that 
kératinocytes are able to continue directional migration over type I collagen apparently 
by secreting CL-1 and degrading the collagen directly underneath each cell. The authors 
speculate that these cells do not attach to degraded collagen and therefore keep moving 
towards uncleaved collagen and chemotactic stimuli. Interestingly, kératinocytes plated 
on type I collagen which contains the mutation in the region of the triple-helical 
collagenase-cleavage site, (Liu et al., 1995), were unable to migrate compared to cells 
plated on normal type I collagen. This result emphasizes the major role of collagenase 
degradation during keratinocyte motility in this system. Collagen-binding integrin
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receptors must be vital to this process of attachment and migration, and are probably 
involved in transducing the signal that identifies the newly-reached substrate as collagen 
to the migrating cell, and therefore leading to continued collagenase production and 
repetition of the whole process. Giannelli et al. (1997) also reported that gelatinase A 
cleavage of laminin-5 induced migration of breast epithelial cells. Proteolytic 
degradation of ECM molecules has been shown to release mitogenic and motogenic 
ECM-derived peptides which can influence cell behaviour (reviewed by Sage, 1997). 
The cellular mechanism of proteinase secretion, to induce or promote motility within an 
extracellular matrix environment to which a cell may possess high-affinity receptors, 
has potential application to the process of tumour cell invasion and metastasis 
(Ruoslahti, 1992; Heino, 1996).
MMPs have long been associated with the malignant phenotype, indeed, collagenase-3 
was originally isolated from a breast carcinoma library (Freije et al., 1994). MMP 
production by tumour cells was thought necessary to clear a path for metastatic cells to 
move through the connective tissue stroma and intravasate the vasculature. As has 
already heen mentioned, this simplistic hypothesis that MMPs only role in tumour cell 
migration was that of a proteolytic "battering ram" has since been amended, and MMPs 
have been shown to have many more subtle influences on tumour growth and 
metastasis (reviewed by Chambers and Matrisian, 1997). By producing MMPs such as 
collagenase-3, cells may dramatically alter their interactions with the interstitial stroma. 
The data presented here suggests that cleavage of type I collagen not only decreases 
HT 1080 cell attachment at 37°C, but may also provide motogenic stimulation which can 
induce fibroblast chemotaxis.
A growing body of literature points to the co-ordination of integrin-mediated signals 
from the ECM, growth factor and cytokine stimulation and MMP production. In vivo, 
cells undergo dynamic interactions with all components of their extracellular 
environment, therefore it is not surprising that stimuli from various classes of cell-
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surface receptor are necessary to trigger profound responses such as induction of cell 
motility or production of matrix-remodeling enzymes. In the experimental system used 
in this study, cytokines, growth factors and chemotactic proteins such as fibronectin are 
all present in the serum towards which the cells invade. A small percentage of these 
factors may well diffuse into the upper, serum-free wells in which the cells are initially 
placed, and thereby activate signaling pathways which co-ordinately lead to induction of 
migration. However, even if cells had been stimulated to move by motility factors, no 
movement would take place if cells were firmly attached to a substratum (as seen when 
HT 1080 cells are plated onto native type I collagen in this system). Complex internal 
rearrangements such as integrin deactivation and disassembly of focal adhesions must 
be undergone prior to cell movement.
The signals which lead to de-adhesion and induction of motility are likely to be 
mediated by integrins as well as mitogens. Sundberg and Rubin (1996) reported that 
ligation of pi integrins expressed by a human diploid foreskin fibroblast cell line led to 
tyrosine phosphorylation of PDGF p-receptors, independent of PDGF. The authors 
suggest that ligand-independent PDGF p-receptor activation during cell adhesion may 
trigger signaling which could bring about modulation of cell interactions with the ECM. 
Jones et al. (1996b) showed that ayp 3 integrin receptor activation by ligand binding 
was necessary for smooth muscle cells to migrate over vitronectin-coated tissue culture 
plastic in response to IGF-1. Interestingly, these authors found that as a consequence of 
IGF-1 stimulation, avP 3 integrin expression and affinity was upregulated but a^pi 
integrin expression was downregulated by these cells. The explanation offered for these 
observations was that ayp3  integrin may be important for potentiating smooth muscle 
cell migration, and that a^pi integrin was either not important or inhibitory to this 
process.
The synergistic effects of ECM and growth factor-derived signals were emphasised by 
the data published by Jones et al. (1997). Tenascin-C is an ECM protein which is
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produced by smooth muscle cells and acts as an autocrine survival factor for these cells 
when they are cultured on a floating type I collagen gel. EGF can stimulate smooth 
muscle cells to proliferate, but ligation of the ayp3 integrin is necessary for EGF- 
dependent growth. Tenascin-C is a ligand for ttvP3 integrin, and is the likely candidate 
for in vivo stimulation of growth.
Recents reports show that integrins may physically associate with other cell surface 
receptors, suggesting that signals outside-in signals may be co-ordinated at the cell 
surface as well as downstream of the receptors. Coppolino et al. (1995b) reported that a 
novel isomer of the integrin subunit expressed by a prostate carcinoma cell line was 
covalently associated with the transferrin receptor. Since transferrin transport of iron 
into cells is vital for cell proliferation, tt3 Pi integrin may be involved in regulation of 
proliferation of this type of cell.
Even more significantly, Schneller et al. (1997) reported that ayp 3 integrin physically 
associated with the PDGFp and insulin receptors. The mitogenic and chemotactic 
effects of PDGF-BB were enhanced in cells plated on a vitronectin substrate, which is a 
ligand for ayp3  integrin. This again indicates that integrin activation by ligand binding 
leads to amplification of growth factor signals, and may represent an additional level for 
regulation of cell activity. To date, most mitogen and ECM-stimulated signals are 
thought to converge further downstream in the signaling cascade (reviewed by Dedhar 
and Hannigan, 1996; Giancotti, 1997). However, other growth factor receptors may 
well be recruited into focal adhesion complexes at the cell surface, allowing the 
signaling molecules of the growth factor receptor and integrin to associate and integrate.
Other cell-surface receptors such as the urokinase plasminogen activator receptor 
(uPAR), which binds PA and allows pericellular plasminogen activation, have been 
shown to interact with the leukocyte P2  integrin subunit (Bohuslav et al, 1995). The 
study by Xue et al. (1997), discussed earlier, demonstrated that uPAR is also likely to
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be physically associated with avPs integrin and several Pi integrins on the surface of 
HT1080 cells. uPAR and integrins showed maximal co-localization within focal 
adhesions. The integrin heterodimer which was found in association with uPAR was 
dependent upon the ECM substrate on which the cells were plated, on fibronectin only 
the tt5 integrin subunit co-localized with uPAR, on vitronectin both Oy and a s  integrin 
subunits were co-localized with uPAR. However, the a ,^ integrin subunit was never 
found lo-localized with uPAR on the surface of cells plated onto vitronectin, and no 
uPAR-integrin association at all was observed when cells were plated on polylysine- 
coated coverslips. This suggests that uPAR association with pi and pg integrins is both 
specific and BCM-regulated. Receptor co locahzation was found to be inhibited by N- 
acetyl-D-glucosamine, suggesting that saccharides of the uPA and/or uPAR molecules 
may participate in interreceptor interactions. The functional significance of uPAR 
interactions with integrins is still under intense research (reviewed by Chapman, 1997), 
however, it is thought that uPAR forms a trimolecular complex with P integrin subunits 
(such as Pi integrin) and caveolin, a membrane protein which binds signaling 
molecules. This complex may regulate integrin-ligand binding and integrin signaling. 
Cell adhesion and migration may also be affected by uPAR binding to integrins, 
possibly by the interaction of plasminogen activator inhibitor-1 (PAI-1) with the 
vitronectin-binding domain of uPAR. Integrins may also spatially regulate uPAR 
distribution. Hence, redistribution of the uPAR in response to ECM components could 
provide a mechanism to achieve polarized pericellular plasmin localization and MMP 
activation. In this manner, focused proteolysis of the ECM by plasmin or MMPs may 
lead to upregulation of tumour cell motility. Whether this method of adhesion and 
motility regulation has any in vivo significance has yet to be demonstrated. However, 
high levels of PAI-1 have been correlated with enhanced breast cancer metastasis, 
suggesting that this hypothesis requires fiither investigation.
A much quoted study by Brooks et al. (1996) reported that a matrix metalloproteinase, 
GLA, interacted directly with ttyPs integrin on the surface angiogenic blood vessels of
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chick chorioallantonic membranes and angiogenic tumour-associated blood vessels of 
immunodeficient mice injected with human melanoma cells. In vitro studies performed 
by this group using purified ttyps integrin, chicken GLA and vitronectin supported 
their observations in vivo. The authors suggest that GLA binding to ttyPs integrin leads 
to cooperative protein activities which promote the invasive behaviour of cells during 
tissue remodeling, angiogenesis and metastasis. Deryugina et al. (1997) found that 
ghoma cell attachment to immobilized C-terminal domain of GLA could be blocked by 
an anti-ttyp3 integrin antibody. These authors to suggest that ayPs integrin binding of 
GLA could localize GLA to the cell surface and focus matrix degradation, leading to 
focused proteolytic degradation of the pericellular matrix.
Cell-surface localization of active GLA is not a novel concept. Detection of the 
transmembrane MT MMPs and the discovery that at least one of these (MT-1 MMP) 
can activate GLA, means that integrin binding of GLA simply to sequester it at the cell 
surface could be considered an example of functional redundancy. It is interesting to 
speculate on the physiological significance of direct binding of an active MMP to an 
integrin, and several major question remain to be answered. Would GLA binding to the 
integrin block integrin function as an ECM receptor, either by directly blocking the 
ligand-binding region of the integrin, or by modulating the integrin configuration by 
binding elsewhere on the molecule? Would binding of the C-terminal domain of GLA to 
the integrin interfere with TIMP inhibition of GLA activity, leading to constitutively 
active GLA being bound to the cell surface? Would GLA binding to the integrin 
interfere with integrin signaling, possibly by inhibiting integrin interactions with other 
cell-surface proteins or disrupting focal adhesion complex formation? Since the studies 
presented in this thesis fail to detect any direct interaction between ŒyPg integrin and 
GLA, no futher light has been shed on these questions. Therefore, important issues 
remain to be resolved regarding the direct interaction of GLA with ttyP3 integrin.
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As previously mentioned, Jones et al. (1996b) found that ligation of ttvPa integrin Was 
essential for expression of tenascin-C, which acts in concert with EGF to promote 
smooth muscle cell survival. An interesting feature of this data was the effect of a 
synthetic MMP inhibitor on smooth muscle cell tenascin-C expression. When cells were 
cultured on native type I collagen, the inhibitor suppressed tenascin-C production. 
However, when cells were cultured on heat-denatured type I collagen, the MMP 
inhibitor had no effect on tenascin-C expression. This is most likely due to ttvPa 
integrin binding to the cryptic RGD sites on type I collagen which are exposed by heat- 
denaturation. The authors allude to the work of Brooks et al. (1996), where GLA was 
postulated to bind directly to ttyPa integrin, possibly indicating that GLA may effect 
tenascin-C expression by smooth muscle cells by binding to ayp3 integrin. However, a 
more likely explanation which the authors themselves favour, is that MMP production 
by smooth muscle cells permits localized degradation of ECM components to generate 
RGD-containing ligands which ligate ttyp3 integrin and potentiate tenascin-C
expression.
The wealth of reports showing that MMP upregulation or TIMP downregulation leads 
to an increase in cell invasiveness or tumourogenicity and that downregulation of MMP 
activity by synthetic inhibitors or TIMPs leads to a decrease in tumour cell 
invasiveness, strongly implies that MMPs do have a role in tumour biology. 
Deregulated or inappropriate MMP expression by tumour and/or stromal cells is thought 
to be a major contributory factor to neoplastic transformation, tumour growth and 
metastasis. Despite tumour cell proliferation being contact- and adhesion-independent, 
ECM reniodehng in the vicinity of tumours probably maintains a suitable environment 
for sustained tumour growth. Degradation of ECM components to mitogenic peptides 
and release of EÇM-bound growth factors are just two potential ways that MMP activity 
could potentiate tumour metastasis, survival and growth (Khokha et al., 1992b; Koop 
et al., 1994).
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To enable solid tumour expansion beyond small growths, vascularization of the tumour 
must occur. MMPs such as GLA have been linked to angiogenesis (Gamble et al., 
1993; Brooks et al., 1994; Cornelius et al., 1995) and MMP inhibitors have been 
shown to inhibit angiogenic blood vessel formation (Galardy et al., 1994). Vascular 
endothelial cell induction of GLA expression, or GLA expression by proximal stromal 
cells, may facilitate angiogenesis by clearing sufficient space for new vessel formation. 
Angiogenesis is also dependent on growth factor stimulation of vascular endotheUal 
cells and expression of ttvPs integrin (Kim et al., 1993; Brooks et al., 1994). One 
report has suggested that VEGF could induce collagenase expression by human 
endothelial cells (Unemori et al., 1992). Thus, MMP expression by endothelial cells 
may be necessary but not deregulated during angiogenesis.
Cell responses to changes in the extracellular environment can be mediated by integrins 
and other membrane receptors. The role of these receptors in tumour progression is still 
not completely understood, however, gain and/or loss of receptors for ECM 
components is a feature of some tumours and has been shown to modulate cell adhesion 
and motility (reviewed by Tang and Honn, 1994; Varner and Cheresh, 1996). Perhaps 
an even more significant consequence of changes in integrin receptor occupancy, is the 
effect that modulation of cell-ECM interactions has on integrin-mediated signaling. 
Since integrin signaling has been shown to affect many aspects of cellular activity, such 
as growth, proliferation and survival, loss of signals due to ligand degradation by 
MMPs is possibly more important than simple lack of adhesion to the particular 
degraded ECM protein.
Growth factors and cytokines have also been shown to affect MMP expression, often in 
association with integrin hgation. This may help to explain the observation that MMPs 
are often found to be produced by stromal cells which surround tumours, rather than by 
the tumours themselves. Examples of these phenomena is seen for collagenase-3, 
which has been shown to be upregulated by interleukin-6 (IL-6) in rat osteoblast
1 1 0
cultures (Franchimont et al., 1997), and has been shown to be regulated at the 
expression level by stromal-epithelial cell interactions in human breast carcinomas (Uria 
et al., 1997). Tumour cell proliferation is facilitated in part by tumour expression of 
growth factors and cytokines, wliich permits autocrine stimulation of growth and may 
influence stromal cell protein synthesis. Some studies have also identified soluble 
factors produced by tumour cells which stimulate stromal cells to produce MMPs and 
other proteins (reviewed by MacDougaU and Matrisian, 1995b).
The expression of MMPs by tumour and stromal cells is now known to be under highly 
complex regulation which is inextricably linked to cell interactions with the ECM and 
cell stimulation by growth factors and cytokines. All these processes rely on 
information being passed down signaling cascades and inibition of one component of 
the signal can have an effect on the other components. A recurrent feature of the 
published hterature concerning the interaction of MMPs, growth factors and integrins is 
the feedback mechanisms by which they co-operate. This suggests that novel therapies 
aimed at inhibiting tumour metastasis could be targeted at more subtle aspects of 
tumourogenicity such as tumour cell interations with ECM and stromal cells, rather than 
the obvious ones (e.g. MMP inhibition).
This thesis comprises a detailed study of tt2Pi integrin-mediated interaction with type I 
collagen fragments generated using a specific collagenase, that has been linked with 
pathological conditions such as malignant breast carcinoma. Such studies are vital to 
our understanding of how cells interact with damaged ECM and can give valuable 
insight into pathological conditions where ECM degradation plays an important part in 
disease progression. It is hoped further study of these interactions, particularly with 
reference to elucidating the mechanism by which type I collagen fi*agments upregulate 
cell motility, will contribute to a better understanding of the mechanisms by which 
tumour cells disseminate fiom the primary tumour site and metastasize to other locations 
within the body.
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Chapter 10 
Future Work
AU the assays detailed in this thesis were performed using monomeric type I coUagen 
which is soluble and can be easily adsorbed to ELISA plates or tissue culture plastic. 
However, in vivo, type I collagen assembles into insoluble fibres which cross-link to 
form 3-dimensional lattice structures. It is very important to bear this point in mind 
when extrapolating the results of the monomeric coUagen studies to physiological 
situations. An interesting investigation by Friedl et al (1997) studied the migration of 
MV3 melanoma cells in 3-dimensional collagen gels consisting of polymerized 
monomeric collagen. After incorporation in the lattice, MV3 cells spontaneously 
developed a slow migration which led to alignment of coUagen fibres at attachment 
sites. Leading cells remodeUed the coUagen fibres as they moved along the coUagen 
lattice, allowing neighbouring cells to migrate along pre formed pa±s. The authors 
postulate the the coUagen lattice remodelUng may be due to both tractional forces 
generated by ceUs, which lead to mechanical bending and stretching of the matrix, and 
proteolytic degradation of the coUagen fibres. a 2^i integrin was found to be colocalized 
with ceU binding sites to the coUagen fibres localized at the leading edge of ceUs, and is 
probably the principal ceU surface receptor which mediates MV3 ceU migration through 
type I coUagen lattices. Thus, if  would be very interesting to study the effects of 
collagenase activity on migration of ceUs through type I coUagen gels, possibly by 
utiUzing a ceU Une which highly expresses collagenase. This could be done using time 
lapse video microscopy (discussed below). In addition, it would be of interest to 
localize the periceUular distribution of coUagenase produced by ceUs invading through a 
type I coUagen matrix, since proteinases have been associated with invadopodia and 
where their activity is thought to faciUtate ceU migration (Chen, 1996). This could be 
assessed using immunolocalization and confocal microscopy.
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As mentioned briefly in Chapter 9, a very important feature of this study which remains 
unresolved is the molecular interaction of a iP i integrin with collagenase-generated type 
I collagen fragments in the heat-unwound (melted) conformation. A suitable apparatus 
for directly measuring association of these molecules is the BIAcore (Pharmacia), with 
which the substrate or receptor can be immobilized on a colloidal gold film, and the 
behaviour of the labelled receptor or substrate can be monitored very closely after 
addition to the film. Comparison of the kinetics of a 2Pi integrin interaction with full- 
length, native collagen and the melted collagen fragments would greatly facilitate 
interpretation of the results of the motility assays reported in this study. This type of 
investigation has been performed for intact laminin-1, fragments of laminin-1 and 
purified tt2Pi and ttvPs integrins (Pfaff et al., 1994). These authors used the BIAcore 
biosensor system to show that the binding affinity of the tt2pi integrin to the PI 
fragment of laminin-1 was considerably higher than the binding affinity of the ttvPa 
integrin to the same laminin peptide.
Further to this point, it is necessary to analyse the expression of other ECM surface 
receptors (such as syndecans) in response to coUagenase-cleaved collagen fragments by 
HT1080 cells. This type of receptor may well be very important in mediating cell 
motility over a substrate with which the cells have little or no interaction mediated by 
integrins. Syndecan-1 has been shown to be a type I collagen receptor (Koda and 
Bemfield, 1984) and therefore may mediate cell movement through degraded collagen, 
either directly or in collaboration with integrins (reviewed by Elenius and Jalkanen, 
1994). Cell surface expression of syndecans could be detected by immunolocalization, 
or by Western blotting of cell lysates.
An important tool for comparison of cell-matrix interactions (such as native and 
degraded type I collagen) is time-lapse video microscopy (TVM). This allows analysis 
of the rate of cell movement and also provides visual information regarding cell 
morphology and distribution during migration. Direct comparisons could be made
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between the speed of cell movement over intact type I collagen or the collagen 
fragments. TVM could also provide information regarding cell attachment to the melted 
type I collagen fragments. A particularly question which could be addressed is whether 
collagenase-degradalioii of collagen might directly lead to increased cell motihty by 
ablation of azPi integrin binding sites on type I collagen. This could be tested in the 
presence of chemotactic or haptotactic agents such as fibronectin or laminin-1, or 
alternatively, the effect of collagenase-cleavage of type I collagen on cell motility could 
be studied in the absence of any exogenous motility stimulant.
TVM is also an ideal medium for study of the effects of exogenous MMPs, TIMPs and 
synthetic metalloproteinase inhibitors on cell motility over native and degraded 
substrates. Cells can be monitored for several hours prior to addition of proteinases or 
inhibitors, and their initial and long-term response to these factors recorded and 
analysed. The importance of individual cell-surface ECM receptors during cell motility 
over native or cleaved type I collagen could also be investigated using TVM. Addition 
of anti-integrin antibodies or ligand-mimicking peptides into the culture system during 
film ing may have more subtle or long-term effects on cell motility over collagen than 
can be observed by the invasion assay system used in this study. The role of other cell- 
surface collagen receptors, cell-cell adhesion receptors and growth factors during cell 
motility can also be examined using specific antibodies or inhibitors and TVM. i
The relevance of cell-cell interactions with regard to changes in cell motility over altered '
matrices has not been addressed during these smdles and therefore merits investigation.
Tucker et al. (1990) showed that rat bladder carcinoma cells (NET II cells) cultured on '
type I collagen initially migrated away from an aggregate as an epithelial sheet. Cell-cell 
contacts were maintained during this initial stage of migration. However, after several ;
days in culture on type I collagen, both liver cell adhesion molecule (L-CAM) and a !
desmosomal protein, desmoglein, expression had dramatically dropped. This reduction i
in cell-cell receptors coincided with dispersal of motile cells from the original "halo" of ,
i
;
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cells which had migrated as an epithelial sheet. Interestingly, these authors also noted 
that maintenance of the collagen triple-helical structure was necessary to promote cell 
migration. Neither heat-denatured collagen or CNBr fragments of collagen supported 
cell motility in this case. It would be of great interest to immunolocalize cell-cell 
adhesion molecules, such as the intercellular adhesion molecules (ICAMs) and 
desmosomal proteins, following NBTII cell culture on native and collagenase-cleaved 
collagen fragments.
The "outside-in" signals generated by cell interactions with native versus substrates 
such as type I collagen are of particular interest, since these might well influence the 
induction of cell motility or eventual cell death. It is possible that integrin-mediated 
signals transduced in response to the denatured substrate, or as a result of receptor 
vacancy, may well be different from the signal transduced in response to contact with 
intact type I collagen. This may be the case during keratinocyte migration in the 
provisional wound environment, where degradation of the type I collagen by 
collagenase-1 both facilitates and obhges cell motility over a collagen matrix (Pilcher et 
al., 1997).
It has been shown that the loss of integrin-mediated cell-matrix contact can induce 
apoptosis (specifically termed "anoikis" in this context; reviewed by Frisch et al. 
(1996)). It would be of great interest to explore the effects of long term culture of cells 
on the melted collagen fragments and compare the signals generated by this 
environment with those generated by culture on the native coUagen molecule. If ceUs 
failed to form appropriate contact with the melted fragments during culture it is possible 
that normal ceU activities might be prevented, possibly leading to anoikitic ceU death. 
However, adhesion-independent cell proliferation is a feature of neoplastic 
transformation, and therefore it would be important to assess growth of normal and 
transformed ceUs on native collagen and the melted coUagen fragments. Integrin- 
mediated signahng is the likely stimulus which triggers anoikis, although the signaling
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pathway (s) which may be involved are not yet well understood. The role ofFA K and 
other, downstream, cell signaling molecules such as protein kinase C (PKC) or tyrosine 
kinases could be investigated using reagents such as calphostin or herbimycin A, which 
specifically block the PKC and tyrosine kinase signaling pathways respectively. By this 
means it might be possible to elucidate the signaling mechanisms which are important 
for cell activities such as motihty and/or survival.
Another aspect of cell regulation of motility and adhesion which would be interesting to 
explore is the effect of the expression of the null mutation of integrin in mice. 
Ablation of the pi subunit prevented the cell-surface expression of mutiple integrin 
heterodimers, disrupting early embryonic development and leading to foetal death 
(Fassler and Meyer, 1995a). Most of the integrin a  subunit-null mice produced to date 
also die during embryogenesis or shortly after birth (reviewed by Fassler et al., 1996). 
However, studies that have "knocked-out" the a i  and ag integrin subunits have shown 
that the resulting mice show no phenotype after loss of the a i  integrin (Gardner et al., 
1996), and only a mild phenotype after loss of the ag integrin (DiPersio et al., 1997). 
This strongly suggests that the overlap in integrin ligand specificity can compensate for 
the loss of individual integrin heterodimers during development. Although the « 2  
integrin subunit has yet to be knocked-out in a mouse model, a single example of a 
spontaneous reduction in human platelet tt2 integrin expression has been reported 
(Nieuwenhuis et al., 1985). This patient suffered from a bleeding disorder which was 
attributed to the lack of platelet interaction with type I collagen. Therefore, it might be 
predicted that a 2-null mutant mice would develop and survive beyond birth. However, 
it would be interesting to study the effect of the mutation on events in the adult animal 
which are known to be partly mediated by tt2Pi integrin, such as platelet interaction 
with damaged vasculature.
Future studies, utilising methods such as the ones detailed above, are aimed at 
broadening our knowledge about the effects of MMP-degradation of type I collagen on
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cell behaviour. However, these investigations could be extended to analyse the effects 
of MMP cleavage of other components of the provisional wound healing matrix. 
Particular emphasis would be placed on the effect of MMPs on cell interactions with 
fibrinogen, thrombospondin, fibronectin and tenascin, which are all important 
components of the healing wound (reviewed by Yamada and Clark, 1996). Since type 
rv  collagen and laminin-1 are major constituents of basement membranes, it would be 
of great interest to investigate tumour cell interactions with the cleaved substrates, such 
as might be found during tumour cell metastasis. Studies are focused on aquiring a 
more detailed understanding of the pathways by which cells receive information and 
respond to dramatic changes in their microenvironment, such as proteolytic degradation 
of their substrate. The results of these in vitro studies can then be tentatively applied to 
the in vivo stituation and potential theraputic targets.
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